id	sid	tid	token	lemma	pos
ajmsi-2312	1	1	pa	pa	PROPN
ajmsi-2312	1	2	ge	ge	PROPN
ajmsi-2312	1	3	1	1	NUM
ajmsi-2312	1	4	pa	pa	PROPN
ajmsi-2312	1	5	ge	ge	PROPN
ajmsi-2312	1	6	1	1	NUM
ajmsi-2312	1	7	american	american	PROPN
ajmsi-2312	1	8	journal	journal	PROPN
ajmsi-2312	1	9	of	of	ADP
ajmsi-2312	1	10	medical	medical	ADJ
ajmsi-2312	1	11	science	science	NOUN
ajmsi-2312	1	12	and	and	CCONJ
ajmsi-2312	1	13	innovation	innovation	NOUN
ajmsi-2312	1	14	(	(	PUNCT
ajmsi-2312	1	15	ajmsi	ajmsi	NOUN
ajmsi-2312	1	16	)	)	PUNCT
ajmsi-2312	1	17	approach	approach	NOUN
ajmsi-2312	1	18	to	to	ADP
ajmsi-2312	1	19	the	the	DET
ajmsi-2312	1	20	diagnosis	diagnosis	NOUN
ajmsi-2312	1	21	and	and	CCONJ
ajmsi-2312	1	22	management	management	NOUN
ajmsi-2312	1	23	of	of	ADP
ajmsi-2312	1	24	essential	essential	ADJ
ajmsi-2312	1	25	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	1	26	in	in	ADP
ajmsi-2312	1	27	a	a	DET
ajmsi-2312	1	28	resource	resource	NOUN
ajmsi-2312	1	29	-	-	PUNCT
ajmsi-2312	1	30	limited	limit	VERB
ajmsi-2312	1	31	setting	setting	NOUN
ajmsi-2312	1	32	vonwicks	vonwick	NOUN
ajmsi-2312	1	33	c.	c.	PROPN
ajmsi-2312	1	34	onyango1	onyango1	PROPN
ajmsi-2312	1	35	*	*	PROPN
ajmsi-2312	1	36	,	,	PUNCT
ajmsi-2312	1	37	anne	anne	PROPN
ajmsi-2312	1	38	w.	w.	PROPN
ajmsi-2312	1	39	theuri1	theuri1	PROPN
ajmsi-2312	1	40	,	,	PUNCT
ajmsi-2312	1	41	samuel	samuel	PROPN
ajmsi-2312	1	42	m.	m.	PROPN
ajmsi-2312	1	43	gachie1	gachie1	PROPN
ajmsi-2312	1	44	,	,	PUNCT
ajmsi-2312	1	45	collins	collins	PROPN
ajmsi-2312	1	46	p.	p.	PROPN
ajmsi-2312	1	47	malalu1	malalu1	PROPN
ajmsi-2312	1	48	,	,	PUNCT
ajmsi-2312	1	49	william	william	PROPN
ajmsi-2312	1	50	c.	c.	PROPN
ajmsi-2312	1	51	fryda1	fryda1	PROPN
ajmsi-2312	1	52	volume	volume	NOUN
ajmsi-2312	1	53	3	3	NUM
ajmsi-2312	1	54	issue	issue	NOUN
ajmsi-2312	1	55	1	1	NUM
ajmsi-2312	1	56	,	,	PUNCT
ajmsi-2312	1	57	year	year	NOUN
ajmsi-2312	1	58	2024	2024	NUM
ajmsi-2312	1	59	issn	issn	X
ajmsi-2312	1	60	:	:	PUNCT
ajmsi-2312	1	61	2836	2836	NUM
ajmsi-2312	1	62	-	-	SYM
ajmsi-2312	1	63	8509	8509	NUM
ajmsi-2312	1	64	(	(	PUNCT
ajmsi-2312	1	65	online	online	ADJ
ajmsi-2312	1	66	)	)	PUNCT
ajmsi-2312	1	67	doi	doi	NOUN
ajmsi-2312	1	68	:	:	PUNCT
ajmsi-2312	1	69	https://doi.org/10.54536/ajmsi.v3i1.2312	https://doi.org/10.54536/ajmsi.v3i1.2312	PROPN
ajmsi-2312	1	70	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	1	71	article	article	NOUN
ajmsi-2312	1	72	information	information	NOUN
ajmsi-2312	1	73	abstract	abstract	ADV
ajmsi-2312	1	74	received	receive	VERB
ajmsi-2312	1	75	:	:	PUNCT
ajmsi-2312	1	76	december	december	PROPN
ajmsi-2312	1	77	02	02	NUM
ajmsi-2312	1	78	,	,	PUNCT
ajmsi-2312	1	79	2023	2023	NUM
ajmsi-2312	1	80	accepted	accept	VERB
ajmsi-2312	1	81	:	:	PUNCT
ajmsi-2312	1	82	december	december	PROPN
ajmsi-2312	1	83	29	29	NUM
ajmsi-2312	1	84	,	,	PUNCT
ajmsi-2312	1	85	2023	2023	NUM
ajmsi-2312	1	86	published	publish	VERB
ajmsi-2312	1	87	:	:	PUNCT
ajmsi-2312	1	88	january	january	PROPN
ajmsi-2312	1	89	02	02	NUM
ajmsi-2312	1	90	,	,	PUNCT
ajmsi-2312	1	91	2024	2024	NUM
ajmsi-2312	1	92	essential	essential	ADJ
ajmsi-2312	1	93	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	1	94	(	(	PUNCT
ajmsi-2312	1	95	et	et	NOUN
ajmsi-2312	1	96	)	)	PUNCT
ajmsi-2312	1	97	is	be	AUX
ajmsi-2312	1	98	a	a	DET
ajmsi-2312	1	99	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	1	100	neoplasm	neoplasm	NOUN
ajmsi-2312	1	101	(	(	PUNCT
ajmsi-2312	1	102	together	together	ADV
ajmsi-2312	1	103	with	with	ADP
ajmsi-2312	1	104	polycythemia	polycythemia	NOUN
ajmsi-2312	1	105	vera	vera	NOUN
ajmsi-2312	1	106	,	,	PUNCT
ajmsi-2312	1	107	chronic	chronic	ADJ
ajmsi-2312	1	108	myelogenous	myelogenous	ADJ
ajmsi-2312	1	109	leukemia	leukemia	NOUN
ajmsi-2312	1	110	,	,	PUNCT
ajmsi-2312	1	111	and	and	CCONJ
ajmsi-2312	1	112	primary	primary	ADJ
ajmsi-2312	1	113	myelofibrosis	myelofibrosis	NOUN
ajmsi-2312	1	114	)	)	PUNCT
ajmsi-2312	1	115	characterized	characterize	VERB
ajmsi-2312	1	116	by	by	ADP
ajmsi-2312	1	117	clonal	clonal	ADJ
ajmsi-2312	1	118	proliferation	proliferation	NOUN
ajmsi-2312	1	119	of	of	ADP
ajmsi-2312	1	120	megakaryocytes	megakaryocyte	NOUN
ajmsi-2312	1	121	,	,	PUNCT
ajmsi-2312	1	122	usually	usually	ADV
ajmsi-2312	1	123	due	due	ADP
ajmsi-2312	1	124	to	to	ADP
ajmsi-2312	1	125	the	the	DET
ajmsi-2312	1	126	presence	presence	NOUN
ajmsi-2312	1	127	of	of	ADP
ajmsi-2312	1	128	jak2	jak2	PROPN
ajmsi-2312	1	129	,	,	PUNCT
ajmsi-2312	1	130	calr	calr	PROPN
ajmsi-2312	1	131	,	,	PUNCT
ajmsi-2312	1	132	or	or	CCONJ
ajmsi-2312	1	133	mpl	mpl	NOUN
ajmsi-2312	1	134	mutations	mutation	NOUN
ajmsi-2312	1	135	.	.	PUNCT
ajmsi-2312	2	1	whereas	whereas	SCONJ
ajmsi-2312	2	2	a	a	DET
ajmsi-2312	2	3	bone	bone	NOUN
ajmsi-2312	2	4	marrow	marrow	NOUN
ajmsi-2312	2	5	aspirate	aspirate	NOUN
ajmsi-2312	2	6	and	and	CCONJ
ajmsi-2312	2	7	genetic	genetic	ADJ
ajmsi-2312	2	8	testing	testing	NOUN
ajmsi-2312	2	9	for	for	ADP
ajmsi-2312	2	10	these	these	DET
ajmsi-2312	2	11	mutations	mutation	NOUN
ajmsi-2312	2	12	are	be	AUX
ajmsi-2312	2	13	necessary	necessary	ADJ
ajmsi-2312	2	14	for	for	ADP
ajmsi-2312	2	15	an	an	DET
ajmsi-2312	2	16	accurate	accurate	ADJ
ajmsi-2312	2	17	diagnosis	diagnosis	NOUN
ajmsi-2312	2	18	of	of	ADP
ajmsi-2312	2	19	et	et	NOUN
ajmsi-2312	2	20	,	,	PUNCT
ajmsi-2312	2	21	in	in	ADP
ajmsi-2312	2	22	resource	resource	NOUN
ajmsi-2312	2	23	-	-	PUNCT
ajmsi-2312	2	24	limited	limit	VERB
ajmsi-2312	2	25	settings	setting	NOUN
ajmsi-2312	2	26	,	,	PUNCT
ajmsi-2312	2	27	these	these	PRON
ajmsi-2312	2	28	are	be	AUX
ajmsi-2312	2	29	often	often	ADV
ajmsi-2312	2	30	either	either	CCONJ
ajmsi-2312	2	31	inaccessible	inaccessible	ADJ
ajmsi-2312	2	32	or	or	CCONJ
ajmsi-2312	2	33	limited	limit	VERB
ajmsi-2312	2	34	by	by	ADP
ajmsi-2312	2	35	prohibitive	prohibitive	ADJ
ajmsi-2312	2	36	costs	cost	NOUN
ajmsi-2312	2	37	.	.	PUNCT
ajmsi-2312	3	1	a	a	DET
ajmsi-2312	3	2	nuanced	nuanced	ADJ
ajmsi-2312	3	3	clinical	clinical	ADJ
ajmsi-2312	3	4	approach	approach	NOUN
ajmsi-2312	3	5	is	be	AUX
ajmsi-2312	3	6	necessary	necessary	ADJ
ajmsi-2312	3	7	to	to	PART
ajmsi-2312	3	8	diagnose	diagnose	VERB
ajmsi-2312	3	9	and	and	CCONJ
ajmsi-2312	3	10	manage	manage	VERB
ajmsi-2312	3	11	et	et	NOUN
ajmsi-2312	3	12	in	in	ADP
ajmsi-2312	3	13	these	these	DET
ajmsi-2312	3	14	settings	setting	NOUN
ajmsi-2312	3	15	.	.	PUNCT
ajmsi-2312	4	1	in	in	ADP
ajmsi-2312	4	2	this	this	DET
ajmsi-2312	4	3	study	study	NOUN
ajmsi-2312	4	4	,	,	PUNCT
ajmsi-2312	4	5	we	we	PRON
ajmsi-2312	4	6	present	present	VERB
ajmsi-2312	4	7	a	a	DET
ajmsi-2312	4	8	case	case	NOUN
ajmsi-2312	4	9	of	of	ADP
ajmsi-2312	4	10	et	et	NOUN
ajmsi-2312	4	11	diagnosed	diagnose	VERB
ajmsi-2312	4	12	and	and	CCONJ
ajmsi-2312	4	13	managed	manage	VERB
ajmsi-2312	4	14	in	in	ADP
ajmsi-2312	4	15	a	a	DET
ajmsi-2312	4	16	resource	resource	NOUN
ajmsi-2312	4	17	-	-	PUNCT
ajmsi-2312	4	18	limited	limit	VERB
ajmsi-2312	4	19	rural	rural	ADJ
ajmsi-2312	4	20	setting	setting	NOUN
ajmsi-2312	4	21	in	in	ADP
ajmsi-2312	4	22	kenya	kenya	NOUN
ajmsi-2312	4	23	with	with	ADP
ajmsi-2312	4	24	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	4	25	and	and	CCONJ
ajmsi-2312	4	26	aspirin	aspirin	NOUN
ajmsi-2312	4	27	.	.	PUNCT
ajmsi-2312	5	1	we	we	PRON
ajmsi-2312	5	2	highlight	highlight	VERB
ajmsi-2312	5	3	the	the	DET
ajmsi-2312	5	4	importance	importance	NOUN
ajmsi-2312	5	5	of	of	ADP
ajmsi-2312	5	6	individualized	individualized	ADJ
ajmsi-2312	5	7	therapeutic	therapeutic	ADJ
ajmsi-2312	5	8	targets	target	NOUN
ajmsi-2312	5	9	,	,	PUNCT
ajmsi-2312	5	10	the	the	DET
ajmsi-2312	5	11	challenges	challenge	NOUN
ajmsi-2312	5	12	with	with	ADP
ajmsi-2312	5	13	dose	dose	NOUN
ajmsi-2312	5	14	adjustments	adjustment	NOUN
ajmsi-2312	5	15	in	in	ADP
ajmsi-2312	5	16	the	the	DET
ajmsi-2312	5	17	setting	setting	NOUN
ajmsi-2312	5	18	of	of	ADP
ajmsi-2312	5	19	hydroxyurea	hydroxyurea	ADV
ajmsi-2312	5	20	-	-	PUNCT
ajmsi-2312	5	21	induced	induce	VERB
ajmsi-2312	5	22	neutropenia	neutropenia	NOUN
ajmsi-2312	5	23	,	,	PUNCT
ajmsi-2312	5	24	and	and	CCONJ
ajmsi-2312	5	25	how	how	SCONJ
ajmsi-2312	5	26	extrapolated	extrapolated	ADJ
ajmsi-2312	5	27	data	datum	NOUN
ajmsi-2312	5	28	from	from	ADP
ajmsi-2312	5	29	the	the	DET
ajmsi-2312	5	30	use	use	NOUN
ajmsi-2312	5	31	of	of	ADP
ajmsi-2312	5	32	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	5	33	elsewhere	elsewhere	ADV
ajmsi-2312	5	34	may	may	AUX
ajmsi-2312	5	35	help	help	VERB
ajmsi-2312	5	36	guide	guide	VERB
ajmsi-2312	5	37	such	such	ADJ
ajmsi-2312	5	38	dose	dose	NOUN
ajmsi-2312	5	39	adjustments	adjustment	NOUN
ajmsi-2312	5	40	.	.	PUNCT
ajmsi-2312	6	1	finally	finally	ADV
ajmsi-2312	6	2	,	,	PUNCT
ajmsi-2312	6	3	we	we	PRON
ajmsi-2312	6	4	propose	propose	VERB
ajmsi-2312	6	5	a	a	DET
ajmsi-2312	6	6	rationalized	rationalized	ADJ
ajmsi-2312	6	7	approach	approach	NOUN
ajmsi-2312	6	8	to	to	ADP
ajmsi-2312	6	9	treating	treat	VERB
ajmsi-2312	6	10	et	et	PRON
ajmsi-2312	6	11	in	in	ADP
ajmsi-2312	6	12	a	a	DET
ajmsi-2312	6	13	resource	resource	NOUN
ajmsi-2312	6	14	-	-	PUNCT
ajmsi-2312	6	15	limited	limit	VERB
ajmsi-2312	6	16	clinical	clinical	ADJ
ajmsi-2312	6	17	setting	setting	NOUN
ajmsi-2312	6	18	.	.	PUNCT
ajmsi-2312	7	1	keywords	keyword	NOUN
ajmsi-2312	7	2	essential	essential	ADJ
ajmsi-2312	7	3	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	7	4	,	,	PUNCT
ajmsi-2312	7	5	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	7	6	neoplasms	neoplasm	NOUN
ajmsi-2312	7	7	,	,	PUNCT
ajmsi-2312	7	8	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	7	9	,	,	PUNCT
ajmsi-2312	7	10	aspirin	aspirin	NOUN
ajmsi-2312	7	11	,	,	PUNCT
ajmsi-2312	7	12	hydroxyurea	hydroxyurea	ADV
ajmsi-2312	7	13	-	-	PUNCT
ajmsi-2312	7	14	induced	induce	VERB
ajmsi-2312	7	15	neutropenia	neutropenia	NOUN
ajmsi-2312	7	16	,	,	PUNCT
ajmsi-2312	7	17	vasomotor	vasomotor	NOUN
ajmsi-2312	7	18	symptoms	symptom	NOUN
ajmsi-2312	7	19	,	,	PUNCT
ajmsi-2312	7	20	thrombohemorrhagic	thrombohemorrhagic	NOUN
ajmsi-2312	7	21	complications	complication	NOUN
ajmsi-2312	7	22	,	,	PUNCT
ajmsi-2312	7	23	kenya	kenya	PROPN
ajmsi-2312	7	24	1	1	NUM
ajmsi-2312	7	25	st	st	PROPN
ajmsi-2312	7	26	.	.	PROPN
ajmsi-2312	7	27	joseph	joseph	PROPN
ajmsi-2312	7	28	rift	rift	PROPN
ajmsi-2312	7	29	valley	valley	PROPN
ajmsi-2312	7	30	hospital	hospital	NOUN
ajmsi-2312	7	31	,	,	PUNCT
ajmsi-2312	7	32	gilgil	gilgil	NOUN
ajmsi-2312	7	33	,	,	PUNCT
ajmsi-2312	7	34	nakuru	nakuru	PROPN
ajmsi-2312	7	35	county	county	PROPN
ajmsi-2312	7	36	,	,	PUNCT
ajmsi-2312	7	37	kenya	kenya	PROPN
ajmsi-2312	7	38	*	*	PUNCT
ajmsi-2312	7	39	corresponding	correspond	VERB
ajmsi-2312	7	40	author	author	NOUN
ajmsi-2312	7	41	’s	’s	PART
ajmsi-2312	7	42	e	e	NOUN
ajmsi-2312	7	43	-	-	NOUN
ajmsi-2312	7	44	mail	mail	NOUN
ajmsi-2312	7	45	:	:	PUNCT
ajmsi-2312	8	1	drvonczelo@gmail.com	drvonczelo@gmail.com	X
ajmsi-2312	8	2	introduction	introduction	NOUN
ajmsi-2312	8	3	essential	essential	ADJ
ajmsi-2312	8	4	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	8	5	(	(	PUNCT
ajmsi-2312	8	6	et	et	NOUN
ajmsi-2312	8	7	)	)	PUNCT
ajmsi-2312	8	8	,	,	PUNCT
ajmsi-2312	8	9	also	also	ADV
ajmsi-2312	8	10	called	call	VERB
ajmsi-2312	8	11	essential	essential	ADJ
ajmsi-2312	8	12	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	8	13	or	or	CCONJ
ajmsi-2312	8	14	primary	primary	ADJ
ajmsi-2312	8	15	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	8	16	,	,	PUNCT
ajmsi-2312	8	17	is	be	AUX
ajmsi-2312	8	18	one	one	NUM
ajmsi-2312	8	19	of	of	ADP
ajmsi-2312	8	20	the	the	DET
ajmsi-2312	8	21	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	8	22	neoplasms	neoplasm	NOUN
ajmsi-2312	8	23	(	(	PUNCT
ajmsi-2312	8	24	mpn	mpn	NOUN
ajmsi-2312	8	25	)	)	PUNCT
ajmsi-2312	8	26	whose	whose	DET
ajmsi-2312	8	27	hallmark	hallmark	NOUN
ajmsi-2312	8	28	is	be	AUX
ajmsi-2312	8	29	the	the	DET
ajmsi-2312	8	30	clonal	clonal	ADJ
ajmsi-2312	8	31	proliferation	proliferation	NOUN
ajmsi-2312	8	32	of	of	ADP
ajmsi-2312	8	33	various	various	ADJ
ajmsi-2312	8	34	myeloid	myeloid	ADJ
ajmsi-2312	8	35	cells	cell	NOUN
ajmsi-2312	8	36	with	with	ADP
ajmsi-2312	8	37	varying	vary	VERB
ajmsi-2312	8	38	morphology	morphology	NOUN
ajmsi-2312	8	39	,	,	PUNCT
ajmsi-2312	8	40	maturity	maturity	NOUN
ajmsi-2312	8	41	,	,	PUNCT
ajmsi-2312	8	42	and	and	CCONJ
ajmsi-2312	8	43	efficiency	efficiency	NOUN
ajmsi-2312	8	44	.	.	PUNCT
ajmsi-2312	9	1	the	the	DET
ajmsi-2312	9	2	other	other	ADJ
ajmsi-2312	9	3	main	main	ADJ
ajmsi-2312	9	4	mpns	mpns	NOUN
ajmsi-2312	9	5	are	be	AUX
ajmsi-2312	9	6	polycythemia	polycythemia	NOUN
ajmsi-2312	9	7	vera	vera	NOUN
ajmsi-2312	9	8	(	(	PUNCT
ajmsi-2312	9	9	pv	pv	NOUN
ajmsi-2312	9	10	)	)	PUNCT
ajmsi-2312	9	11	,	,	PUNCT
ajmsi-2312	9	12	chronic	chronic	ADJ
ajmsi-2312	9	13	myelogenous	myelogenous	ADJ
ajmsi-2312	9	14	leukemia	leukemia	NOUN
ajmsi-2312	9	15	(	(	PUNCT
ajmsi-2312	9	16	cml	cml	PROPN
ajmsi-2312	9	17	)	)	PUNCT
ajmsi-2312	9	18	,	,	PUNCT
ajmsi-2312	9	19	and	and	CCONJ
ajmsi-2312	9	20	primary	primary	ADJ
ajmsi-2312	9	21	myelofibrosis	myelofibrosis	NOUN
ajmsi-2312	9	22	(	(	PUNCT
ajmsi-2312	9	23	pmf	pmf	NOUN
ajmsi-2312	9	24	)	)	PUNCT
ajmsi-2312	9	25	(	(	PUNCT
ajmsi-2312	9	26	arber	arber	PROPN
ajmsi-2312	9	27	et	et	PROPN
ajmsi-2312	9	28	al	al	PROPN
ajmsi-2312	9	29	.	.	PROPN
ajmsi-2312	9	30	,	,	PUNCT
ajmsi-2312	9	31	2016	2016	NUM
ajmsi-2312	9	32	)	)	PUNCT
ajmsi-2312	9	33	.	.	PUNCT
ajmsi-2312	10	1	et	et	PROPN
ajmsi-2312	10	2	is	be	AUX
ajmsi-2312	10	3	characterized	characterize	VERB
ajmsi-2312	10	4	by	by	ADP
ajmsi-2312	10	5	sustained	sustained	ADJ
ajmsi-2312	10	6	megakaryocyte	megakaryocyte	NOUN
ajmsi-2312	10	7	proliferation	proliferation	NOUN
ajmsi-2312	10	8	that	that	PRON
ajmsi-2312	10	9	leads	lead	VERB
ajmsi-2312	10	10	to	to	ADP
ajmsi-2312	10	11	increased	increase	VERB
ajmsi-2312	10	12	numbers	number	NOUN
ajmsi-2312	10	13	of	of	ADP
ajmsi-2312	10	14	circulating	circulate	VERB
ajmsi-2312	10	15	platelets	platelet	NOUN
ajmsi-2312	10	16	,	,	PUNCT
ajmsi-2312	10	17	often	often	ADV
ajmsi-2312	10	18	of	of	ADP
ajmsi-2312	10	19	various	various	ADJ
ajmsi-2312	10	20	sizes	size	NOUN
ajmsi-2312	10	21	(	(	PUNCT
ajmsi-2312	10	22	platelet	platelet	NOUN
ajmsi-2312	10	23	anisocytosis	anisocytosis	NOUN
ajmsi-2312	10	24	)	)	PUNCT
ajmsi-2312	10	25	.	.	PUNCT
ajmsi-2312	11	1	figure	figure	NOUN
ajmsi-2312	11	2	1	1	NUM
ajmsi-2312	11	3	,	,	PUNCT
ajmsi-2312	11	4	panel	panel	NOUN
ajmsi-2312	11	5	by	by	ADP
ajmsi-2312	11	6	schafer	schafer	PROPN
ajmsi-2312	11	7	et	et	PROPN
ajmsi-2312	11	8	al	al	PROPN
ajmsi-2312	11	9	.	.	PROPN
ajmsi-2312	11	10	,	,	PUNCT
ajmsi-2312	11	11	shows	show	VERB
ajmsi-2312	11	12	the	the	DET
ajmsi-2312	11	13	appearance	appearance	NOUN
ajmsi-2312	11	14	of	of	ADP
ajmsi-2312	11	15	et	et	NOUN
ajmsi-2312	11	16	on	on	ADP
ajmsi-2312	11	17	a	a	DET
ajmsi-2312	11	18	peripheral	peripheral	ADJ
ajmsi-2312	11	19	blood	blood	NOUN
ajmsi-2312	11	20	film	film	NOUN
ajmsi-2312	11	21	and	and	CCONJ
ajmsi-2312	11	22	on	on	ADP
ajmsi-2312	11	23	a	a	DET
ajmsi-2312	11	24	bone	bone	NOUN
ajmsi-2312	11	25	marrow	marrow	NOUN
ajmsi-2312	11	26	assay	assay	VERB
ajmsi-2312	11	27	.	.	PUNCT
ajmsi-2312	12	1	(	(	PUNCT
ajmsi-2312	12	2	tefferi	tefferi	PROPN
ajmsi-2312	12	3	&	&	CCONJ
ajmsi-2312	12	4	pardanani	pardanani	PROPN
ajmsi-2312	12	5	,	,	PUNCT
ajmsi-2312	12	6	2019	2019	NUM
ajmsi-2312	12	7	)	)	PUNCT
ajmsi-2312	12	8	.	.	PUNCT
ajmsi-2312	13	1	approximately	approximately	ADV
ajmsi-2312	13	2	85	85	NUM
ajmsi-2312	13	3	-	-	SYM
ajmsi-2312	13	4	90	90	NUM
ajmsi-2312	13	5	%	%	NOUN
ajmsi-2312	13	6	of	of	ADP
ajmsi-2312	13	7	patients	patient	NOUN
ajmsi-2312	13	8	with	with	ADP
ajmsi-2312	13	9	mpns	mpns	NOUN
ajmsi-2312	13	10	will	will	AUX
ajmsi-2312	13	11	demonstrate	demonstrate	VERB
ajmsi-2312	13	12	mutually	mutually	ADV
ajmsi-2312	13	13	exclusive	exclusive	ADJ
ajmsi-2312	13	14	mutations	mutation	NOUN
ajmsi-2312	13	15	in	in	ADP
ajmsi-2312	13	16	the	the	DET
ajmsi-2312	13	17	jak2	jak2	NOUN
ajmsi-2312	13	18	(	(	PUNCT
ajmsi-2312	13	19	60	60	NUM
ajmsi-2312	13	20	-	-	SYM
ajmsi-2312	13	21	65	65	NUM
ajmsi-2312	13	22	%	%	NOUN
ajmsi-2312	13	23	)	)	PUNCT
ajmsi-2312	13	24	,	,	PUNCT
ajmsi-2312	13	25	calr	calr	NOUN
ajmsi-2312	13	26	(	(	PUNCT
ajmsi-2312	13	27	20	20	NUM
ajmsi-2312	13	28	-	-	SYM
ajmsi-2312	13	29	25	25	NUM
ajmsi-2312	13	30	%	%	NOUN
ajmsi-2312	13	31	)	)	PUNCT
ajmsi-2312	13	32	,	,	PUNCT
ajmsi-2312	13	33	or	or	CCONJ
ajmsi-2312	13	34	mpl	mpl	NOUN
ajmsi-2312	13	35	(	(	PUNCT
ajmsi-2312	13	36	5	5	NUM
ajmsi-2312	13	37	%	%	NOUN
ajmsi-2312	13	38	)	)	PUNCT
ajmsi-2312	13	39	genes	gene	NOUN
ajmsi-2312	13	40	(	(	PUNCT
ajmsi-2312	13	41	cazzola	cazzola	PROPN
ajmsi-2312	13	42	&	&	CCONJ
ajmsi-2312	13	43	kralovics	kralovics	PROPN
ajmsi-2312	13	44	,	,	PUNCT
ajmsi-2312	13	45	2014	2014	NUM
ajmsi-2312	13	46	;	;	PUNCT
ajmsi-2312	13	47	klampfl	klampfl	PROPN
ajmsi-2312	13	48	et	et	PROPN
ajmsi-2312	13	49	al	al	PROPN
ajmsi-2312	13	50	.	.	PROPN
ajmsi-2312	13	51	,	,	PUNCT
ajmsi-2312	13	52	2013	2013	NUM
ajmsi-2312	13	53	;	;	PUNCT
ajmsi-2312	13	54	nielsen	nielsen	PROPN
ajmsi-2312	13	55	et	et	PROPN
ajmsi-2312	13	56	al	al	PROPN
ajmsi-2312	13	57	.	.	PROPN
ajmsi-2312	13	58	,	,	PUNCT
ajmsi-2312	13	59	2013	2013	NUM
ajmsi-2312	13	60	)	)	PUNCT
ajmsi-2312	13	61	.	.	PUNCT
ajmsi-2312	14	1	about	about	ADV
ajmsi-2312	14	2	10	10	NUM
ajmsi-2312	14	3	-	-	SYM
ajmsi-2312	14	4	15	15	NUM
ajmsi-2312	14	5	%	%	NOUN
ajmsi-2312	14	6	of	of	ADP
ajmsi-2312	14	7	patients	patient	NOUN
ajmsi-2312	14	8	have	have	VERB
ajmsi-2312	14	9	no	no	DET
ajmsi-2312	14	10	such	such	ADJ
ajmsi-2312	14	11	mutations	mutation	NOUN
ajmsi-2312	14	12	(	(	PUNCT
ajmsi-2312	14	13	the	the	DET
ajmsi-2312	14	14	so	so	ADV
ajmsi-2312	14	15	-	-	PUNCT
ajmsi-2312	14	16	called	call	VERB
ajmsi-2312	14	17	‘	'	PUNCT
ajmsi-2312	14	18	triple	triple	ADJ
ajmsi-2312	14	19	-	-	PUNCT
ajmsi-2312	14	20	negative	negative	ADJ
ajmsi-2312	14	21	’	'	PUNCT
ajmsi-2312	14	22	)	)	PUNCT
ajmsi-2312	15	1	(	(	PUNCT
ajmsi-2312	15	2	tefferi	tefferi	ADV
ajmsi-2312	15	3	et	et	PROPN
ajmsi-2312	15	4	al	al	PROPN
ajmsi-2312	15	5	.	.	PROPN
ajmsi-2312	15	6	,	,	PUNCT
ajmsi-2312	15	7	2014	2014	NUM
ajmsi-2312	15	8	)	)	PUNCT
ajmsi-2312	15	9	.	.	PUNCT
ajmsi-2312	16	1	et	et	PROPN
ajmsi-2312	16	2	constitutes	constitute	VERB
ajmsi-2312	16	3	approximately	approximately	ADV
ajmsi-2312	16	4	a	a	DET
ajmsi-2312	16	5	third	third	NOUN
ajmsi-2312	16	6	of	of	ADP
ajmsi-2312	16	7	all	all	DET
ajmsi-2312	16	8	cases	case	NOUN
ajmsi-2312	16	9	of	of	ADP
ajmsi-2312	16	10	mpns	mpns	NOUN
ajmsi-2312	16	11	in	in	ADP
ajmsi-2312	16	12	developed	develop	VERB
ajmsi-2312	16	13	countries	country	NOUN
ajmsi-2312	16	14	,	,	PUNCT
ajmsi-2312	16	15	with	with	ADP
ajmsi-2312	16	16	a	a	DET
ajmsi-2312	16	17	median	median	ADJ
ajmsi-2312	16	18	age	age	NOUN
ajmsi-2312	16	19	at	at	ADP
ajmsi-2312	16	20	diagnosis	diagnosis	NOUN
ajmsi-2312	16	21	of	of	ADP
ajmsi-2312	16	22	60	60	NUM
ajmsi-2312	16	23	years	year	NOUN
ajmsi-2312	16	24	.	.	PUNCT
ajmsi-2312	17	1	most	most	ADJ
ajmsi-2312	17	2	patients	patient	NOUN
ajmsi-2312	17	3	enjoy	enjoy	VERB
ajmsi-2312	17	4	a	a	DET
ajmsi-2312	17	5	normal	normal	ADJ
ajmsi-2312	17	6	life	life	NOUN
ajmsi-2312	17	7	expectancy	expectancy	NOUN
ajmsi-2312	17	8	,	,	PUNCT
ajmsi-2312	17	9	but	but	CCONJ
ajmsi-2312	17	10	survival	survival	NOUN
ajmsi-2312	17	11	is	be	AUX
ajmsi-2312	17	12	decreased	decrease	VERB
ajmsi-2312	17	13	in	in	ADP
ajmsi-2312	17	14	older	old	ADJ
ajmsi-2312	17	15	patients	patient	NOUN
ajmsi-2312	17	16	and	and	CCONJ
ajmsi-2312	17	17	those	those	PRON
ajmsi-2312	17	18	with	with	ADP
ajmsi-2312	17	19	thrombotic	thrombotic	ADJ
ajmsi-2312	17	20	complications	complication	NOUN
ajmsi-2312	17	21	(	(	PUNCT
ajmsi-2312	17	22	hultcrantz	hultcrantz	NOUN
ajmsi-2312	17	23	et	et	PROPN
ajmsi-2312	17	24	al	al	PROPN
ajmsi-2312	17	25	.	.	PROPN
ajmsi-2312	17	26	,	,	PUNCT
ajmsi-2312	17	27	2015	2015	NUM
ajmsi-2312	17	28	;	;	PUNCT
ajmsi-2312	17	29	roaldsnes	roaldsne	NOUN
ajmsi-2312	17	30	et	et	PROPN
ajmsi-2312	17	31	al	al	PROPN
ajmsi-2312	17	32	.	.	PROPN
ajmsi-2312	17	33	,	,	PUNCT
ajmsi-2312	17	34	2017	2017	NUM
ajmsi-2312	17	35	;	;	PUNCT
ajmsi-2312	17	36	srour	srour	VERB
ajmsi-2312	17	37	et	et	PROPN
ajmsi-2312	17	38	al	al	PROPN
ajmsi-2312	17	39	.	.	PROPN
ajmsi-2312	17	40	,	,	PUNCT
ajmsi-2312	17	41	2016	2016	NUM
ajmsi-2312	17	42	;	;	PUNCT
ajmsi-2312	17	43	tefferi	tefferi	PROPN
ajmsi-2312	17	44	&	&	CCONJ
ajmsi-2312	17	45	barbui	barbui	ADJ
ajmsi-2312	17	46	,	,	PUNCT
ajmsi-2312	17	47	2017	2017	NUM
ajmsi-2312	17	48	)	)	PUNCT
ajmsi-2312	17	49	.	.	PUNCT
ajmsi-2312	18	1	the	the	DET
ajmsi-2312	18	2	main	main	ADJ
ajmsi-2312	18	3	features	feature	NOUN
ajmsi-2312	18	4	of	of	ADP
ajmsi-2312	18	5	et	et	NOUN
ajmsi-2312	18	6	include	include	VERB
ajmsi-2312	18	7	a	a	DET
ajmsi-2312	18	8	persistently	persistently	ADV
ajmsi-2312	18	9	elevated	elevated	ADJ
ajmsi-2312	18	10	platelet	platelet	NOUN
ajmsi-2312	18	11	count	count	NOUN
ajmsi-2312	18	12	of	of	ADP
ajmsi-2312	18	13	>	>	X
ajmsi-2312	18	14	450,000/µl	450,000/µl	NUM
ajmsi-2312	18	15	on	on	ADP
ajmsi-2312	18	16	a	a	DET
ajmsi-2312	18	17	complete	complete	ADJ
ajmsi-2312	18	18	blood	blood	NOUN
ajmsi-2312	18	19	count	count	NOUN
ajmsi-2312	18	20	,	,	PUNCT
ajmsi-2312	18	21	a	a	DET
ajmsi-2312	18	22	clinical	clinical	ADJ
ajmsi-2312	18	23	course	course	NOUN
ajmsi-2312	18	24	characterized	characterize	VERB
ajmsi-2312	18	25	by	by	ADP
ajmsi-2312	18	26	thrombotic	thrombotic	ADJ
ajmsi-2312	18	27	and/or	and/or	CCONJ
ajmsi-2312	18	28	hemorrhagic	hemorrhagic	VERB
ajmsi-2312	18	29	events	event	NOUN
ajmsi-2312	18	30	with	with	ADP
ajmsi-2312	18	31	a	a	DET
ajmsi-2312	18	32	possible	possible	ADJ
ajmsi-2312	18	33	splenomegaly	splenomegaly	NOUN
ajmsi-2312	18	34	,	,	PUNCT
ajmsi-2312	18	35	and	and	CCONJ
ajmsi-2312	18	36	marked	mark	VERB
ajmsi-2312	18	37	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	18	38	and	and	CCONJ
ajmsi-2312	18	39	hyperplasia	hyperplasia	NOUN
ajmsi-2312	18	40	of	of	ADP
ajmsi-2312	18	41	megakaryocytes	megakaryocyte	NOUN
ajmsi-2312	18	42	on	on	ADP
ajmsi-2312	18	43	peripheral	peripheral	ADJ
ajmsi-2312	18	44	blood	blood	NOUN
ajmsi-2312	18	45	smear	smear	NOUN
ajmsi-2312	18	46	figure	figure	NOUN
ajmsi-2312	18	47	1	1	NUM
ajmsi-2312	18	48	:	:	PUNCT
ajmsi-2312	18	49	histologic	histologic	ADJ
ajmsi-2312	18	50	features	feature	NOUN
ajmsi-2312	18	51	of	of	ADP
ajmsi-2312	18	52	essential	essential	ADJ
ajmsi-2312	18	53	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	18	54	(	(	PUNCT
ajmsi-2312	18	55	schafer	schafer	NOUN
ajmsi-2312	18	56	,	,	PUNCT
ajmsi-2312	18	57	2004	2004	NUM
ajmsi-2312	18	58	)	)	PUNCT
ajmsi-2312	18	59	in	in	ADP
ajmsi-2312	18	60	panel	panel	NOUN
ajmsi-2312	18	61	a	a	NOUN
ajmsi-2312	18	62	,	,	PUNCT
ajmsi-2312	18	63	a	a	DET
ajmsi-2312	18	64	peripheral	peripheral	ADJ
ajmsi-2312	18	65	-	-	PUNCT
ajmsi-2312	18	66	blood	blood	NOUN
ajmsi-2312	18	67	smear	smear	NOUN
ajmsi-2312	18	68	from	from	ADP
ajmsi-2312	18	69	a	a	DET
ajmsi-2312	18	70	patient	patient	NOUN
ajmsi-2312	18	71	with	with	ADP
ajmsi-2312	18	72	essential	essential	ADJ
ajmsi-2312	18	73	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	18	74	contains	contain	VERB
ajmsi-2312	18	75	an	an	DET
ajmsi-2312	18	76	increased	increase	VERB
ajmsi-2312	18	77	number	number	NOUN
ajmsi-2312	18	78	of	of	ADP
ajmsi-2312	18	79	platelets	platelet	NOUN
ajmsi-2312	18	80	,	,	PUNCT
ajmsi-2312	18	81	including	include	VERB
ajmsi-2312	18	82	giant	giant	ADJ
ajmsi-2312	18	83	platelets	platelet	NOUN
ajmsi-2312	18	84	(	(	PUNCT
ajmsi-2312	18	85	arrow	arrow	NOUN
ajmsi-2312	18	86	;	;	PUNCT
ajmsi-2312	18	87	wright	wright	PROPN
ajmsi-2312	18	88	’s	’s	PART
ajmsi-2312	18	89	stain	stain	NOUN
ajmsi-2312	18	90	,	,	PUNCT
ajmsi-2312	18	91	×100	×100	PROPN
ajmsi-2312	18	92	)	)	PUNCT
ajmsi-2312	18	93	.	.	PUNCT
ajmsi-2312	19	1	in	in	ADP
ajmsi-2312	19	2	panel	panel	NOUN
ajmsi-2312	19	3	b	b	PROPN
ajmsi-2312	19	4	,	,	PUNCT
ajmsi-2312	19	5	a	a	DET
ajmsi-2312	19	6	specimen	speciman	NOUN
ajmsi-2312	19	7	of	of	ADP
ajmsi-2312	19	8	bone	bone	NOUN
ajmsi-2312	19	9	marrow	marrow	NOUN
ajmsi-2312	19	10	from	from	ADP
ajmsi-2312	19	11	a	a	DET
ajmsi-2312	19	12	patient	patient	NOUN
ajmsi-2312	19	13	with	with	ADP
ajmsi-2312	19	14	essential	essential	ADJ
ajmsi-2312	19	15	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	19	16	contains	contain	VERB
ajmsi-2312	19	17	an	an	DET
ajmsi-2312	19	18	increased	increase	VERB
ajmsi-2312	19	19	number	number	NOUN
ajmsi-2312	19	20	of	of	ADP
ajmsi-2312	19	21	megakaryocytes	megakaryocyte	NOUN
ajmsi-2312	19	22	(	(	PUNCT
ajmsi-2312	19	23	hematoxylin	hematoxylin	NOUN
ajmsi-2312	19	24	and	and	CCONJ
ajmsi-2312	19	25	eosin	eosin	NOUN
ajmsi-2312	19	26	,	,	PUNCT
ajmsi-2312	19	27	×100	×100	PROPN
ajmsi-2312	19	28	)	)	PUNCT
ajmsi-2312	19	29	.	.	PUNCT
ajmsi-2312	20	1	(	(	PUNCT
ajmsi-2312	20	2	courtesy	courtesy	NOUN
ajmsi-2312	20	3	of	of	ADP
ajmsi-2312	20	4	dr	dr	PROPN
ajmsi-2312	20	5	.	.	PROPN
ajmsi-2312	20	6	scott	scott	PROPN
ajmsi-2312	20	7	murphy	murphy	PROPN
ajmsi-2312	20	8	,	,	PUNCT
ajmsi-2312	20	9	american	american	PROPN
ajmsi-2312	20	10	red	red	PROPN
ajmsi-2312	20	11	cross	cross	PROPN
ajmsi-2312	20	12	blood	blood	NOUN
ajmsi-2312	20	13	services	services	PROPN
ajmsi-2312	20	14	,	,	PUNCT
ajmsi-2312	20	15	penn	penn	PROPN
ajmsi-2312	20	16	–	–	PUNCT
ajmsi-2312	20	17	jersey	jersey	PROPN
ajmsi-2312	20	18	region	region	NOUN
ajmsi-2312	20	19	,	,	PUNCT
ajmsi-2312	20	20	philadelphia	philadelphia	PROPN
ajmsi-2312	20	21	.	.	PUNCT
ajmsi-2312	20	22	)	)	PUNCT
ajmsi-2312	21	1	pa	pa	PROPN
ajmsi-2312	21	2	ge	ge	PROPN
ajmsi-2312	21	3	2	2	NUM
ajmsi-2312	21	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	21	5	am	be	AUX
ajmsi-2312	21	6	.	.	PUNCT
ajmsi-2312	22	1	j.	j.	PROPN
ajmsi-2312	22	2	med	med	PROPN
ajmsi-2312	22	3	.	.	PUNCT
ajmsi-2312	23	1	sci	sci	PROPN
ajmsi-2312	23	2	.	.	PUNCT
ajmsi-2312	23	3	innov	innov	PROPN
ajmsi-2312	23	4	.	.	PUNCT
ajmsi-2312	24	1	3(1	3(1	NUM
ajmsi-2312	24	2	)	)	PUNCT
ajmsi-2312	24	3	1	1	NUM
ajmsi-2312	24	4	-	-	SYM
ajmsi-2312	24	5	7	7	NUM
ajmsi-2312	24	6	,	,	PUNCT
ajmsi-2312	24	7	2024	2024	NUM
ajmsi-2312	24	8	and	and	CCONJ
ajmsi-2312	24	9	bone	bone	NOUN
ajmsi-2312	24	10	marrow	marrow	NOUN
ajmsi-2312	24	11	assays	assay	NOUN
ajmsi-2312	24	12	,	,	PUNCT
ajmsi-2312	24	13	respectively	respectively	ADV
ajmsi-2312	24	14	(	(	PUNCT
ajmsi-2312	24	15	tefferi	tefferi	ADJ
ajmsi-2312	24	16	&	&	CCONJ
ajmsi-2312	24	17	barbui	barbui	ADJ
ajmsi-2312	24	18	,	,	PUNCT
ajmsi-2312	24	19	2020	2020	NUM
ajmsi-2312	24	20	)	)	PUNCT
ajmsi-2312	24	21	.	.	PUNCT
ajmsi-2312	25	1	asymptomatic	asymptomatic	ADJ
ajmsi-2312	25	2	patients	patient	NOUN
ajmsi-2312	25	3	with	with	ADP
ajmsi-2312	25	4	et	et	PROPN
ajmsi-2312	25	5	(	(	PUNCT
ajmsi-2312	25	6	about	about	ADV
ajmsi-2312	25	7	50	50	NUM
ajmsi-2312	25	8	%	%	NOUN
ajmsi-2312	25	9	of	of	ADP
ajmsi-2312	25	10	all	all	DET
ajmsi-2312	25	11	cases	case	NOUN
ajmsi-2312	25	12	)	)	PUNCT
ajmsi-2312	25	13	may	may	AUX
ajmsi-2312	25	14	be	be	AUX
ajmsi-2312	25	15	found	find	VERB
ajmsi-2312	25	16	when	when	SCONJ
ajmsi-2312	25	17	persistent	persistent	ADJ
ajmsi-2312	25	18	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	25	19	is	be	AUX
ajmsi-2312	25	20	noted	note	VERB
ajmsi-2312	25	21	on	on	ADP
ajmsi-2312	25	22	routine	routine	ADJ
ajmsi-2312	25	23	complete	complete	ADJ
ajmsi-2312	25	24	blood	blood	NOUN
ajmsi-2312	25	25	counts	count	NOUN
ajmsi-2312	25	26	for	for	ADP
ajmsi-2312	25	27	other	other	ADJ
ajmsi-2312	25	28	reasons	reason	NOUN
ajmsi-2312	25	29	.	.	PUNCT
ajmsi-2312	26	1	disease	disease	NOUN
ajmsi-2312	26	2	-	-	PUNCT
ajmsi-2312	26	3	related	relate	VERB
ajmsi-2312	26	4	symptoms	symptom	NOUN
ajmsi-2312	26	5	of	of	ADP
ajmsi-2312	26	6	et	et	NOUN
ajmsi-2312	26	7	are	be	AUX
ajmsi-2312	26	8	largely	largely	ADV
ajmsi-2312	26	9	vasomotor	vasomotor	ADJ
ajmsi-2312	26	10	due	due	ADP
ajmsi-2312	26	11	to	to	ADP
ajmsi-2312	26	12	disturbances	disturbance	NOUN
ajmsi-2312	26	13	in	in	ADP
ajmsi-2312	26	14	microvascular	microvascular	ADJ
ajmsi-2312	26	15	circulations	circulation	NOUN
ajmsi-2312	26	16	and	and	CCONJ
ajmsi-2312	26	17	include	include	VERB
ajmsi-2312	26	18	headaches	headache	NOUN
ajmsi-2312	26	19	,	,	PUNCT
ajmsi-2312	26	20	dizziness	dizziness	NOUN
ajmsi-2312	26	21	,	,	PUNCT
ajmsi-2312	26	22	fainting	fainting	NOUN
ajmsi-2312	26	23	,	,	PUNCT
ajmsi-2312	26	24	blurring	blurring	NOUN
ajmsi-2312	26	25	or	or	CCONJ
ajmsi-2312	26	26	transient	transient	ADJ
ajmsi-2312	26	27	loss	loss	NOUN
ajmsi-2312	26	28	of	of	ADP
ajmsi-2312	26	29	vision	vision	NOUN
ajmsi-2312	26	30	(	(	PUNCT
ajmsi-2312	26	31	e.g.	e.g.	ADV
ajmsi-2312	26	32	,	,	PUNCT
ajmsi-2312	26	33	amaurosis	amaurosis	NOUN
ajmsi-2312	26	34	fugax	fugax	NOUN
ajmsi-2312	26	35	,	,	PUNCT
ajmsi-2312	26	36	ocular	ocular	ADJ
ajmsi-2312	26	37	migraines	migraine	NOUN
ajmsi-2312	26	38	)	)	PUNCT
ajmsi-2312	26	39	,	,	PUNCT
ajmsi-2312	26	40	non	non	ADJ
ajmsi-2312	26	41	-	-	ADJ
ajmsi-2312	26	42	specific	specific	ADJ
ajmsi-2312	26	43	fatigue	fatigue	NOUN
ajmsi-2312	26	44	,	,	PUNCT
ajmsi-2312	26	45	atypical	atypical	ADJ
ajmsi-2312	26	46	chest	chest	NOUN
ajmsi-2312	26	47	pains	pain	NOUN
ajmsi-2312	26	48	,	,	PUNCT
ajmsi-2312	26	49	myalgias	myalgias	PROPN
ajmsi-2312	26	50	,	,	PUNCT
ajmsi-2312	26	51	acral	acral	ADJ
ajmsi-2312	26	52	paresthesia	paresthesia	NOUN
ajmsi-2312	26	53	,	,	PUNCT
ajmsi-2312	26	54	erythromelalgias	erythromelalgias	VERB
ajmsi-2312	26	55	,	,	PUNCT
ajmsi-2312	26	56	and	and	CCONJ
ajmsi-2312	26	57	livedo	livedo	PROPN
ajmsi-2312	26	58	reticularis	reticularis	PROPN
ajmsi-2312	26	59	,	,	PUNCT
ajmsi-2312	26	60	etc	etc	X
ajmsi-2312	26	61	.	.	X
ajmsi-2312	27	1	(	(	PUNCT
ajmsi-2312	27	2	wolanskyj	wolanskyj	ADV
ajmsi-2312	27	3	et	et	NOUN
ajmsi-2312	27	4	al	al	PROPN
ajmsi-2312	27	5	.	.	PROPN
ajmsi-2312	27	6	,	,	PUNCT
ajmsi-2312	27	7	2005	2005	NUM
ajmsi-2312	27	8	)	)	PUNCT
ajmsi-2312	27	9	.	.	PUNCT
ajmsi-2312	28	1	patients	patient	NOUN
ajmsi-2312	28	2	may	may	AUX
ajmsi-2312	28	3	also	also	ADV
ajmsi-2312	28	4	present	present	VERB
ajmsi-2312	28	5	with	with	ADP
ajmsi-2312	28	6	complications	complication	NOUN
ajmsi-2312	28	7	related	relate	VERB
ajmsi-2312	28	8	to	to	ADP
ajmsi-2312	28	9	thrombosis	thrombosis	NOUN
ajmsi-2312	28	10	(	(	PUNCT
ajmsi-2312	28	11	due	due	ADP
ajmsi-2312	28	12	to	to	ADP
ajmsi-2312	28	13	both	both	CCONJ
ajmsi-2312	28	14	quantitative	quantitative	ADJ
ajmsi-2312	28	15	and	and	CCONJ
ajmsi-2312	28	16	qualitative	qualitative	ADJ
ajmsi-2312	28	17	plate	plate	NOUN
ajmsi-2312	28	18	dysfunctions	dysfunction	NOUN
ajmsi-2312	28	19	)	)	PUNCT
ajmsi-2312	28	20	in	in	ADP
ajmsi-2312	28	21	various	various	ADJ
ajmsi-2312	28	22	organs	organ	NOUN
ajmsi-2312	28	23	,	,	PUNCT
ajmsi-2312	28	24	e.g.	e.g.	ADV
ajmsi-2312	28	25	,	,	PUNCT
ajmsi-2312	28	26	strokes	stroke	NOUN
ajmsi-2312	28	27	,	,	PUNCT
ajmsi-2312	28	28	acute	acute	ADJ
ajmsi-2312	28	29	coronary	coronary	ADJ
ajmsi-2312	28	30	syndromes	syndrome	NOUN
ajmsi-2312	28	31	,	,	PUNCT
ajmsi-2312	28	32	superficial	superficial	ADJ
ajmsi-2312	28	33	thrombophlebitis	thrombophlebitis	NOUN
ajmsi-2312	28	34	,	,	PUNCT
ajmsi-2312	28	35	deep	deep	ADJ
ajmsi-2312	28	36	vein	vein	NOUN
ajmsi-2312	28	37	thrombosis	thrombosis	NOUN
ajmsi-2312	28	38	,	,	PUNCT
ajmsi-2312	28	39	pulmonary	pulmonary	ADJ
ajmsi-2312	28	40	embolism	embolism	NOUN
ajmsi-2312	28	41	,	,	PUNCT
ajmsi-2312	28	42	hepatic	hepatic	ADJ
ajmsi-2312	28	43	or	or	CCONJ
ajmsi-2312	28	44	portal	portal	ADJ
ajmsi-2312	28	45	vein	vein	NOUN
ajmsi-2312	28	46	thrombosis	thrombosis	NOUN
ajmsi-2312	28	47	,	,	PUNCT
ajmsi-2312	28	48	digital	digital	ADJ
ajmsi-2312	28	49	ischemia	ischemia	NOUN
ajmsi-2312	28	50	,	,	PUNCT
ajmsi-2312	28	51	thrombosis	thrombosis	NOUN
ajmsi-2312	28	52	-	-	PUNCT
ajmsi-2312	28	53	related	relate	VERB
ajmsi-2312	28	54	first	first	ADJ
ajmsi-2312	28	55	-	-	PUNCT
ajmsi-2312	28	56	trimester	trimester	NOUN
ajmsi-2312	28	57	pregnancy	pregnancy	NOUN
ajmsi-2312	28	58	losses	loss	NOUN
ajmsi-2312	28	59	,	,	PUNCT
ajmsi-2312	28	60	etc	etc	X
ajmsi-2312	28	61	.	.	X
ajmsi-2312	29	1	(	(	PUNCT
ajmsi-2312	29	2	tefferi	tefferi	ADJ
ajmsi-2312	29	3	&	&	CCONJ
ajmsi-2312	29	4	barbui	barbui	ADJ
ajmsi-2312	29	5	,	,	PUNCT
ajmsi-2312	29	6	2017	2017	NUM
ajmsi-2312	29	7	)	)	PUNCT
ajmsi-2312	29	8	.	.	PUNCT
ajmsi-2312	30	1	hemorrhagic	hemorrhagic	NOUN
ajmsi-2312	30	2	manifestations	manifestation	NOUN
ajmsi-2312	30	3	tend	tend	VERB
ajmsi-2312	30	4	to	to	PART
ajmsi-2312	30	5	occur	occur	VERB
ajmsi-2312	30	6	in	in	ADP
ajmsi-2312	30	7	cases	case	NOUN
ajmsi-2312	30	8	of	of	ADP
ajmsi-2312	30	9	extreme	extreme	ADJ
ajmsi-2312	30	10	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	30	11	(	(	PUNCT
ajmsi-2312	30	12	platelet	platelet	NOUN
ajmsi-2312	30	13	counts	count	NOUN
ajmsi-2312	30	14	>	>	X
ajmsi-2312	30	15	1000,000/	1000,000/	NUM
ajmsi-2312	30	16	µl	µl	NOUN
ajmsi-2312	30	17	)	)	PUNCT
ajmsi-2312	30	18	as	as	ADV
ajmsi-2312	30	19	well	well	ADV
ajmsi-2312	30	20	as	as	ADP
ajmsi-2312	30	21	following	follow	VERB
ajmsi-2312	30	22	treatment	treatment	NOUN
ajmsi-2312	30	23	with	with	ADP
ajmsi-2312	30	24	high	high	ADJ
ajmsi-2312	30	25	doses	dose	NOUN
ajmsi-2312	30	26	of	of	ADP
ajmsi-2312	30	27	non	non	ADJ
ajmsi-2312	30	28	-	-	ADJ
ajmsi-2312	30	29	steroidal	steroidal	ADJ
ajmsi-2312	30	30	anti	anti	ADJ
ajmsi-2312	30	31	-	-	ADJ
ajmsi-2312	30	32	inflammatory	inflammatory	ADJ
ajmsi-2312	30	33	drugs	drug	NOUN
ajmsi-2312	30	34	(	(	PUNCT
ajmsi-2312	30	35	bellucci	bellucci	PROPN
ajmsi-2312	30	36	et	et	PROPN
ajmsi-2312	30	37	al	al	PROPN
ajmsi-2312	30	38	.	.	PROPN
ajmsi-2312	30	39	,	,	PUNCT
ajmsi-2312	30	40	1986	1986	NUM
ajmsi-2312	30	41	;	;	PUNCT
ajmsi-2312	30	42	landolfi	landolfi	PROPN
ajmsi-2312	30	43	et	et	PROPN
ajmsi-2312	30	44	al	al	PROPN
ajmsi-2312	30	45	.	.	PROPN
ajmsi-2312	30	46	,	,	PUNCT
ajmsi-2312	30	47	2006	2006	NUM
ajmsi-2312	30	48	)	)	PUNCT
ajmsi-2312	30	49	.	.	PUNCT
ajmsi-2312	31	1	treatment	treatment	NOUN
ajmsi-2312	31	2	of	of	ADP
ajmsi-2312	31	3	et	et	NOUN
ajmsi-2312	31	4	is	be	AUX
ajmsi-2312	31	5	based	base	VERB
ajmsi-2312	31	6	on	on	ADP
ajmsi-2312	31	7	individualized	individualized	ADJ
ajmsi-2312	31	8	stratification	stratification	NOUN
ajmsi-2312	31	9	of	of	ADP
ajmsi-2312	31	10	the	the	DET
ajmsi-2312	31	11	risks	risk	NOUN
ajmsi-2312	31	12	and/or	and/or	CCONJ
ajmsi-2312	31	13	occurrence	occurrence	NOUN
ajmsi-2312	31	14	of	of	ADP
ajmsi-2312	31	15	thrombosis	thrombosis	NOUN
ajmsi-2312	31	16	or	or	CCONJ
ajmsi-2312	31	17	bleeding	bleed	VERB
ajmsi-2312	31	18	(	(	PUNCT
ajmsi-2312	31	19	barbui	barbui	PROPN
ajmsi-2312	31	20	et	et	PROPN
ajmsi-2312	31	21	al	al	PROPN
ajmsi-2312	31	22	.	.	PROPN
ajmsi-2312	31	23	,	,	PUNCT
ajmsi-2312	31	24	2015	2015	NUM
ajmsi-2312	31	25	)	)	PUNCT
ajmsi-2312	31	26	and	and	CCONJ
ajmsi-2312	31	27	generally	generally	ADV
ajmsi-2312	31	28	includes	include	VERB
ajmsi-2312	31	29	observation	observation	NOUN
ajmsi-2312	31	30	and	and	CCONJ
ajmsi-2312	31	31	cytoreductive	cytoreductive	ADJ
ajmsi-2312	31	32	therapy	therapy	NOUN
ajmsi-2312	31	33	with	with	ADP
ajmsi-2312	31	34	medications	medication	NOUN
ajmsi-2312	31	35	such	such	ADJ
ajmsi-2312	31	36	as	as	ADP
ajmsi-2312	31	37	low	low	ADV
ajmsi-2312	31	38	-	-	PUNCT
ajmsi-2312	31	39	dose	dose	NOUN
ajmsi-2312	31	40	aspirin	aspirin	NOUN
ajmsi-2312	31	41	and	and	CCONJ
ajmsi-2312	31	42	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	31	43	(	(	PUNCT
ajmsi-2312	31	44	first	first	ADJ
ajmsi-2312	31	45	-	-	PUNCT
ajmsi-2312	31	46	line	line	NOUN
ajmsi-2312	31	47	therapy	therapy	NOUN
ajmsi-2312	31	48	)	)	PUNCT
ajmsi-2312	31	49	(	(	PUNCT
ajmsi-2312	31	50	rocca	rocca	PROPN
ajmsi-2312	31	51	et	et	PROPN
ajmsi-2312	31	52	al	al	PROPN
ajmsi-2312	31	53	.	.	PROPN
ajmsi-2312	31	54	,	,	PUNCT
ajmsi-2312	31	55	2020	2020	NUM
ajmsi-2312	31	56	;	;	PUNCT
ajmsi-2312	31	57	tefferi	tefferi	PROPN
ajmsi-2312	31	58	&	&	CCONJ
ajmsi-2312	31	59	barbui	barbui	ADJ
ajmsi-2312	31	60	,	,	PUNCT
ajmsi-2312	31	61	2020	2020	NUM
ajmsi-2312	31	62	)	)	PUNCT
ajmsi-2312	31	63	.	.	PUNCT
ajmsi-2312	32	1	interferon	interferon	ADJ
ajmsi-2312	32	2	alfa	alfa	PROPN
ajmsi-2312	32	3	,	,	PUNCT
ajmsi-2312	32	4	anagrelide	anagrelide	ADJ
ajmsi-2312	32	5	,	,	PUNCT
ajmsi-2312	32	6	ruxolitinib	ruxolitinib	NOUN
ajmsi-2312	32	7	,	,	PUNCT
ajmsi-2312	32	8	and	and	CCONJ
ajmsi-2312	32	9	apheresis	apheresis	NOUN
ajmsi-2312	32	10	may	may	AUX
ajmsi-2312	32	11	be	be	AUX
ajmsi-2312	32	12	used	use	VERB
ajmsi-2312	32	13	as	as	ADP
ajmsi-2312	32	14	second	second	ADJ
ajmsi-2312	32	15	-	-	PUNCT
ajmsi-2312	32	16	line	line	NOUN
ajmsi-2312	32	17	agents	agent	NOUN
ajmsi-2312	32	18	(	(	PUNCT
ajmsi-2312	32	19	birgegård	birgegård	ADV
ajmsi-2312	32	20	,	,	PUNCT
ajmsi-2312	32	21	2016	2016	NUM
ajmsi-2312	32	22	;	;	PUNCT
ajmsi-2312	32	23	tefferi	tefferi	PROPN
ajmsi-2312	32	24	&	&	CCONJ
ajmsi-2312	32	25	barbui	barbui	ADJ
ajmsi-2312	32	26	,	,	PUNCT
ajmsi-2312	32	27	2020	2020	NUM
ajmsi-2312	32	28	)	)	PUNCT
ajmsi-2312	32	29	.	.	PUNCT
ajmsi-2312	33	1	older	old	ADJ
ajmsi-2312	33	2	agents	agent	NOUN
ajmsi-2312	33	3	like	like	ADP
ajmsi-2312	33	4	busulphan	busulphan	NOUN
ajmsi-2312	33	5	and	and	CCONJ
ajmsi-2312	33	6	phosphorus-32	phosphorus-32	PROPN
ajmsi-2312	33	7	(	(	PUNCT
ajmsi-2312	33	8	32p	32p	NOUN
ajmsi-2312	33	9	)	)	PUNCT
ajmsi-2312	33	10	may	may	AUX
ajmsi-2312	33	11	also	also	ADV
ajmsi-2312	33	12	be	be	AUX
ajmsi-2312	33	13	used	use	VERB
ajmsi-2312	33	14	as	as	ADP
ajmsi-2312	33	15	second	second	ADJ
ajmsi-2312	33	16	-	-	PUNCT
ajmsi-2312	33	17	line	line	NOUN
ajmsi-2312	33	18	agents	agent	NOUN
ajmsi-2312	33	19	but	but	CCONJ
ajmsi-2312	33	20	have	have	AUX
ajmsi-2312	33	21	been	be	AUX
ajmsi-2312	33	22	associated	associate	VERB
ajmsi-2312	33	23	with	with	ADP
ajmsi-2312	33	24	increased	increase	VERB
ajmsi-2312	33	25	risks	risk	NOUN
ajmsi-2312	33	26	of	of	ADP
ajmsi-2312	33	27	acute	acute	ADJ
ajmsi-2312	33	28	myelogenous	myelogenous	ADJ
ajmsi-2312	33	29	leukemia	leukemia	NOUN
ajmsi-2312	33	30	(	(	PUNCT
ajmsi-2312	33	31	finazzi	finazzi	NOUN
ajmsi-2312	33	32	et	et	PROPN
ajmsi-2312	33	33	al	al	PROPN
ajmsi-2312	33	34	.	.	PROPN
ajmsi-2312	33	35	,	,	PUNCT
ajmsi-2312	33	36	2005	2005	NUM
ajmsi-2312	33	37	;	;	PUNCT
ajmsi-2312	33	38	tefferi	tefferi	PROPN
ajmsi-2312	33	39	&	&	CCONJ
ajmsi-2312	33	40	barbui	barbui	ADJ
ajmsi-2312	33	41	,	,	PUNCT
ajmsi-2312	33	42	2020	2020	NUM
ajmsi-2312	33	43	)	)	PUNCT
ajmsi-2312	33	44	.	.	PUNCT
ajmsi-2312	34	1	case	case	NOUN
ajmsi-2312	34	2	summary	summary	NOUN
ajmsi-2312	34	3	history	history	NOUN
ajmsi-2312	34	4	and	and	CCONJ
ajmsi-2312	34	5	physical	physical	ADJ
ajmsi-2312	34	6	examination	examination	NOUN
ajmsi-2312	34	7	a	a	DET
ajmsi-2312	34	8	60	60	NUM
ajmsi-2312	34	9	-	-	PUNCT
ajmsi-2312	34	10	year	year	NOUN
ajmsi-2312	34	11	-	-	PUNCT
ajmsi-2312	34	12	old	old	ADJ
ajmsi-2312	34	13	married	married	ADJ
ajmsi-2312	34	14	father	father	NOUN
ajmsi-2312	34	15	of	of	ADP
ajmsi-2312	34	16	three	three	NUM
ajmsi-2312	34	17	adults	adult	NOUN
ajmsi-2312	34	18	,	,	PUNCT
ajmsi-2312	34	19	a	a	DET
ajmsi-2312	34	20	tailor	tailor	NOUN
ajmsi-2312	34	21	by	by	ADP
ajmsi-2312	34	22	profession	profession	NOUN
ajmsi-2312	34	23	from	from	ADP
ajmsi-2312	34	24	pipeline	pipeline	NOUN
ajmsi-2312	34	25	estate	estate	NOUN
ajmsi-2312	34	26	,	,	PUNCT
ajmsi-2312	34	27	nakuru	nakuru	PROPN
ajmsi-2312	34	28	county	county	PROPN
ajmsi-2312	34	29	,	,	PUNCT
ajmsi-2312	34	30	kenya	kenya	PROPN
ajmsi-2312	34	31	,	,	PUNCT
ajmsi-2312	34	32	with	with	ADP
ajmsi-2312	34	33	no	no	DET
ajmsi-2312	34	34	preceding	precede	VERB
ajmsi-2312	34	35	significant	significant	ADJ
ajmsi-2312	34	36	medical	medical	ADJ
ajmsi-2312	34	37	history	history	NOUN
ajmsi-2312	34	38	,	,	PUNCT
ajmsi-2312	34	39	first	first	ADV
ajmsi-2312	34	40	presented	present	VERB
ajmsi-2312	34	41	to	to	ADP
ajmsi-2312	34	42	us	we	PRON
ajmsi-2312	34	43	in	in	ADP
ajmsi-2312	34	44	february	february	PROPN
ajmsi-2312	34	45	2022	2022	NUM
ajmsi-2312	34	46	,	,	PUNCT
ajmsi-2312	34	47	with	with	ADP
ajmsi-2312	34	48	concerns	concern	NOUN
ajmsi-2312	34	49	of	of	ADP
ajmsi-2312	34	50	pain	pain	NOUN
ajmsi-2312	34	51	and	and	CCONJ
ajmsi-2312	34	52	darkish	darkish	ADJ
ajmsi-2312	34	53	discoloration	discoloration	NOUN
ajmsi-2312	34	54	of	of	ADP
ajmsi-2312	34	55	the	the	DET
ajmsi-2312	34	56	small	small	ADJ
ajmsi-2312	34	57	left	left	ADJ
ajmsi-2312	34	58	toe	toe	NOUN
ajmsi-2312	34	59	.	.	PUNCT
ajmsi-2312	35	1	this	this	PRON
ajmsi-2312	35	2	was	be	AUX
ajmsi-2312	35	3	associated	associate	VERB
ajmsi-2312	35	4	with	with	ADP
ajmsi-2312	35	5	a	a	DET
ajmsi-2312	35	6	≥6	≥6	ADJ
ajmsi-2312	35	7	-	-	ADJ
ajmsi-2312	35	8	month	month	NOUN
ajmsi-2312	35	9	’	'	PUNCT
ajmsi-2312	35	10	history	history	NOUN
ajmsi-2312	35	11	of	of	ADP
ajmsi-2312	35	12	bilateral	bilateral	ADJ
ajmsi-2312	35	13	lower	low	ADJ
ajmsi-2312	35	14	limb	limb	NOUN
ajmsi-2312	35	15	numbness	numbness	NOUN
ajmsi-2312	35	16	,	,	PUNCT
ajmsi-2312	35	17	paresthesia	paresthesia	NOUN
ajmsi-2312	35	18	,	,	PUNCT
ajmsi-2312	35	19	and	and	CCONJ
ajmsi-2312	35	20	burning	burn	VERB
ajmsi-2312	35	21	pain	pain	NOUN
ajmsi-2312	35	22	of	of	ADP
ajmsi-2312	35	23	both	both	DET
ajmsi-2312	35	24	hands	hand	NOUN
ajmsi-2312	35	25	and	and	CCONJ
ajmsi-2312	35	26	feet	foot	NOUN
ajmsi-2312	35	27	in	in	ADP
ajmsi-2312	35	28	a	a	DET
ajmsi-2312	35	29	stocking	stocking	NOUN
ajmsi-2312	35	30	-	-	PUNCT
ajmsi-2312	35	31	and	and	CCONJ
ajmsi-2312	35	32	-	-	PUNCT
ajmsi-2312	35	33	gloving	gloving	NOUN
ajmsi-2312	35	34	distribution	distribution	NOUN
ajmsi-2312	35	35	.	.	PUNCT
ajmsi-2312	36	1	he	he	PRON
ajmsi-2312	36	2	’d	’d	NOUN
ajmsi-2312	36	3	also	also	ADV
ajmsi-2312	36	4	experienced	experience	VERB
ajmsi-2312	36	5	recurrent	recurrent	ADJ
ajmsi-2312	36	6	global	global	ADJ
ajmsi-2312	36	7	headaches	headache	NOUN
ajmsi-2312	36	8	,	,	PUNCT
ajmsi-2312	36	9	blurring	blur	VERB
ajmsi-2312	36	10	of	of	ADP
ajmsi-2312	36	11	vision	vision	NOUN
ajmsi-2312	36	12	,	,	PUNCT
ajmsi-2312	36	13	occasional	occasional	ADJ
ajmsi-2312	36	14	dizziness	dizziness	NOUN
ajmsi-2312	36	15	,	,	PUNCT
ajmsi-2312	36	16	myalgias	myalgias	PROPN
ajmsi-2312	36	17	,	,	PUNCT
ajmsi-2312	36	18	general	general	ADJ
ajmsi-2312	36	19	fatigue	fatigue	NOUN
ajmsi-2312	36	20	,	,	PUNCT
ajmsi-2312	36	21	reduced	reduce	VERB
ajmsi-2312	36	22	effort	effort	NOUN
ajmsi-2312	36	23	tolerance	tolerance	NOUN
ajmsi-2312	36	24	,	,	PUNCT
ajmsi-2312	36	25	and	and	CCONJ
ajmsi-2312	36	26	mild	mild	ADJ
ajmsi-2312	36	27	bipedal	bipedal	ADJ
ajmsi-2312	36	28	edema	edema	NOUN
ajmsi-2312	36	29	.	.	PUNCT
ajmsi-2312	37	1	however	however	ADV
ajmsi-2312	37	2	,	,	PUNCT
ajmsi-2312	37	3	he	he	PRON
ajmsi-2312	37	4	had	have	VERB
ajmsi-2312	37	5	no	no	DET
ajmsi-2312	37	6	history	history	NOUN
ajmsi-2312	37	7	to	to	PART
ajmsi-2312	37	8	suggest	suggest	VERB
ajmsi-2312	37	9	heart	heart	NOUN
ajmsi-2312	37	10	failure	failure	NOUN
ajmsi-2312	37	11	,	,	PUNCT
ajmsi-2312	37	12	bleeding	bleed	VERB
ajmsi-2312	37	13	diatheses	diathese	NOUN
ajmsi-2312	37	14	,	,	PUNCT
ajmsi-2312	37	15	stroke	stroke	NOUN
ajmsi-2312	37	16	-	-	PUNCT
ajmsi-2312	37	17	like	like	ADJ
ajmsi-2312	37	18	symptoms	symptom	NOUN
ajmsi-2312	37	19	,	,	PUNCT
ajmsi-2312	37	20	or	or	CCONJ
ajmsi-2312	37	21	deep	deep	ADJ
ajmsi-2312	37	22	venous	venous	ADJ
ajmsi-2312	37	23	thrombosis	thrombosis	NOUN
ajmsi-2312	37	24	.	.	PUNCT
ajmsi-2312	38	1	he	he	PRON
ajmsi-2312	38	2	had	have	VERB
ajmsi-2312	38	3	no	no	DET
ajmsi-2312	38	4	known	know	VERB
ajmsi-2312	38	5	family	family	NOUN
ajmsi-2312	38	6	history	history	NOUN
ajmsi-2312	38	7	of	of	ADP
ajmsi-2312	38	8	any	any	DET
ajmsi-2312	38	9	hematological	hematological	ADJ
ajmsi-2312	38	10	or	or	CCONJ
ajmsi-2312	38	11	cardiovascular	cardiovascular	ADJ
ajmsi-2312	38	12	diseases	disease	NOUN
ajmsi-2312	38	13	.	.	PUNCT
ajmsi-2312	39	1	the	the	DET
ajmsi-2312	39	2	rest	rest	NOUN
ajmsi-2312	39	3	of	of	ADP
ajmsi-2312	39	4	the	the	DET
ajmsi-2312	39	5	systemic	systemic	ADJ
ajmsi-2312	39	6	inquiry	inquiry	NOUN
ajmsi-2312	39	7	was	be	AUX
ajmsi-2312	39	8	unremarkable	unremarkable	ADJ
ajmsi-2312	39	9	.	.	PUNCT
ajmsi-2312	40	1	on	on	ADP
ajmsi-2312	40	2	examination	examination	NOUN
ajmsi-2312	40	3	,	,	PUNCT
ajmsi-2312	40	4	he	he	PRON
ajmsi-2312	40	5	was	be	AUX
ajmsi-2312	40	6	in	in	ADP
ajmsi-2312	40	7	fair	fair	ADJ
ajmsi-2312	40	8	general	general	ADJ
ajmsi-2312	40	9	health	health	NOUN
ajmsi-2312	40	10	.	.	PUNCT
ajmsi-2312	41	1	his	his	PRON
ajmsi-2312	41	2	lower	low	ADJ
ajmsi-2312	41	3	limb	limb	NOUN
ajmsi-2312	41	4	examination	examination	NOUN
ajmsi-2312	41	5	revealed	reveal	VERB
ajmsi-2312	41	6	multiple	multiple	ADJ
ajmsi-2312	41	7	macular	macular	NOUN
ajmsi-2312	41	8	-	-	PUNCT
ajmsi-2312	41	9	to	to	ADP
ajmsi-2312	41	10	-	-	PUNCT
ajmsi-2312	41	11	patchy	patchy	ADJ
ajmsi-2312	41	12	non	non	ADJ
ajmsi-2312	41	13	-	-	ADJ
ajmsi-2312	41	14	tender	tender	ADJ
ajmsi-2312	41	15	,	,	PUNCT
ajmsi-2312	41	16	non	non	ADJ
ajmsi-2312	41	17	-	-	ADJ
ajmsi-2312	41	18	blanching	blanching	ADJ
ajmsi-2312	41	19	discrete	discrete	ADJ
ajmsi-2312	41	20	skin	skin	NOUN
ajmsi-2312	41	21	lesions	lesion	NOUN
ajmsi-2312	41	22	on	on	ADP
ajmsi-2312	41	23	both	both	DET
ajmsi-2312	41	24	legs	leg	NOUN
ajmsi-2312	41	25	and	and	CCONJ
ajmsi-2312	41	26	thighs	thigh	NOUN
ajmsi-2312	41	27	,	,	PUNCT
ajmsi-2312	41	28	mild	mild	ADJ
ajmsi-2312	41	29	bilateral	bilateral	ADJ
ajmsi-2312	41	30	pitting	pit	VERB
ajmsi-2312	41	31	ankle	ankle	NOUN
ajmsi-2312	41	32	edema	edema	NOUN
ajmsi-2312	41	33	,	,	PUNCT
ajmsi-2312	41	34	with	with	ADP
ajmsi-2312	41	35	the	the	DET
ajmsi-2312	41	36	left	left	ADJ
ajmsi-2312	41	37	small	small	ADJ
ajmsi-2312	41	38	toe	toe	NOUN
ajmsi-2312	41	39	appearing	appear	VERB
ajmsi-2312	41	40	remarkably	remarkably	ADV
ajmsi-2312	41	41	darkened	darken	VERB
ajmsi-2312	41	42	but	but	CCONJ
ajmsi-2312	41	43	non	non	ADJ
ajmsi-2312	41	44	-	-	ADJ
ajmsi-2312	41	45	tender	tender	ADJ
ajmsi-2312	41	46	,	,	PUNCT
ajmsi-2312	41	47	and	and	CCONJ
ajmsi-2312	41	48	with	with	ADP
ajmsi-2312	41	49	an	an	DET
ajmsi-2312	41	50	associated	associated	ADJ
ajmsi-2312	41	51	septic	septic	ADJ
ajmsi-2312	41	52	wound	wound	NOUN
ajmsi-2312	41	53	on	on	ADP
ajmsi-2312	41	54	its	its	PRON
ajmsi-2312	41	55	tip	tip	NOUN
ajmsi-2312	41	56	.	.	PUNCT
ajmsi-2312	42	1	the	the	DET
ajmsi-2312	42	2	neurovascular	neurovascular	ADJ
ajmsi-2312	42	3	exam	exam	NOUN
ajmsi-2312	42	4	of	of	ADP
ajmsi-2312	42	5	both	both	DET
ajmsi-2312	42	6	legs	leg	NOUN
ajmsi-2312	42	7	as	as	ADV
ajmsi-2312	42	8	well	well	ADV
ajmsi-2312	42	9	as	as	ADP
ajmsi-2312	42	10	the	the	DET
ajmsi-2312	42	11	rest	rest	NOUN
ajmsi-2312	42	12	of	of	ADP
ajmsi-2312	42	13	the	the	DET
ajmsi-2312	42	14	musculoskeletal	musculoskeletal	ADJ
ajmsi-2312	42	15	exam	exam	NOUN
ajmsi-2312	42	16	were	be	AUX
ajmsi-2312	42	17	normal	normal	ADJ
ajmsi-2312	42	18	.	.	PUNCT
ajmsi-2312	43	1	he	he	PRON
ajmsi-2312	43	2	had	have	VERB
ajmsi-2312	43	3	no	no	DET
ajmsi-2312	43	4	features	feature	NOUN
ajmsi-2312	43	5	of	of	ADP
ajmsi-2312	43	6	chronic	chronic	ADJ
ajmsi-2312	43	7	liver	liver	NOUN
ajmsi-2312	43	8	disease	disease	NOUN
ajmsi-2312	43	9	but	but	CCONJ
ajmsi-2312	43	10	had	have	VERB
ajmsi-2312	43	11	a	a	DET
ajmsi-2312	43	12	dull	dull	ADJ
ajmsi-2312	43	13	percussion	percussion	NOUN
ajmsi-2312	43	14	note	note	NOUN
ajmsi-2312	43	15	over	over	ADP
ajmsi-2312	43	16	traube	traube	NOUN
ajmsi-2312	43	17	’s	’s	PART
ajmsi-2312	43	18	space	space	NOUN
ajmsi-2312	43	19	,	,	PUNCT
ajmsi-2312	43	20	indicating	indicate	VERB
ajmsi-2312	43	21	splenomegaly	splenomegaly	ADJ
ajmsi-2312	43	22	.	.	PUNCT
ajmsi-2312	44	1	a	a	DET
ajmsi-2312	44	2	full	full	ADJ
ajmsi-2312	44	3	neurological	neurological	ADJ
ajmsi-2312	44	4	exam	exam	NOUN
ajmsi-2312	44	5	only	only	ADV
ajmsi-2312	44	6	showed	show	VERB
ajmsi-2312	44	7	mild	mild	ADJ
ajmsi-2312	44	8	impairment	impairment	NOUN
ajmsi-2312	44	9	in	in	ADP
ajmsi-2312	44	10	the	the	DET
ajmsi-2312	44	11	peripheries	periphery	NOUN
ajmsi-2312	44	12	of	of	ADP
ajmsi-2312	44	13	light	light	ADJ
ajmsi-2312	44	14	touch	touch	NOUN
ajmsi-2312	44	15	and	and	CCONJ
ajmsi-2312	44	16	vibration	vibration	NOUN
ajmsi-2312	44	17	,	,	PUNCT
ajmsi-2312	44	18	while	while	SCONJ
ajmsi-2312	44	19	examination	examination	NOUN
ajmsi-2312	44	20	of	of	ADP
ajmsi-2312	44	21	the	the	DET
ajmsi-2312	44	22	other	other	ADJ
ajmsi-2312	44	23	systems	system	NOUN
ajmsi-2312	44	24	was	be	AUX
ajmsi-2312	44	25	unremarkable	unremarkable	ADJ
ajmsi-2312	44	26	.	.	PUNCT
ajmsi-2312	45	1	diagnostic	diagnostic	ADJ
ajmsi-2312	45	2	evaluation	evaluation	NOUN
ajmsi-2312	45	3	during	during	ADP
ajmsi-2312	45	4	that	that	DET
ajmsi-2312	45	5	first	first	ADJ
ajmsi-2312	45	6	encounter	encounter	NOUN
ajmsi-2312	45	7	,	,	PUNCT
ajmsi-2312	45	8	it	it	PRON
ajmsi-2312	45	9	was	be	AUX
ajmsi-2312	45	10	noted	note	VERB
ajmsi-2312	45	11	on	on	ADP
ajmsi-2312	45	12	a	a	DET
ajmsi-2312	45	13	complete	complete	ADJ
ajmsi-2312	45	14	blood	blood	NOUN
ajmsi-2312	45	15	count	count	NOUN
ajmsi-2312	45	16	that	that	SCONJ
ajmsi-2312	45	17	his	his	PRON
ajmsi-2312	45	18	total	total	ADJ
ajmsi-2312	45	19	platelet	platelet	NOUN
ajmsi-2312	45	20	count	count	NOUN
ajmsi-2312	45	21	was	be	AUX
ajmsi-2312	45	22	markedly	markedly	ADV
ajmsi-2312	45	23	elevated	elevate	VERB
ajmsi-2312	45	24	at	at	ADP
ajmsi-2312	45	25	2306	2306	NUM
ajmsi-2312	45	26	x103/µl	x103/µl	PROPN
ajmsi-2312	46	1	(	(	PUNCT
ajmsi-2312	46	2	the	the	DET
ajmsi-2312	46	3	normal	normal	ADJ
ajmsi-2312	46	4	range	range	NOUN
ajmsi-2312	46	5	is	be	AUX
ajmsi-2312	46	6	150450	150450	NUM
ajmsi-2312	46	7	x103/µl	x103/µl	X
ajmsi-2312	46	8	)	)	PUNCT
ajmsi-2312	46	9	,	,	PUNCT
ajmsi-2312	46	10	while	while	SCONJ
ajmsi-2312	46	11	the	the	DET
ajmsi-2312	46	12	total	total	ADJ
ajmsi-2312	46	13	leucocyte	leucocyte	NOUN
ajmsi-2312	46	14	count	count	NOUN
ajmsi-2312	46	15	and	and	CCONJ
ajmsi-2312	46	16	hemoglobin	hemoglobin	NOUN
ajmsi-2312	46	17	were	be	AUX
ajmsi-2312	46	18	both	both	ADV
ajmsi-2312	46	19	normal	normal	ADJ
ajmsi-2312	46	20	at	at	ADP
ajmsi-2312	46	21	10.4	10.4	NUM
ajmsi-2312	46	22	x103/µl	x103/µl	NOUN
ajmsi-2312	46	23	and	and	CCONJ
ajmsi-2312	46	24	14	14	NUM
ajmsi-2312	46	25	g	g	PROPN
ajmsi-2312	46	26	/	/	SYM
ajmsi-2312	46	27	dl	dl	NOUN
ajmsi-2312	46	28	,	,	PUNCT
ajmsi-2312	46	29	respectively	respectively	ADV
ajmsi-2312	46	30	.	.	PUNCT
ajmsi-2312	47	1	he	he	PRON
ajmsi-2312	47	2	had	have	VERB
ajmsi-2312	47	3	normal	normal	ADJ
ajmsi-2312	47	4	random	random	ADJ
ajmsi-2312	47	5	blood	blood	NOUN
ajmsi-2312	47	6	glucose	glucose	NOUN
ajmsi-2312	47	7	,	,	PUNCT
ajmsi-2312	47	8	normal	normal	ADJ
ajmsi-2312	47	9	renal	renal	ADJ
ajmsi-2312	47	10	and	and	CCONJ
ajmsi-2312	47	11	liver	liver	NOUN
ajmsi-2312	47	12	panels	panel	NOUN
ajmsi-2312	47	13	,	,	PUNCT
ajmsi-2312	47	14	a	a	DET
ajmsi-2312	47	15	negative	negative	ADJ
ajmsi-2312	47	16	hiv	hiv	PROPN
ajmsi-2312	47	17	rapid	rapid	ADJ
ajmsi-2312	47	18	test	test	NOUN
ajmsi-2312	47	19	,	,	PUNCT
ajmsi-2312	47	20	a	a	DET
ajmsi-2312	47	21	negative	negative	ADJ
ajmsi-2312	47	22	covid-19	covid-19	PROPN
ajmsi-2312	47	23	rapid	rapid	ADJ
ajmsi-2312	47	24	antigen	antigen	ADJ
ajmsi-2312	47	25	test	test	NOUN
ajmsi-2312	47	26	,	,	PUNCT
ajmsi-2312	47	27	a	a	DET
ajmsi-2312	47	28	normal	normal	ADJ
ajmsi-2312	47	29	chest	chest	NOUN
ajmsi-2312	47	30	x	x	NOUN
ajmsi-2312	47	31	-	-	NOUN
ajmsi-2312	47	32	ray	ray	NOUN
ajmsi-2312	47	33	and	and	CCONJ
ajmsi-2312	47	34	electrocardiogram	electrocardiogram	NOUN
ajmsi-2312	47	35	,	,	PUNCT
ajmsi-2312	47	36	and	and	CCONJ
ajmsi-2312	47	37	a	a	DET
ajmsi-2312	47	38	normal	normal	ADJ
ajmsi-2312	47	39	erythrocyte	erythrocyte	NOUN
ajmsi-2312	47	40	sedimentation	sedimentation	NOUN
ajmsi-2312	47	41	rate	rate	NOUN
ajmsi-2312	47	42	of	of	ADP
ajmsi-2312	47	43	8	8	NUM
ajmsi-2312	47	44	mm	mm	NOUN
ajmsi-2312	47	45	/	/	SYM
ajmsi-2312	47	46	hr	hr	PROPN
ajmsi-2312	47	47	.	.	PUNCT
ajmsi-2312	48	1	ultrasonography	ultrasonography	NOUN
ajmsi-2312	48	2	showed	show	VERB
ajmsi-2312	48	3	a	a	DET
ajmsi-2312	48	4	mild	mild	ADJ
ajmsi-2312	48	5	splenomegaly	splenomegaly	NOUN
ajmsi-2312	48	6	of	of	ADP
ajmsi-2312	48	7	14	14	NUM
ajmsi-2312	48	8	cm	cm	NOUN
ajmsi-2312	48	9	and	and	CCONJ
ajmsi-2312	48	10	early	early	ADJ
ajmsi-2312	48	11	bilateral	bilateral	ADJ
ajmsi-2312	48	12	leg	leg	NOUN
ajmsi-2312	48	13	varicose	varicose	NOUN
ajmsi-2312	48	14	veins	vein	NOUN
ajmsi-2312	48	15	,	,	PUNCT
ajmsi-2312	48	16	but	but	CCONJ
ajmsi-2312	48	17	no	no	DET
ajmsi-2312	48	18	deep	deep	ADJ
ajmsi-2312	48	19	venous	venous	ADJ
ajmsi-2312	48	20	thrombosis	thrombosis	NOUN
ajmsi-2312	48	21	.	.	PUNCT
ajmsi-2312	49	1	he	he	PRON
ajmsi-2312	49	2	was	be	AUX
ajmsi-2312	49	3	assessed	assess	VERB
ajmsi-2312	49	4	to	to	PART
ajmsi-2312	49	5	have	have	VERB
ajmsi-2312	49	6	features	feature	NOUN
ajmsi-2312	49	7	of	of	ADP
ajmsi-2312	49	8	a	a	DET
ajmsi-2312	49	9	possible	possible	ADJ
ajmsi-2312	49	10	underlying	underlying	ADJ
ajmsi-2312	49	11	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	49	12	disorder	disorder	NOUN
ajmsi-2312	49	13	,	,	PUNCT
ajmsi-2312	49	14	predominantly	predominantly	ADV
ajmsi-2312	49	15	of	of	ADP
ajmsi-2312	49	16	the	the	DET
ajmsi-2312	49	17	et	et	NOUN
ajmsi-2312	49	18	phenotype	phenotype	NOUN
ajmsi-2312	49	19	.	.	PUNCT
ajmsi-2312	50	1	he	he	PRON
ajmsi-2312	50	2	got	get	AUX
ajmsi-2312	50	3	lost	lose	VERB
ajmsi-2312	50	4	to	to	PART
ajmsi-2312	50	5	follow	follow	VERB
ajmsi-2312	50	6	-	-	PUNCT
ajmsi-2312	50	7	up	up	NOUN
ajmsi-2312	50	8	until	until	ADP
ajmsi-2312	50	9	nine	nine	NUM
ajmsi-2312	50	10	months	month	NOUN
ajmsi-2312	50	11	later	later	ADV
ajmsi-2312	50	12	,	,	PUNCT
ajmsi-2312	50	13	when	when	SCONJ
ajmsi-2312	50	14	he	he	PRON
ajmsi-2312	50	15	re	re	VERB
ajmsi-2312	50	16	-	-	VERB
ajmsi-2312	50	17	presented	present	VERB
ajmsi-2312	50	18	with	with	ADP
ajmsi-2312	50	19	a	a	DET
ajmsi-2312	50	20	worsening	worsening	NOUN
ajmsi-2312	50	21	of	of	ADP
ajmsi-2312	50	22	similar	similar	ADJ
ajmsi-2312	50	23	symptoms	symptom	NOUN
ajmsi-2312	50	24	.	.	PUNCT
ajmsi-2312	51	1	his	his	PRON
ajmsi-2312	51	2	platelet	platelet	NOUN
ajmsi-2312	51	3	count	count	NOUN
ajmsi-2312	51	4	had	have	AUX
ajmsi-2312	51	5	further	far	ADV
ajmsi-2312	51	6	increased	increase	VERB
ajmsi-2312	51	7	to	to	ADP
ajmsi-2312	51	8	2733	2733	NUM
ajmsi-2312	51	9	x103/µl	x103/µl	X
ajmsi-2312	51	10	.	.	PUNCT
ajmsi-2312	52	1	a	a	DET
ajmsi-2312	52	2	peripheral	peripheral	ADJ
ajmsi-2312	52	3	blood	blood	NOUN
ajmsi-2312	52	4	film	film	NOUN
ajmsi-2312	52	5	showed	show	VERB
ajmsi-2312	52	6	extreme	extreme	ADJ
ajmsi-2312	52	7	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	52	8	with	with	ADP
ajmsi-2312	52	9	both	both	CCONJ
ajmsi-2312	52	10	giant	giant	ADJ
ajmsi-2312	52	11	and	and	CCONJ
ajmsi-2312	52	12	small	small	ADJ
ajmsi-2312	52	13	platelets	platelet	NOUN
ajmsi-2312	52	14	,	,	PUNCT
ajmsi-2312	52	15	consistent	consistent	ADJ
ajmsi-2312	52	16	with	with	ADP
ajmsi-2312	52	17	primary	primary	ADJ
ajmsi-2312	52	18	(	(	PUNCT
ajmsi-2312	52	19	essential	essential	ADJ
ajmsi-2312	52	20	)	)	PUNCT
ajmsi-2312	52	21	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	52	22	.	.	PUNCT
ajmsi-2312	53	1	due	due	ADP
ajmsi-2312	53	2	to	to	ADP
ajmsi-2312	53	3	severe	severe	ADJ
ajmsi-2312	53	4	financial	financial	ADJ
ajmsi-2312	53	5	and	and	CCONJ
ajmsi-2312	53	6	logistical	logistical	ADJ
ajmsi-2312	53	7	challenges	challenge	NOUN
ajmsi-2312	53	8	,	,	PUNCT
ajmsi-2312	53	9	it	it	PRON
ajmsi-2312	53	10	was	be	AUX
ajmsi-2312	53	11	impossible	impossible	ADJ
ajmsi-2312	53	12	to	to	PART
ajmsi-2312	53	13	do	do	VERB
ajmsi-2312	53	14	a	a	DET
ajmsi-2312	53	15	bone	bone	NOUN
ajmsi-2312	53	16	marrow	marrow	NOUN
ajmsi-2312	53	17	aspirate	aspirate	NOUN
ajmsi-2312	53	18	or	or	CCONJ
ajmsi-2312	53	19	any	any	DET
ajmsi-2312	53	20	genetic	genetic	ADJ
ajmsi-2312	53	21	tests	test	NOUN
ajmsi-2312	53	22	.	.	PUNCT
ajmsi-2312	54	1	management	management	NOUN
ajmsi-2312	54	2	and	and	CCONJ
ajmsi-2312	54	3	follow	follow	VERB
ajmsi-2312	54	4	-	-	PUNCT
ajmsi-2312	54	5	up	up	NOUN
ajmsi-2312	54	6	his	his	PRON
ajmsi-2312	54	7	clinical	clinical	ADJ
ajmsi-2312	54	8	syndrome	syndrome	NOUN
ajmsi-2312	54	9	was	be	AUX
ajmsi-2312	54	10	most	most	ADV
ajmsi-2312	54	11	consistent	consistent	ADJ
ajmsi-2312	54	12	with	with	ADP
ajmsi-2312	54	13	et	et	NOUN
ajmsi-2312	54	14	,	,	PUNCT
ajmsi-2312	54	15	with	with	ADP
ajmsi-2312	54	16	predominant	predominant	ADJ
ajmsi-2312	54	17	vasomotor	vasomotor	NOUN
ajmsi-2312	54	18	symptoms	symptom	NOUN
ajmsi-2312	54	19	and	and	CCONJ
ajmsi-2312	54	20	associated	associate	VERB
ajmsi-2312	54	21	sensory	sensory	ADJ
ajmsi-2312	54	22	peripheral	peripheral	ADJ
ajmsi-2312	54	23	neuropathy	neuropathy	ADJ
ajmsi-2312	54	24	.	.	PUNCT
ajmsi-2312	55	1	he	he	PRON
ajmsi-2312	55	2	was	be	AUX
ajmsi-2312	55	3	put	put	VERB
ajmsi-2312	55	4	on	on	ADP
ajmsi-2312	55	5	oral	oral	ADJ
ajmsi-2312	55	6	hydroxyurea	hydroxyurea	NOUN
ajmsi-2312	55	7	(	(	PUNCT
ajmsi-2312	55	8	hu	hu	PROPN
ajmsi-2312	55	9	)	)	PUNCT
ajmsi-2312	55	10	starting	start	VERB
ajmsi-2312	55	11	at	at	ADP
ajmsi-2312	55	12	a	a	DET
ajmsi-2312	55	13	dose	dose	NOUN
ajmsi-2312	55	14	of	of	ADP
ajmsi-2312	55	15	1	1	NUM
ajmsi-2312	55	16	g	g	NOUN
ajmsi-2312	55	17	daily	daily	ADJ
ajmsi-2312	55	18	and	and	CCONJ
ajmsi-2312	55	19	aspirin	aspirin	NOUN
ajmsi-2312	55	20	at	at	ADP
ajmsi-2312	55	21	75	75	NUM
ajmsi-2312	55	22	mg	mg	NOUN
ajmsi-2312	55	23	daily	daily	ADV
ajmsi-2312	55	24	.	.	PUNCT
ajmsi-2312	56	1	for	for	ADP
ajmsi-2312	56	2	the	the	DET
ajmsi-2312	56	3	neuropathy	neuropathy	ADJ
ajmsi-2312	56	4	,	,	PUNCT
ajmsi-2312	56	5	he	he	PRON
ajmsi-2312	56	6	was	be	AUX
ajmsi-2312	56	7	put	put	VERB
ajmsi-2312	56	8	on	on	ADP
ajmsi-2312	56	9	pregabalin	pregabalin	NOUN
ajmsi-2312	56	10	75	75	NUM
ajmsi-2312	56	11	mg	mg	PROPN
ajmsi-2312	56	12	daily	daily	ADV
ajmsi-2312	56	13	(	(	PUNCT
ajmsi-2312	56	14	and	and	CCONJ
ajmsi-2312	56	15	amitriptyline	amitriptyline	PROPN
ajmsi-2312	56	16	25	25	NUM
ajmsi-2312	56	17	mg	mg	PROPN
ajmsi-2312	56	18	nocte	nocte	NOUN
ajmsi-2312	56	19	was	be	AUX
ajmsi-2312	56	20	later	later	ADV
ajmsi-2312	56	21	added	add	VERB
ajmsi-2312	56	22	during	during	ADP
ajmsi-2312	56	23	follow	follow	NOUN
ajmsi-2312	56	24	-	-	PUNCT
ajmsi-2312	56	25	up	up	NOUN
ajmsi-2312	56	26	)	)	PUNCT
ajmsi-2312	56	27	.	.	PUNCT
ajmsi-2312	57	1	the	the	DET
ajmsi-2312	57	2	septic	septic	ADJ
ajmsi-2312	57	3	wound	wound	NOUN
ajmsi-2312	57	4	was	be	AUX
ajmsi-2312	57	5	surgically	surgically	ADV
ajmsi-2312	57	6	managed	manage	VERB
ajmsi-2312	57	7	to	to	ADP
ajmsi-2312	57	8	full	full	ADJ
ajmsi-2312	57	9	healing	healing	NOUN
ajmsi-2312	57	10	.	.	PUNCT
ajmsi-2312	58	1	while	while	SCONJ
ajmsi-2312	58	2	on	on	ADP
ajmsi-2312	58	3	hu	hu	PROPN
ajmsi-2312	58	4	,	,	PUNCT
ajmsi-2312	58	5	he	he	PRON
ajmsi-2312	58	6	developed	develop	VERB
ajmsi-2312	58	7	symptomatic	symptomatic	ADJ
ajmsi-2312	58	8	hyperuricemia	hyperuricemia	NOUN
ajmsi-2312	58	9	due	due	ADJ
ajmsi-2312	58	10	to	to	ADP
ajmsi-2312	58	11	huinduced	huinduce	VERB
ajmsi-2312	58	12	platelet	platelet	NOUN
ajmsi-2312	58	13	degradation	degradation	NOUN
ajmsi-2312	58	14	(	(	PUNCT
ajmsi-2312	58	15	with	with	ADP
ajmsi-2312	58	16	a	a	DET
ajmsi-2312	58	17	clinical	clinical	ADJ
ajmsi-2312	58	18	syndrome	syndrome	NOUN
ajmsi-2312	58	19	of	of	ADP
ajmsi-2312	58	20	non	non	ADJ
ajmsi-2312	58	21	-	-	ADJ
ajmsi-2312	58	22	tophaceous	tophaceous	ADJ
ajmsi-2312	58	23	acute	acute	NOUN
ajmsi-2312	58	24	gouty	gouty	ADJ
ajmsi-2312	58	25	polyarthritis	polyarthritis	NOUN
ajmsi-2312	58	26	)	)	PUNCT
ajmsi-2312	58	27	,	,	PUNCT
ajmsi-2312	58	28	which	which	PRON
ajmsi-2312	58	29	was	be	AUX
ajmsi-2312	58	30	successfully	successfully	ADV
ajmsi-2312	58	31	managed	manage	VERB
ajmsi-2312	58	32	with	with	ADP
ajmsi-2312	58	33	allopurinol	allopurinol	NOUN
ajmsi-2312	58	34	and	and	CCONJ
ajmsi-2312	58	35	analgesics	analgesic	NOUN
ajmsi-2312	58	36	.	.	PUNCT
ajmsi-2312	59	1	besides	besides	SCONJ
ajmsi-2312	59	2	,	,	PUNCT
ajmsi-2312	59	3	the	the	DET
ajmsi-2312	59	4	dose	dose	NOUN
ajmsi-2312	59	5	of	of	ADP
ajmsi-2312	59	6	hu	hu	PROPN
ajmsi-2312	59	7	was	be	AUX
ajmsi-2312	59	8	adjusted	adjust	VERB
ajmsi-2312	59	9	to	to	ADP
ajmsi-2312	59	10	a	a	DET
ajmsi-2312	59	11	maximum	maximum	ADJ
ajmsi-2312	59	12	tolerable	tolerable	ADJ
ajmsi-2312	59	13	dose	dose	NOUN
ajmsi-2312	59	14	of	of	ADP
ajmsi-2312	59	15	1.5	1.5	NUM
ajmsi-2312	59	16	g	g	NOUN
ajmsi-2312	59	17	/	/	SYM
ajmsi-2312	59	18	day	day	NOUN
ajmsi-2312	59	19	,	,	PUNCT
ajmsi-2312	59	20	aiming	aim	VERB
ajmsi-2312	59	21	to	to	PART
ajmsi-2312	59	22	keep	keep	VERB
ajmsi-2312	59	23	an	an	DET
ajmsi-2312	59	24	absolute	absolute	ADJ
ajmsi-2312	59	25	neutrophil	neutrophil	ADJ
ajmsi-2312	59	26	count	count	NOUN
ajmsi-2312	59	27	of	of	ADP
ajmsi-2312	59	28	≥1.5	≥1.5	PROPN
ajmsi-2312	59	29	x103/µl	x103/µl	PROPN
ajmsi-2312	59	30	.	.	PUNCT
ajmsi-2312	60	1	significantly	significantly	ADV
ajmsi-2312	60	2	,	,	PUNCT
ajmsi-2312	60	3	whenever	whenever	SCONJ
ajmsi-2312	60	4	his	his	PRON
ajmsi-2312	60	5	absolute	absolute	ADJ
ajmsi-2312	60	6	neutrophil	neutrophil	ADJ
ajmsi-2312	60	7	count	count	NOUN
ajmsi-2312	60	8	reduced	reduce	VERB
ajmsi-2312	60	9	to	to	ADP
ajmsi-2312	60	10	<	<	X
ajmsi-2312	60	11	1.5	1.5	NUM
ajmsi-2312	60	12	x103/µl	x103/µl	X
ajmsi-2312	60	13	,	,	PUNCT
ajmsi-2312	60	14	he	he	PRON
ajmsi-2312	60	15	developed	develop	VERB
ajmsi-2312	60	16	a	a	DET
ajmsi-2312	60	17	recurrent	recurrent	ADJ
ajmsi-2312	60	18	triad	triad	NOUN
ajmsi-2312	60	19	of	of	ADP
ajmsi-2312	60	20	oropharyngeal	oropharyngeal	ADJ
ajmsi-2312	60	21	candidiasis	candidiasis	NOUN
ajmsi-2312	60	22	,	,	PUNCT
ajmsi-2312	60	23	septic	septic	ADJ
ajmsi-2312	60	24	grade	grade	NOUN
ajmsi-2312	60	25	2	2	NUM
ajmsi-2312	60	26	tonsillitis	tonsillitis	NOUN
ajmsi-2312	60	27	,	,	PUNCT
ajmsi-2312	60	28	and	and	CCONJ
ajmsi-2312	60	29	cystitis	cystitis	NOUN
ajmsi-2312	60	30	.	.	PUNCT
ajmsi-2312	61	1	this	this	PRON
ajmsi-2312	61	2	was	be	AUX
ajmsi-2312	61	3	fully	fully	ADV
ajmsi-2312	61	4	treated	treat	VERB
ajmsi-2312	61	5	with	with	ADP
ajmsi-2312	61	6	antimicrobials	antimicrobial	NOUN
ajmsi-2312	61	7	and	and	CCONJ
ajmsi-2312	61	8	supportive	supportive	ADJ
ajmsi-2312	61	9	therapy	therapy	NOUN
ajmsi-2312	61	10	.	.	PUNCT
ajmsi-2312	62	1	the	the	DET
ajmsi-2312	62	2	hu	hu	PROPN
ajmsi-2312	62	3	in	in	ADP
ajmsi-2312	62	4	each	each	DET
ajmsi-2312	62	5	case	case	NOUN
ajmsi-2312	62	6	was	be	AUX
ajmsi-2312	62	7	stopped	stop	VERB
ajmsi-2312	62	8	for	for	ADP
ajmsi-2312	62	9	a	a	DET
ajmsi-2312	62	10	week	week	NOUN
ajmsi-2312	62	11	and	and	CCONJ
ajmsi-2312	62	12	subsequently	subsequently	ADV
ajmsi-2312	62	13	restarted	restart	VERB
ajmsi-2312	62	14	at	at	ADP
ajmsi-2312	62	15	a	a	DET
ajmsi-2312	62	16	much	much	ADV
ajmsi-2312	62	17	lower	low	ADJ
ajmsi-2312	62	18	dosage	dosage	NOUN
ajmsi-2312	62	19	,	,	PUNCT
ajmsi-2312	62	20	resulting	result	VERB
ajmsi-2312	62	21	in	in	ADP
ajmsi-2312	62	22	the	the	DET
ajmsi-2312	62	23	resolution	resolution	NOUN
ajmsi-2312	62	24	of	of	ADP
ajmsi-2312	62	25	the	the	DET
ajmsi-2312	62	26	neutropenia	neutropenia	NOUN
ajmsi-2312	62	27	and	and	CCONJ
ajmsi-2312	62	28	the	the	DET
ajmsi-2312	62	29	recovery	recovery	NOUN
ajmsi-2312	62	30	of	of	ADP
ajmsi-2312	62	31	the	the	DET
ajmsi-2312	62	32	target	target	NOUN
ajmsi-2312	62	33	absolute	absolute	ADJ
ajmsi-2312	62	34	neutrophil	neutrophil	ADJ
ajmsi-2312	62	35	count	count	NOUN
ajmsi-2312	62	36	.	.	PUNCT
ajmsi-2312	63	1	however	however	ADV
ajmsi-2312	63	2	,	,	PUNCT
ajmsi-2312	63	3	the	the	DET
ajmsi-2312	63	4	platelets	platelet	NOUN
ajmsi-2312	63	5	pa	pa	PROPN
ajmsi-2312	63	6	ge	ge	PROPN
ajmsi-2312	63	7	3	3	NUM
ajmsi-2312	63	8	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	63	9	am	be	AUX
ajmsi-2312	63	10	.	.	PUNCT
ajmsi-2312	64	1	j.	j.	PROPN
ajmsi-2312	64	2	med	med	PROPN
ajmsi-2312	64	3	.	.	PUNCT
ajmsi-2312	65	1	sci	sci	PROPN
ajmsi-2312	65	2	.	.	PUNCT
ajmsi-2312	65	3	innov	innov	PROPN
ajmsi-2312	65	4	.	.	PUNCT
ajmsi-2312	66	1	3(1	3(1	NUM
ajmsi-2312	66	2	)	)	PUNCT
ajmsi-2312	66	3	1	1	NUM
ajmsi-2312	66	4	-	-	SYM
ajmsi-2312	66	5	7	7	NUM
ajmsi-2312	66	6	,	,	PUNCT
ajmsi-2312	66	7	2024	2024	NUM
ajmsi-2312	66	8	and	and	CCONJ
ajmsi-2312	66	9	the	the	DET
ajmsi-2312	66	10	uric	uric	ADJ
ajmsi-2312	66	11	acid	acid	PROPN
ajmsi-2312	66	12	levels	level	NOUN
ajmsi-2312	66	13	rose	rise	VERB
ajmsi-2312	66	14	precipitously	precipitously	ADV
ajmsi-2312	66	15	when	when	SCONJ
ajmsi-2312	66	16	hu	hu	PROPN
ajmsi-2312	66	17	was	be	AUX
ajmsi-2312	66	18	stopped	stop	VERB
ajmsi-2312	66	19	(	(	PUNCT
ajmsi-2312	66	20	or	or	CCONJ
ajmsi-2312	66	21	dosage	dosage	NOUN
ajmsi-2312	66	22	reduced	reduce	VERB
ajmsi-2312	66	23	)	)	PUNCT
ajmsi-2312	66	24	,	,	PUNCT
ajmsi-2312	66	25	with	with	ADP
ajmsi-2312	66	26	a	a	DET
ajmsi-2312	66	27	corresponding	corresponding	ADJ
ajmsi-2312	66	28	recurrence	recurrence	NOUN
ajmsi-2312	66	29	of	of	ADP
ajmsi-2312	66	30	mild	mild	ADJ
ajmsi-2312	66	31	-	-	PUNCT
ajmsi-2312	66	32	to	to	ADP
ajmsi-2312	66	33	-	-	PUNCT
ajmsi-2312	66	34	moderate	moderate	ADJ
ajmsi-2312	66	35	vasomotor	vasomotor	NOUN
ajmsi-2312	66	36	symptoms	symptom	NOUN
ajmsi-2312	66	37	and	and	CCONJ
ajmsi-2312	66	38	gouty	gouty	ADJ
ajmsi-2312	66	39	polyarthritis	polyarthritis	NOUN
ajmsi-2312	66	40	.	.	PUNCT
ajmsi-2312	67	1	these	these	PRON
ajmsi-2312	67	2	have	have	AUX
ajmsi-2312	67	3	been	be	AUX
ajmsi-2312	67	4	fully	fully	ADV
ajmsi-2312	67	5	controlled	control	VERB
ajmsi-2312	67	6	with	with	ADP
ajmsi-2312	67	7	a	a	DET
ajmsi-2312	67	8	corresponding	correspond	VERB
ajmsi-2312	67	9	adjustment	adjustment	NOUN
ajmsi-2312	67	10	of	of	ADP
ajmsi-2312	67	11	the	the	DET
ajmsi-2312	67	12	various	various	ADJ
ajmsi-2312	67	13	drug	drug	NOUN
ajmsi-2312	67	14	dosages	dosage	NOUN
ajmsi-2312	67	15	.	.	PUNCT
ajmsi-2312	68	1	he	he	PRON
ajmsi-2312	68	2	is	be	AUX
ajmsi-2312	68	3	currently	currently	ADV
ajmsi-2312	68	4	on	on	ADP
ajmsi-2312	68	5	follow	follow	NOUN
ajmsi-2312	68	6	-	-	PUNCT
ajmsi-2312	68	7	up	up	NOUN
ajmsi-2312	68	8	at	at	ADP
ajmsi-2312	68	9	the	the	DET
ajmsi-2312	68	10	medical	medical	ADJ
ajmsi-2312	68	11	clinic	clinic	NOUN
ajmsi-2312	68	12	with	with	ADP
ajmsi-2312	68	13	ongoing	ongoing	ADJ
ajmsi-2312	68	14	clinical	clinical	ADJ
ajmsi-2312	68	15	and	and	CCONJ
ajmsi-2312	68	16	laboratory	laboratory	NOUN
ajmsi-2312	68	17	monitoring	monitoring	NOUN
ajmsi-2312	68	18	to	to	PART
ajmsi-2312	68	19	target	target	VERB
ajmsi-2312	68	20	the	the	DET
ajmsi-2312	68	21	individualized	individualized	ADJ
ajmsi-2312	68	22	therapeutic	therapeutic	ADJ
ajmsi-2312	68	23	goals	goal	NOUN
ajmsi-2312	68	24	described	describe	VERB
ajmsi-2312	68	25	earlier	early	ADV
ajmsi-2312	68	26	and	and	CCONJ
ajmsi-2312	68	27	clinical	clinical	ADJ
ajmsi-2312	68	28	surveillance	surveillance	NOUN
ajmsi-2312	68	29	for	for	ADP
ajmsi-2312	68	30	infections	infection	NOUN
ajmsi-2312	68	31	,	,	PUNCT
ajmsi-2312	68	32	transformation	transformation	NOUN
ajmsi-2312	68	33	to	to	ADP
ajmsi-2312	68	34	other	other	ADJ
ajmsi-2312	68	35	mpns	mpns	NOUN
ajmsi-2312	68	36	,	,	PUNCT
ajmsi-2312	68	37	and	and	CCONJ
ajmsi-2312	68	38	any	any	DET
ajmsi-2312	68	39	adverse	adverse	ADJ
ajmsi-2312	68	40	effects	effect	NOUN
ajmsi-2312	68	41	of	of	ADP
ajmsi-2312	68	42	the	the	DET
ajmsi-2312	68	43	various	various	ADJ
ajmsi-2312	68	44	drugs	drug	NOUN
ajmsi-2312	68	45	.	.	PUNCT
ajmsi-2312	69	1	table	table	NOUN
ajmsi-2312	69	2	1	1	NUM
ajmsi-2312	69	3	below	below	ADV
ajmsi-2312	69	4	shows	show	VERB
ajmsi-2312	69	5	a	a	DET
ajmsi-2312	69	6	composite	composite	ADJ
ajmsi-2312	69	7	summary	summary	NOUN
ajmsi-2312	69	8	of	of	ADP
ajmsi-2312	69	9	his	his	PRON
ajmsi-2312	69	10	complete	complete	ADJ
ajmsi-2312	69	11	blood	blood	NOUN
ajmsi-2312	69	12	count	count	NOUN
ajmsi-2312	69	13	,	,	PUNCT
ajmsi-2312	69	14	uric	uric	ADJ
ajmsi-2312	69	15	acid	acid	NOUN
ajmsi-2312	69	16	levels	level	NOUN
ajmsi-2312	69	17	,	,	PUNCT
ajmsi-2312	69	18	and	and	CCONJ
ajmsi-2312	69	19	relevant	relevant	ADJ
ajmsi-2312	69	20	interventions	intervention	NOUN
ajmsi-2312	69	21	.	.	PUNCT
ajmsi-2312	70	1	table	table	NOUN
ajmsi-2312	70	2	1	1	NUM
ajmsi-2312	70	3	:	:	PUNCT
ajmsi-2312	70	4	summary	summary	NOUN
ajmsi-2312	70	5	of	of	ADP
ajmsi-2312	70	6	the	the	DET
ajmsi-2312	70	7	complete	complete	ADJ
ajmsi-2312	70	8	blood	blood	NOUN
ajmsi-2312	70	9	count	count	NOUN
ajmsi-2312	70	10	,	,	PUNCT
ajmsi-2312	70	11	uric	uric	ADJ
ajmsi-2312	70	12	acid	acid	NOUN
ajmsi-2312	70	13	levels	level	NOUN
ajmsi-2312	70	14	,	,	PUNCT
ajmsi-2312	70	15	and	and	CCONJ
ajmsi-2312	70	16	interventions	intervention	NOUN
ajmsi-2312	70	17	date	date	NOUN
ajmsi-2312	70	18	total	total	ADJ
ajmsi-2312	70	19	platelets	platelet	NOUN
ajmsi-2312	70	20	total	total	ADJ
ajmsi-2312	70	21	wbc	wbc	PROPN
ajmsi-2312	70	22	hemoglobin	hemoglobin	NOUN
ajmsi-2312	70	23	uric	uric	ADJ
ajmsi-2312	70	24	acid	acid	PROPN
ajmsi-2312	70	25	interventions	intervention	NOUN
ajmsi-2312	70	26	(	(	PUNCT
ajmsi-2312	70	27	150	150	NUM
ajmsi-2312	70	28	-	-	SYM
ajmsi-2312	70	29	450	450	NUM
ajmsi-2312	70	30	x103/µl	x103/µl	X
ajmsi-2312	70	31	)	)	PUNCT
ajmsi-2312	70	32	(	(	PUNCT
ajmsi-2312	70	33	4	4	NUM
ajmsi-2312	70	34	-	-	SYM
ajmsi-2312	70	35	11	11	NUM
ajmsi-2312	70	36	x103/µl	x103/µl	NOUN
ajmsi-2312	70	37	)	)	PUNCT
ajmsi-2312	70	38	n	n	CCONJ
ajmsi-2312	70	39	=	=	NOUN
ajmsi-2312	70	40	neutrophils	neutrophil	NOUN
ajmsi-2312	70	41	,	,	PUNCT
ajmsi-2312	70	42	l	l	NOUN
ajmsi-2312	70	43	=	=	NOUN
ajmsi-2312	70	44	lymphocytes	lymphocyte	VERB
ajmsi-2312	70	45	anc	anc	PROPN
ajmsi-2312	70	46	=	=	SYM
ajmsi-2312	70	47	absolute	absolute	ADJ
ajmsi-2312	70	48	neutrophil	neutrophil	ADJ
ajmsi-2312	70	49	count	count	NOUN
ajmsi-2312	70	50	(	(	PUNCT
ajmsi-2312	70	51	11	11	NUM
ajmsi-2312	70	52	-	-	SYM
ajmsi-2312	70	53	16	16	NUM
ajmsi-2312	70	54	g	g	PROPN
ajmsi-2312	70	55	/	/	SYM
ajmsi-2312	70	56	dl	dl	NOUN
ajmsi-2312	70	57	)	)	PUNCT
ajmsi-2312	70	58	(	(	PUNCT
ajmsi-2312	70	59	3.4	3.4	NUM
ajmsi-2312	70	60	-	-	PUNCT
ajmsi-2312	70	61	7mg	7mg	NOUN
ajmsi-2312	70	62	/	/	SYM
ajmsi-2312	70	63	dl	dl	PROPN
ajmsi-2312	70	64	)	)	PUNCT
ajmsi-2312	70	65	hu	hu	PROPN
ajmsi-2312	71	1	=	=	SYM
ajmsi-2312	71	2	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	71	3	,	,	PUNCT
ajmsi-2312	71	4	asa	asa	PROPN
ajmsi-2312	71	5	=	=	PROPN
ajmsi-2312	71	6	aspirin	aspirin	NOUN
ajmsi-2312	71	7	,	,	PUNCT
ajmsi-2312	71	8	alp	alp	PROPN
ajmsi-2312	71	9	=	=	NOUN
ajmsi-2312	71	10	allopurinol	allopurinol	NOUN
ajmsi-2312	71	11	,	,	PUNCT
ajmsi-2312	71	12	ctx=	ctx=	PROPN
ajmsi-2312	71	13	cotrimoxazole	cotrimoxazole	NOUN
ajmsi-2312	71	14	,	,	PUNCT
ajmsi-2312	71	15	od=	od=	NOUN
ajmsi-2312	71	16	once	once	ADV
ajmsi-2312	71	17	daily	daily	ADJ
ajmsi-2312	71	18	abx=	abx=	PROPN
ajmsi-2312	71	19	antibiotics	antibiotic	NOUN
ajmsi-2312	71	20	22/2/2022	22/2/2022	NOUN
ajmsi-2312	71	21	2306	2306	NUM
ajmsi-2312	71	22	10.4	10.4	NUM
ajmsi-2312	71	23	14.0	14.0	NUM
ajmsi-2312	71	24	15/11/2022	15/11/2022	NUM
ajmsi-2312	71	25	2733	2733	NUM
ajmsi-2312	71	26	11.4	11.4	NUM
ajmsi-2312	71	27	11.7	11.7	NUM
ajmsi-2312	71	28	2.3	2.3	NUM
ajmsi-2312	71	29	hu	hu	NOUN
ajmsi-2312	71	30	1	1	NUM
ajmsi-2312	71	31	g	g	PROPN
ajmsi-2312	71	32	+	+	PROPN
ajmsi-2312	71	33	asa	asa	PROPN
ajmsi-2312	71	34	75	75	NUM
ajmsi-2312	71	35	mg	mg	PROPN
ajmsi-2312	71	36	od	od	PROPN
ajmsi-2312	71	37	started	start	VERB
ajmsi-2312	71	38	22/11/2022	22/11/2022	NUM
ajmsi-2312	71	39	2472	2472	NUM
ajmsi-2312	71	40	10.9	10.9	NUM
ajmsi-2312	71	41	12.1	12.1	NUM
ajmsi-2312	71	42	hu	hu	NOUN
ajmsi-2312	71	43	1	1	NUM
ajmsi-2312	71	44	g	g	PROPN
ajmsi-2312	71	45	+	+	PROPN
ajmsi-2312	71	46	asa	asa	PROPN
ajmsi-2312	71	47	75	75	NUM
ajmsi-2312	71	48	mg	mg	PROPN
ajmsi-2312	71	49	od	od	NUM
ajmsi-2312	71	50	2/12/2022	2/12/2022	NUM
ajmsi-2312	71	51	2124	2124	NUM
ajmsi-2312	71	52	9.7	9.7	NUM
ajmsi-2312	71	53	12.0	12.0	NUM
ajmsi-2312	71	54	13.2	13.2	NUM
ajmsi-2312	71	55	hu	hu	NOUN
ajmsi-2312	71	56	1.5	1.5	NUM
ajmsi-2312	71	57	g	g	NOUN
ajmsi-2312	71	58	+	+	PROPN
ajmsi-2312	71	59	asa	asa	PROPN
ajmsi-2312	71	60	75	75	NUM
ajmsi-2312	71	61	mg	mg	PROPN
ajmsi-2312	72	1	+	+	CCONJ
ajmsi-2312	72	2	alp	alp	PROPN
ajmsi-2312	72	3	100	100	NUM
ajmsi-2312	72	4	mg	mg	NOUN
ajmsi-2312	72	5	od	od	NUM
ajmsi-2312	72	6	29/12/2022	29/12/2022	NUM
ajmsi-2312	72	7	942	942	NUM
ajmsi-2312	72	8	7.0	7.0	NUM
ajmsi-2312	72	9	12.4	12.4	NUM
ajmsi-2312	72	10	7.9	7.9	NUM
ajmsi-2312	72	11	hu	hu	NOUN
ajmsi-2312	72	12	1.5	1.5	NUM
ajmsi-2312	72	13	g	g	NOUN
ajmsi-2312	72	14	+	+	PROPN
ajmsi-2312	72	15	asa	asa	PROPN
ajmsi-2312	72	16	75	75	NUM
ajmsi-2312	72	17	mg	mg	PROPN
ajmsi-2312	73	1	+	+	CCONJ
ajmsi-2312	73	2	alp	alp	PROPN
ajmsi-2312	73	3	200	200	NUM
ajmsi-2312	73	4	mg	mg	PROPN
ajmsi-2312	73	5	od	od	NUM
ajmsi-2312	73	6	27/1/2023	27/1/2023	NUM
ajmsi-2312	73	7	918	918	NUM
ajmsi-2312	74	1	3.6(n=67	3.6(n=67	NUM
ajmsi-2312	74	2	%	%	NOUN
ajmsi-2312	74	3	,	,	PUNCT
ajmsi-2312	74	4	anc=2412/µl	anc=2412/µl	INTJ
ajmsi-2312	74	5	,	,	PUNCT
ajmsi-2312	74	6	l=28	l=28	ADJ
ajmsi-2312	74	7	%	%	NOUN
ajmsi-2312	74	8	)	)	PUNCT
ajmsi-2312	74	9	12.3	12.3	NUM
ajmsi-2312	74	10	12.9	12.9	NUM
ajmsi-2312	74	11	hu	hu	NOUN
ajmsi-2312	74	12	1.5	1.5	NUM
ajmsi-2312	74	13	g	g	NOUN
ajmsi-2312	74	14	+	+	PROPN
ajmsi-2312	74	15	asa	asa	PROPN
ajmsi-2312	74	16	75	75	NUM
ajmsi-2312	74	17	mg	mg	PROPN
ajmsi-2312	75	1	+	+	CCONJ
ajmsi-2312	75	2	alp	alp	PROPN
ajmsi-2312	75	3	300	300	NUM
ajmsi-2312	75	4	mg	mg	NOUN
ajmsi-2312	75	5	od	od	NUM
ajmsi-2312	75	6	10/3/2023	10/3/2023	NUM
ajmsi-2312	75	7	745	745	NUM
ajmsi-2312	75	8	3.1	3.1	NUM
ajmsi-2312	75	9	(	(	PUNCT
ajmsi-2312	75	10	n=64	n=64	PROPN
ajmsi-2312	75	11	%	%	NOUN
ajmsi-2312	75	12	,	,	PUNCT
ajmsi-2312	75	13	anc=1984/µl	anc=1984/µl	INTJ
ajmsi-2312	75	14	,	,	PUNCT
ajmsi-2312	75	15	l=28	l=28	ADJ
ajmsi-2312	75	16	%	%	NOUN
ajmsi-2312	75	17	)	)	PUNCT
ajmsi-2312	75	18	13.0	13.0	NUM
ajmsi-2312	75	19	4.6	4.6	NUM
ajmsi-2312	75	20	hu	hu	NOUN
ajmsi-2312	75	21	1.5	1.5	NUM
ajmsi-2312	75	22	g	g	NOUN
ajmsi-2312	75	23	+	+	PROPN
ajmsi-2312	75	24	asa	asa	PROPN
ajmsi-2312	75	25	75	75	NUM
ajmsi-2312	75	26	mg	mg	PROPN
ajmsi-2312	76	1	+	+	CCONJ
ajmsi-2312	76	2	alp	alp	PROPN
ajmsi-2312	76	3	300	300	NUM
ajmsi-2312	76	4	mg	mg	NOUN
ajmsi-2312	76	5	od	od	NUM
ajmsi-2312	76	6	5/5/2023	5/5/2023	NUM
ajmsi-2312	76	7	675	675	NUM
ajmsi-2312	76	8	2.2	2.2	NUM
ajmsi-2312	76	9	(	(	PUNCT
ajmsi-2312	76	10	n=63	n=63	ADJ
ajmsi-2312	76	11	%	%	INTJ
ajmsi-2312	76	12	,	,	PUNCT
ajmsi-2312	76	13	anc=1386/µl	anc=1386/µl	PROPN
ajmsi-2312	76	14	,	,	PUNCT
ajmsi-2312	76	15	l=31	l=31	PROPN
ajmsi-2312	76	16	%	%	NOUN
ajmsi-2312	76	17	)	)	PUNCT
ajmsi-2312	77	1	12.6	12.6	NUM
ajmsi-2312	77	2	3.0	3.0	NUM
ajmsi-2312	77	3	hu	hu	NOUN
ajmsi-2312	77	4	1	1	NUM
ajmsi-2312	77	5	g	g	PROPN
ajmsi-2312	77	6	+	+	PROPN
ajmsi-2312	77	7	asa	asa	PROPN
ajmsi-2312	77	8	75	75	NUM
ajmsi-2312	77	9	mg	mg	PROPN
ajmsi-2312	77	10	+	+	CCONJ
ajmsi-2312	77	11	alp	alp	PROPN
ajmsi-2312	77	12	100	100	NUM
ajmsi-2312	77	13	mg	mg	PROPN
ajmsi-2312	77	14	od	od	PROPN
ajmsi-2312	77	15	+	+	NUM
ajmsi-2312	77	16	abx	abx	NOUN
ajmsi-2312	77	17	3/7/2023	3/7/2023	NUM
ajmsi-2312	77	18	977	977	NUM
ajmsi-2312	77	19	2.6	2.6	NUM
ajmsi-2312	77	20	(	(	PUNCT
ajmsi-2312	77	21	n=59	n=59	X
ajmsi-2312	77	22	%	%	NOUN
ajmsi-2312	77	23	,	,	PUNCT
ajmsi-2312	77	24	anc=1534/µl	anc=1534/µl	PROPN
ajmsi-2312	77	25	,	,	PUNCT
ajmsi-2312	77	26	l=34	l=34	PROPN
ajmsi-2312	77	27	%	%	NOUN
ajmsi-2312	77	28	)	)	PUNCT
ajmsi-2312	77	29	13.3	13.3	NUM
ajmsi-2312	77	30	4.6	4.6	NUM
ajmsi-2312	77	31	hu	hu	NOUN
ajmsi-2312	77	32	1.5	1.5	NUM
ajmsi-2312	77	33	g	g	NOUN
ajmsi-2312	77	34	+	+	PROPN
ajmsi-2312	77	35	asa	asa	PROPN
ajmsi-2312	77	36	75mg+	75mg+	NUM
ajmsi-2312	77	37	alp	alp	NOUN
ajmsi-2312	77	38	100	100	NUM
ajmsi-2312	77	39	mg	mg	PROPN
ajmsi-2312	77	40	od	od	NUM
ajmsi-2312	77	41	14/8/2023	14/8/2023	NUM
ajmsi-2312	77	42	673	673	NUM
ajmsi-2312	77	43	2.8	2.8	NUM
ajmsi-2312	77	44	(	(	PUNCT
ajmsi-2312	77	45	n=57	n=57	NOUN
ajmsi-2312	77	46	%	%	NOUN
ajmsi-2312	77	47	,	,	PUNCT
ajmsi-2312	77	48	anc=1596/µl	anc=1596/µl	INTJ
ajmsi-2312	77	49	,	,	PUNCT
ajmsi-2312	77	50	l=38	l=38	ADJ
ajmsi-2312	77	51	%	%	NOUN
ajmsi-2312	77	52	)	)	PUNCT
ajmsi-2312	77	53	13.4	13.4	NUM
ajmsi-2312	77	54	4.0	4.0	NUM
ajmsi-2312	77	55	hu	hu	NOUN
ajmsi-2312	77	56	1.5	1.5	NUM
ajmsi-2312	77	57	g	g	NOUN
ajmsi-2312	77	58	+	+	PROPN
ajmsi-2312	77	59	asa	asa	PROPN
ajmsi-2312	77	60	75mg+	75mg+	NUM
ajmsi-2312	77	61	alp	alp	NOUN
ajmsi-2312	77	62	100	100	NUM
ajmsi-2312	77	63	mg	mg	NOUN
ajmsi-2312	77	64	od	od	NUM
ajmsi-2312	77	65	11/9/2023	11/9/2023	NUM
ajmsi-2312	77	66	535	535	NUM
ajmsi-2312	77	67	2.5	2.5	NUM
ajmsi-2312	77	68	(	(	PUNCT
ajmsi-2312	77	69	n=59	n=59	X
ajmsi-2312	77	70	%	%	NOUN
ajmsi-2312	77	71	,	,	PUNCT
ajmsi-2312	77	72	anc=1475/µl	anc=1475/µl	PROPN
ajmsi-2312	77	73	,	,	PUNCT
ajmsi-2312	77	74	l=30	l=30	PROPN
ajmsi-2312	77	75	%	%	NOUN
ajmsi-2312	77	76	)	)	PUNCT
ajmsi-2312	77	77	13.0	13.0	NUM
ajmsi-2312	77	78	3.5	3.5	NUM
ajmsi-2312	77	79	hu	hu	NOUN
ajmsi-2312	77	80	0.5	0.5	NUM
ajmsi-2312	77	81	g	g	PROPN
ajmsi-2312	77	82	+	+	PROPN
ajmsi-2312	77	83	asa	asa	PROPN
ajmsi-2312	77	84	75mg+	75mg+	NUM
ajmsi-2312	77	85	alp	alp	NOUN
ajmsi-2312	77	86	100	100	NUM
ajmsi-2312	77	87	mg	mg	PROPN
ajmsi-2312	77	88	od	od	PROPN
ajmsi-2312	77	89	+	+	NUM
ajmsi-2312	77	90	abx	abx	NOUN
ajmsi-2312	77	91	9/10/2023	9/10/2023	NUM
ajmsi-2312	77	92	1445	1445	NUM
ajmsi-2312	77	93	4.0	4.0	NUM
ajmsi-2312	77	94	13.0	13.0	NUM
ajmsi-2312	77	95	8.6	8.6	NUM
ajmsi-2312	77	96	hu	hu	NOUN
ajmsi-2312	77	97	1	1	NUM
ajmsi-2312	77	98	g	g	PROPN
ajmsi-2312	77	99	+	+	PROPN
ajmsi-2312	77	100	asa	asa	PROPN
ajmsi-2312	77	101	75	75	NUM
ajmsi-2312	77	102	mg	mg	PROPN
ajmsi-2312	78	1	+	+	CCONJ
ajmsi-2312	78	2	alp	alp	PROPN
ajmsi-2312	78	3	200	200	NUM
ajmsi-2312	78	4	mg	mg	PROPN
ajmsi-2312	78	5	od	od	PROPN
ajmsi-2312	78	6	8/11/2023	8/11/2023	NUM
ajmsi-2312	78	7	899	899	NUM
ajmsi-2312	78	8	3.8	3.8	NUM
ajmsi-2312	78	9	(	(	PUNCT
ajmsi-2312	78	10	n=63	n=63	ADJ
ajmsi-2312	78	11	%	%	INTJ
ajmsi-2312	78	12	,	,	PUNCT
ajmsi-2312	78	13	anc=2394/µl	anc=2394/µl	PROPN
ajmsi-2312	78	14	,	,	PUNCT
ajmsi-2312	78	15	l=31	l=31	PROPN
ajmsi-2312	78	16	%	%	NOUN
ajmsi-2312	78	17	)	)	PUNCT
ajmsi-2312	78	18	12.7	12.7	NUM
ajmsi-2312	78	19	2.5	2.5	NUM
ajmsi-2312	78	20	hu	hu	NOUN
ajmsi-2312	78	21	1.5	1.5	NUM
ajmsi-2312	78	22	g	g	NOUN
ajmsi-2312	78	23	+	+	PROPN
ajmsi-2312	78	24	asa	asa	PROPN
ajmsi-2312	78	25	75	75	NUM
ajmsi-2312	78	26	mg	mg	PROPN
ajmsi-2312	79	1	+	+	CCONJ
ajmsi-2312	79	2	alp	alp	PROPN
ajmsi-2312	79	3	200	200	NUM
ajmsi-2312	79	4	mg	mg	PROPN
ajmsi-2312	79	5	od	od	PROPN
ajmsi-2312	79	6	key	key	NOUN
ajmsi-2312	79	7	:	:	PUNCT
ajmsi-2312	79	8	note	note	VERB
ajmsi-2312	79	9	the	the	DET
ajmsi-2312	79	10	adjustment	adjustment	NOUN
ajmsi-2312	79	11	of	of	ADP
ajmsi-2312	79	12	hu	hu	PROPN
ajmsi-2312	79	13	dosages	dosage	NOUN
ajmsi-2312	79	14	whenever	whenever	SCONJ
ajmsi-2312	79	15	the	the	DET
ajmsi-2312	79	16	absolute	absolute	ADJ
ajmsi-2312	79	17	neutrophil	neutrophil	ADJ
ajmsi-2312	79	18	count	count	NOUN
ajmsi-2312	79	19	dropped	drop	VERB
ajmsi-2312	79	20	below	below	ADP
ajmsi-2312	79	21	1500/µl	1500/µl	NUM
ajmsi-2312	79	22	,	,	PUNCT
ajmsi-2312	79	23	and	and	CCONJ
ajmsi-2312	79	24	the	the	DET
ajmsi-2312	79	25	subsequent	subsequent	ADJ
ajmsi-2312	79	26	precipitous	precipitous	ADJ
ajmsi-2312	79	27	increase	increase	NOUN
ajmsi-2312	79	28	in	in	ADP
ajmsi-2312	79	29	platelet	platelet	NOUN
ajmsi-2312	79	30	counts	count	NOUN
ajmsi-2312	79	31	and	and	CCONJ
ajmsi-2312	79	32	uric	uric	ADJ
ajmsi-2312	79	33	acid	acid	NOUN
ajmsi-2312	79	34	levels	level	NOUN
ajmsi-2312	79	35	results	result	VERB
ajmsi-2312	79	36	and	and	CCONJ
ajmsi-2312	79	37	discussion	discussion	VERB
ajmsi-2312	79	38	a	a	DET
ajmsi-2312	79	39	diagnostic	diagnostic	ADJ
ajmsi-2312	79	40	evaluation	evaluation	NOUN
ajmsi-2312	79	41	of	of	ADP
ajmsi-2312	79	42	suspected	suspect	VERB
ajmsi-2312	79	43	et	et	NOUN
ajmsi-2312	79	44	includes	include	VERB
ajmsi-2312	79	45	a	a	DET
ajmsi-2312	79	46	medical	medical	ADJ
ajmsi-2312	79	47	history	history	NOUN
ajmsi-2312	79	48	focused	focus	VERB
ajmsi-2312	79	49	on	on	ADP
ajmsi-2312	79	50	the	the	DET
ajmsi-2312	79	51	occurrence	occurrence	NOUN
ajmsi-2312	79	52	of	of	ADP
ajmsi-2312	79	53	thrombotic	thrombotic	ADJ
ajmsi-2312	79	54	and	and	CCONJ
ajmsi-2312	79	55	hemorrhagic	hemorrhagic	ADJ
ajmsi-2312	79	56	manifestations	manifestation	NOUN
ajmsi-2312	79	57	,	,	PUNCT
ajmsi-2312	79	58	with	with	ADP
ajmsi-2312	79	59	a	a	DET
ajmsi-2312	79	60	careful	careful	ADJ
ajmsi-2312	79	61	search	search	NOUN
ajmsi-2312	79	62	for	for	ADP
ajmsi-2312	79	63	concomitant	concomitant	ADJ
ajmsi-2312	79	64	cardiovascular	cardiovascular	ADJ
ajmsi-2312	79	65	risk	risk	NOUN
ajmsi-2312	79	66	factors	factor	NOUN
ajmsi-2312	79	67	in	in	ADP
ajmsi-2312	79	68	the	the	DET
ajmsi-2312	79	69	setting	setting	NOUN
ajmsi-2312	79	70	of	of	ADP
ajmsi-2312	79	71	thrombotic	thrombotic	ADJ
ajmsi-2312	79	72	complications	complication	NOUN
ajmsi-2312	79	73	.	.	PUNCT
ajmsi-2312	80	1	the	the	DET
ajmsi-2312	80	2	diagnostic	diagnostic	ADJ
ajmsi-2312	80	3	criteria	criterion	NOUN
ajmsi-2312	80	4	of	of	ADP
ajmsi-2312	80	5	et	et	PRON
ajmsi-2312	80	6	by	by	ADP
ajmsi-2312	80	7	the	the	DET
ajmsi-2312	80	8	world	world	PROPN
ajmsi-2312	80	9	health	health	PROPN
ajmsi-2312	80	10	organization	organization	NOUN
ajmsi-2312	80	11	and	and	CCONJ
ajmsi-2312	80	12	the	the	DET
ajmsi-2312	80	13	international	international	ADJ
ajmsi-2312	80	14	consensus	consensus	NOUN
ajmsi-2312	80	15	classification	classification	NOUN
ajmsi-2312	80	16	(	(	PUNCT
ajmsi-2312	80	17	arber	arber	PROPN
ajmsi-2312	80	18	et	et	PROPN
ajmsi-2312	80	19	al	al	PROPN
ajmsi-2312	80	20	.	.	PROPN
ajmsi-2312	80	21	,	,	PUNCT
ajmsi-2312	80	22	2022	2022	NUM
ajmsi-2312	80	23	)	)	PUNCT
ajmsi-2312	80	24	require	require	VERB
ajmsi-2312	80	25	either	either	CCONJ
ajmsi-2312	80	26	all	all	DET
ajmsi-2312	80	27	four	four	NUM
ajmsi-2312	80	28	of	of	ADP
ajmsi-2312	80	29	the	the	DET
ajmsi-2312	80	30	major	major	ADJ
ajmsi-2312	80	31	criteria	criterion	NOUN
ajmsi-2312	80	32	or	or	CCONJ
ajmsi-2312	80	33	the	the	DET
ajmsi-2312	80	34	first	first	ADJ
ajmsi-2312	80	35	three	three	NUM
ajmsi-2312	80	36	major	major	ADJ
ajmsi-2312	80	37	criteria	criterion	NOUN
ajmsi-2312	80	38	plus	plus	CCONJ
ajmsi-2312	80	39	the	the	DET
ajmsi-2312	80	40	minor	minor	ADJ
ajmsi-2312	80	41	criterion	criterion	NOUN
ajmsi-2312	80	42	,	,	PUNCT
ajmsi-2312	80	43	as	as	SCONJ
ajmsi-2312	80	44	shown	show	VERB
ajmsi-2312	80	45	in	in	ADP
ajmsi-2312	80	46	table	table	NOUN
ajmsi-2312	80	47	2	2	NUM
ajmsi-2312	80	48	below	below	ADV
ajmsi-2312	80	49	.	.	PUNCT
ajmsi-2312	81	1	pa	pa	PROPN
ajmsi-2312	81	2	ge	ge	PROPN
ajmsi-2312	81	3	4	4	NUM
ajmsi-2312	81	4	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	81	5	am	be	AUX
ajmsi-2312	81	6	.	.	PUNCT
ajmsi-2312	82	1	j.	j.	PROPN
ajmsi-2312	82	2	med	med	PROPN
ajmsi-2312	82	3	.	.	PUNCT
ajmsi-2312	83	1	sci	sci	PROPN
ajmsi-2312	83	2	.	.	PUNCT
ajmsi-2312	83	3	innov	innov	PROPN
ajmsi-2312	83	4	.	.	PUNCT
ajmsi-2312	84	1	3(1	3(1	NUM
ajmsi-2312	84	2	)	)	PUNCT
ajmsi-2312	84	3	1	1	NUM
ajmsi-2312	84	4	-	-	SYM
ajmsi-2312	84	5	7	7	NUM
ajmsi-2312	84	6	,	,	PUNCT
ajmsi-2312	84	7	2024	2024	NUM
ajmsi-2312	84	8	in	in	ADP
ajmsi-2312	84	9	our	our	PRON
ajmsi-2312	84	10	patient	patient	NOUN
ajmsi-2312	84	11	,	,	PUNCT
ajmsi-2312	84	12	it	it	PRON
ajmsi-2312	84	13	was	be	AUX
ajmsi-2312	84	14	not	not	PART
ajmsi-2312	84	15	possible	possible	ADJ
ajmsi-2312	84	16	to	to	PART
ajmsi-2312	84	17	do	do	VERB
ajmsi-2312	84	18	a	a	DET
ajmsi-2312	84	19	bone	bone	NOUN
ajmsi-2312	84	20	marrow	marrow	NOUN
ajmsi-2312	84	21	aspiration	aspiration	NOUN
ajmsi-2312	84	22	and	and	CCONJ
ajmsi-2312	84	23	trephine	trephine	NOUN
ajmsi-2312	84	24	biopsy	biopsy	NOUN
ajmsi-2312	84	25	(	(	PUNCT
ajmsi-2312	84	26	bmat	bmat	NOUN
ajmsi-2312	84	27	)	)	PUNCT
ajmsi-2312	84	28	or	or	CCONJ
ajmsi-2312	84	29	any	any	DET
ajmsi-2312	84	30	genetic	genetic	ADJ
ajmsi-2312	84	31	tests	test	NOUN
ajmsi-2312	84	32	for	for	ADP
ajmsi-2312	84	33	jak2	jak2	NOUN
ajmsi-2312	84	34	,	,	PUNCT
ajmsi-2312	84	35	calr	calr	ADJ
ajmsi-2312	84	36	,	,	PUNCT
ajmsi-2312	84	37	or	or	CCONJ
ajmsi-2312	84	38	mpl	mpl	NOUN
ajmsi-2312	84	39	mutations	mutation	NOUN
ajmsi-2312	84	40	due	due	ADJ
ajmsi-2312	84	41	to	to	ADP
ajmsi-2312	84	42	severe	severe	ADJ
ajmsi-2312	84	43	financial	financial	ADJ
ajmsi-2312	84	44	challenges	challenge	NOUN
ajmsi-2312	84	45	.	.	PUNCT
ajmsi-2312	85	1	these	these	DET
ajmsi-2312	85	2	services	service	NOUN
ajmsi-2312	85	3	are	be	AUX
ajmsi-2312	85	4	not	not	PART
ajmsi-2312	85	5	readily	readily	ADV
ajmsi-2312	85	6	available	available	ADJ
ajmsi-2312	85	7	in	in	ADP
ajmsi-2312	85	8	the	the	DET
ajmsi-2312	85	9	vast	vast	ADJ
ajmsi-2312	85	10	majority	majority	NOUN
ajmsi-2312	85	11	of	of	ADP
ajmsi-2312	85	12	our	our	PRON
ajmsi-2312	85	13	health	health	NOUN
ajmsi-2312	85	14	centers	center	NOUN
ajmsi-2312	85	15	,	,	PUNCT
ajmsi-2312	85	16	and	and	CCONJ
ajmsi-2312	85	17	their	their	PRON
ajmsi-2312	85	18	access	access	NOUN
ajmsi-2312	85	19	upon	upon	SCONJ
ajmsi-2312	85	20	referrals	referral	NOUN
ajmsi-2312	85	21	to	to	ADP
ajmsi-2312	85	22	regional	regional	ADJ
ajmsi-2312	85	23	reference	reference	NOUN
ajmsi-2312	85	24	laboratory	laboratory	NOUN
ajmsi-2312	85	25	centers	center	NOUN
ajmsi-2312	85	26	is	be	AUX
ajmsi-2312	85	27	severely	severely	ADV
ajmsi-2312	85	28	hindered	hinder	VERB
ajmsi-2312	85	29	by	by	ADP
ajmsi-2312	85	30	their	their	PRON
ajmsi-2312	85	31	prohibitive	prohibitive	ADJ
ajmsi-2312	85	32	costs	cost	NOUN
ajmsi-2312	85	33	.	.	PUNCT
ajmsi-2312	86	1	the	the	DET
ajmsi-2312	86	2	main	main	ADJ
ajmsi-2312	86	3	differential	differential	ADJ
ajmsi-2312	86	4	diagnosis	diagnosis	NOUN
ajmsi-2312	86	5	for	for	ADP
ajmsi-2312	86	6	et	et	NOUN
ajmsi-2312	86	7	is	be	AUX
ajmsi-2312	86	8	reactive	reactive	ADJ
ajmsi-2312	86	9	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	86	10	(	(	PUNCT
ajmsi-2312	86	11	rt	rt	NOUN
ajmsi-2312	86	12	)	)	PUNCT
ajmsi-2312	86	13	.	.	PUNCT
ajmsi-2312	87	1	platelets	platelet	NOUN
ajmsi-2312	87	2	are	be	AUX
ajmsi-2312	87	3	also	also	ADV
ajmsi-2312	87	4	members	member	NOUN
ajmsi-2312	87	5	of	of	ADP
ajmsi-2312	87	6	the	the	DET
ajmsi-2312	87	7	acute	acute	ADJ
ajmsi-2312	87	8	phase	phase	NOUN
ajmsi-2312	87	9	reactant	reactant	NOUN
ajmsi-2312	87	10	superfamily	superfamily	NOUN
ajmsi-2312	87	11	,	,	PUNCT
ajmsi-2312	87	12	which	which	PRON
ajmsi-2312	87	13	will	will	AUX
ajmsi-2312	87	14	be	be	AUX
ajmsi-2312	87	15	elevated	elevate	VERB
ajmsi-2312	87	16	in	in	ADP
ajmsi-2312	87	17	many	many	ADJ
ajmsi-2312	87	18	inflammatory	inflammatory	ADJ
ajmsi-2312	87	19	and	and	CCONJ
ajmsi-2312	87	20	other	other	ADJ
ajmsi-2312	87	21	conditions	condition	NOUN
ajmsi-2312	87	22	,	,	PUNCT
ajmsi-2312	87	23	e.g.	e.g.	ADV
ajmsi-2312	87	24	,	,	PUNCT
ajmsi-2312	87	25	infections	infection	NOUN
ajmsi-2312	87	26	,	,	PUNCT
ajmsi-2312	87	27	iron	iron	NOUN
ajmsi-2312	87	28	deficiency	deficiency	NOUN
ajmsi-2312	87	29	anemia	anemia	NOUN
ajmsi-2312	87	30	,	,	PUNCT
ajmsi-2312	87	31	acute	acute	NOUN
ajmsi-2312	87	32	bleeding	bleeding	NOUN
ajmsi-2312	87	33	,	,	PUNCT
ajmsi-2312	87	34	trauma	trauma	NOUN
ajmsi-2312	87	35	,	,	PUNCT
ajmsi-2312	87	36	asplenia	asplenia	NOUN
ajmsi-2312	87	37	,	,	PUNCT
ajmsi-2312	87	38	etc	etc	X
ajmsi-2312	87	39	.	.	PUNCT
ajmsi-2312	87	40	)	)	PUNCT
ajmsi-2312	88	1	patients	patient	NOUN
ajmsi-2312	88	2	with	with	ADP
ajmsi-2312	88	3	rt	rt	PROPN
ajmsi-2312	88	4	will	will	AUX
ajmsi-2312	88	5	have	have	VERB
ajmsi-2312	88	6	evidence	evidence	NOUN
ajmsi-2312	88	7	of	of	ADP
ajmsi-2312	88	8	these	these	DET
ajmsi-2312	88	9	conditions	condition	NOUN
ajmsi-2312	88	10	as	as	ADV
ajmsi-2312	88	11	well	well	ADV
ajmsi-2312	88	12	as	as	ADP
ajmsi-2312	88	13	elevation	elevation	NOUN
ajmsi-2312	88	14	of	of	ADP
ajmsi-2312	88	15	other	other	ADJ
ajmsi-2312	88	16	acute	acute	ADJ
ajmsi-2312	88	17	phase	phase	NOUN
ajmsi-2312	88	18	reactants	reactant	NOUN
ajmsi-2312	88	19	(	(	PUNCT
ajmsi-2312	88	20	e.g.	e.g.	ADV
ajmsi-2312	88	21	,	,	PUNCT
ajmsi-2312	88	22	c	c	NOUN
ajmsi-2312	88	23	-	-	PUNCT
ajmsi-2312	88	24	reactive	reactive	ADJ
ajmsi-2312	88	25	protein	protein	NOUN
ajmsi-2312	88	26	,	,	PUNCT
ajmsi-2312	88	27	erythrocyte	erythrocyte	PROPN
ajmsi-2312	88	28	sedimentation	sedimentation	NOUN
ajmsi-2312	88	29	rate	rate	NOUN
ajmsi-2312	88	30	,	,	PUNCT
ajmsi-2312	88	31	ferritin	ferritin	ADJ
ajmsi-2312	88	32	,	,	PUNCT
ajmsi-2312	88	33	etc	etc	X
ajmsi-2312	88	34	.	.	X
ajmsi-2312	88	35	)	)	PUNCT
ajmsi-2312	88	36	.	.	PUNCT
ajmsi-2312	89	1	(	(	PUNCT
ajmsi-2312	89	2	schafer	schafer	NOUN
ajmsi-2312	89	3	,	,	PUNCT
ajmsi-2312	89	4	2004	2004	NUM
ajmsi-2312	89	5	)	)	PUNCT
ajmsi-2312	89	6	.	.	PUNCT
ajmsi-2312	90	1	other	other	ADJ
ajmsi-2312	90	2	mpns	mpns	NOUN
ajmsi-2312	90	3	must	must	AUX
ajmsi-2312	90	4	also	also	ADV
ajmsi-2312	90	5	be	be	AUX
ajmsi-2312	90	6	excluded	exclude	VERB
ajmsi-2312	90	7	prior	prior	ADV
ajmsi-2312	90	8	to	to	ADP
ajmsi-2312	90	9	initiating	initiate	VERB
ajmsi-2312	90	10	treatment	treatment	NOUN
ajmsi-2312	90	11	for	for	ADP
ajmsi-2312	90	12	et	et	NOUN
ajmsi-2312	90	13	.	.	PUNCT
ajmsi-2312	91	1	in	in	ADP
ajmsi-2312	91	2	our	our	PRON
ajmsi-2312	91	3	patient	patient	NOUN
ajmsi-2312	91	4	,	,	PUNCT
ajmsi-2312	91	5	a	a	DET
ajmsi-2312	91	6	targeted	target	VERB
ajmsi-2312	91	7	clinical	clinical	ADJ
ajmsi-2312	91	8	evaluation	evaluation	NOUN
ajmsi-2312	91	9	ruled	rule	VERB
ajmsi-2312	91	10	out	out	ADP
ajmsi-2312	91	11	alternative	alternative	ADJ
ajmsi-2312	91	12	diagnoses	diagnosis	NOUN
ajmsi-2312	91	13	.	.	PUNCT
ajmsi-2312	92	1	he	he	PRON
ajmsi-2312	92	2	had	have	VERB
ajmsi-2312	92	3	no	no	DET
ajmsi-2312	92	4	features	feature	NOUN
ajmsi-2312	92	5	of	of	ADP
ajmsi-2312	92	6	inflammation	inflammation	NOUN
ajmsi-2312	92	7	or	or	CCONJ
ajmsi-2312	92	8	trauma	trauma	NOUN
ajmsi-2312	92	9	;	;	PUNCT
ajmsi-2312	92	10	he	he	PRON
ajmsi-2312	92	11	had	have	VERB
ajmsi-2312	92	12	a	a	DET
ajmsi-2312	92	13	normal	normal	ADJ
ajmsi-2312	92	14	esr	esr	NOUN
ajmsi-2312	92	15	;	;	PUNCT
ajmsi-2312	92	16	he	he	PRON
ajmsi-2312	92	17	maintained	maintain	VERB
ajmsi-2312	92	18	a	a	DET
ajmsi-2312	92	19	persistently	persistently	ADV
ajmsi-2312	92	20	normal	normal	ADJ
ajmsi-2312	92	21	leucocyte	leucocyte	NOUN
ajmsi-2312	92	22	count	count	NOUN
ajmsi-2312	92	23	(	(	PUNCT
ajmsi-2312	92	24	pretreatment	pretreatment	NOUN
ajmsi-2312	92	25	)	)	PUNCT
ajmsi-2312	92	26	and	and	CCONJ
ajmsi-2312	92	27	normal	normal	ADJ
ajmsi-2312	92	28	hemoglobin	hemoglobin	NOUN
ajmsi-2312	92	29	;	;	PUNCT
ajmsi-2312	92	30	and	and	CCONJ
ajmsi-2312	92	31	his	his	PRON
ajmsi-2312	92	32	platelets	platelet	NOUN
ajmsi-2312	92	33	were	be	AUX
ajmsi-2312	92	34	too	too	ADV
ajmsi-2312	92	35	high	high	ADJ
ajmsi-2312	92	36	to	to	PART
ajmsi-2312	92	37	be	be	AUX
ajmsi-2312	92	38	compatible	compatible	ADJ
ajmsi-2312	92	39	with	with	ADP
ajmsi-2312	92	40	just	just	ADV
ajmsi-2312	92	41	a	a	DET
ajmsi-2312	92	42	rt	rt	PROPN
ajmsi-2312	92	43	.	.	PUNCT
ajmsi-2312	93	1	a	a	DET
ajmsi-2312	93	2	validated	validate	VERB
ajmsi-2312	93	3	simple	simple	ADJ
ajmsi-2312	93	4	laboratory	laboratory	NOUN
ajmsi-2312	93	5	scoring	scoring	NOUN
ajmsi-2312	93	6	system	system	NOUN
ajmsi-2312	93	7	based	base	VERB
ajmsi-2312	93	8	on	on	ADP
ajmsi-2312	93	9	a	a	DET
ajmsi-2312	93	10	complete	complete	ADJ
ajmsi-2312	93	11	blood	blood	NOUN
ajmsi-2312	93	12	count	count	NOUN
ajmsi-2312	93	13	that	that	PRON
ajmsi-2312	93	14	distinguishes	distinguish	VERB
ajmsi-2312	93	15	et	et	PRON
ajmsi-2312	93	16	from	from	ADP
ajmsi-2312	93	17	rt	rt	PROPN
ajmsi-2312	93	18	is	be	AUX
ajmsi-2312	93	19	consistent	consistent	ADJ
ajmsi-2312	93	20	with	with	ADP
ajmsi-2312	93	21	our	our	PRON
ajmsi-2312	93	22	assessment	assessment	NOUN
ajmsi-2312	93	23	of	of	ADP
ajmsi-2312	93	24	et	et	PRON
ajmsi-2312	93	25	in	in	ADP
ajmsi-2312	93	26	this	this	DET
ajmsi-2312	93	27	case	case	NOUN
ajmsi-2312	93	28	(	(	PUNCT
ajmsi-2312	93	29	shen	shen	NOUN
ajmsi-2312	93	30	et	et	PROPN
ajmsi-2312	93	31	al	al	PROPN
ajmsi-2312	93	32	.	.	PROPN
ajmsi-2312	93	33	,	,	PUNCT
ajmsi-2312	93	34	2021	2021	NUM
ajmsi-2312	93	35	)	)	PUNCT
ajmsi-2312	93	36	.	.	PUNCT
ajmsi-2312	94	1	at	at	ADP
ajmsi-2312	94	2	any	any	DET
ajmsi-2312	94	3	rate	rate	NOUN
ajmsi-2312	94	4	,	,	PUNCT
ajmsi-2312	94	5	one	one	PRON
ajmsi-2312	94	6	would	would	AUX
ajmsi-2312	94	7	expect	expect	VERB
ajmsi-2312	94	8	massive	massive	ADJ
ajmsi-2312	94	9	splenomegaly	splenomegaly	NOUN
ajmsi-2312	94	10	with	with	ADP
ajmsi-2312	94	11	cml	cml	PROPN
ajmsi-2312	94	12	(	(	PUNCT
ajmsi-2312	94	13	and	and	CCONJ
ajmsi-2312	94	14	severe	severe	ADJ
ajmsi-2312	94	15	leukocytosis	leukocytosis	NOUN
ajmsi-2312	94	16	)	)	PUNCT
ajmsi-2312	94	17	and	and	CCONJ
ajmsi-2312	94	18	pmf	pmf	PROPN
ajmsi-2312	94	19	(	(	PUNCT
ajmsi-2312	94	20	and	and	CCONJ
ajmsi-2312	94	21	severe	severe	ADJ
ajmsi-2312	94	22	anemia	anemia	NOUN
ajmsi-2312	94	23	)	)	PUNCT
ajmsi-2312	94	24	,	,	PUNCT
ajmsi-2312	94	25	while	while	SCONJ
ajmsi-2312	94	26	pv	pv	NOUN
ajmsi-2312	94	27	would	would	AUX
ajmsi-2312	94	28	have	have	AUX
ajmsi-2312	94	29	marked	mark	VERB
ajmsi-2312	94	30	polycythemia	polycythemia	NOUN
ajmsi-2312	94	31	.	.	PUNCT
ajmsi-2312	95	1	the	the	DET
ajmsi-2312	95	2	goals	goal	NOUN
ajmsi-2312	95	3	of	of	ADP
ajmsi-2312	95	4	treatment	treatment	NOUN
ajmsi-2312	95	5	in	in	ADP
ajmsi-2312	95	6	et	et	NOUN
ajmsi-2312	95	7	are	be	AUX
ajmsi-2312	95	8	to	to	PART
ajmsi-2312	95	9	alleviate	alleviate	VERB
ajmsi-2312	95	10	vasomotor	vasomotor	NOUN
ajmsi-2312	95	11	symptoms	symptom	NOUN
ajmsi-2312	95	12	,	,	PUNCT
ajmsi-2312	95	13	reduce	reduce	VERB
ajmsi-2312	95	14	the	the	DET
ajmsi-2312	95	15	complications	complication	NOUN
ajmsi-2312	95	16	related	relate	VERB
ajmsi-2312	95	17	to	to	ADP
ajmsi-2312	95	18	thrombosis	thrombosis	NOUN
ajmsi-2312	95	19	and/or	and/or	CCONJ
ajmsi-2312	95	20	hemorrhage	hemorrhage	NOUN
ajmsi-2312	95	21	,	,	PUNCT
ajmsi-2312	95	22	and	and	CCONJ
ajmsi-2312	95	23	control	control	NOUN
ajmsi-2312	95	24	splenomegaly	splenomegaly	PROPN
ajmsi-2312	96	1	(	(	PUNCT
ajmsi-2312	96	2	if	if	SCONJ
ajmsi-2312	96	3	present	present	ADJ
ajmsi-2312	96	4	)	)	PUNCT
ajmsi-2312	96	5	.	.	PUNCT
ajmsi-2312	97	1	decisions	decision	NOUN
ajmsi-2312	97	2	on	on	ADP
ajmsi-2312	97	3	therapeutic	therapeutic	ADJ
ajmsi-2312	97	4	choices	choice	NOUN
ajmsi-2312	97	5	are	be	AUX
ajmsi-2312	97	6	based	base	VERB
ajmsi-2312	97	7	on	on	ADP
ajmsi-2312	97	8	individual	individual	ADJ
ajmsi-2312	97	9	risk	risk	NOUN
ajmsi-2312	97	10	stratification	stratification	NOUN
ajmsi-2312	97	11	and	and	CCONJ
ajmsi-2312	97	12	the	the	DET
ajmsi-2312	97	13	availability	availability	NOUN
ajmsi-2312	97	14	and	and	CCONJ
ajmsi-2312	97	15	tolerability	tolerability	NOUN
ajmsi-2312	97	16	of	of	ADP
ajmsi-2312	97	17	the	the	DET
ajmsi-2312	97	18	various	various	ADJ
ajmsi-2312	97	19	agents	agent	NOUN
ajmsi-2312	97	20	.	.	PUNCT
ajmsi-2312	98	1	low	low	ADJ
ajmsi-2312	98	2	-	-	PUNCT
ajmsi-2312	98	3	dose	dose	NOUN
ajmsi-2312	98	4	aspirin	aspirin	NOUN
ajmsi-2312	98	5	(	(	PUNCT
ajmsi-2312	98	6	40100	40100	NUM
ajmsi-2312	98	7	mg	mg	PRON
ajmsi-2312	98	8	orally	orally	ADV
ajmsi-2312	98	9	administered	administer	VERB
ajmsi-2312	98	10	once	once	ADV
ajmsi-2312	98	11	daily	daily	ADV
ajmsi-2312	98	12	)	)	PUNCT
ajmsi-2312	98	13	and	and	CCONJ
ajmsi-2312	98	14	hu	hu	PROPN
ajmsi-2312	98	15	(	(	PUNCT
ajmsi-2312	98	16	at	at	ADP
ajmsi-2312	98	17	15	15	NUM
ajmsi-2312	98	18	mg	mg	PROPN
ajmsi-2312	98	19	/	/	SYM
ajmsi-2312	98	20	kg	kg	NOUN
ajmsi-2312	98	21	/	/	SYM
ajmsi-2312	98	22	day	day	NOUN
ajmsi-2312	98	23	orally	orally	ADV
ajmsi-2312	98	24	administered	administer	VERB
ajmsi-2312	98	25	at	at	ADP
ajmsi-2312	98	26	a	a	DET
ajmsi-2312	98	27	usual	usual	ADJ
ajmsi-2312	98	28	starting	starting	NOUN
ajmsi-2312	98	29	dose	dose	NOUN
ajmsi-2312	98	30	of	of	ADP
ajmsi-2312	98	31	500	500	NUM
ajmsi-2312	98	32	mg	mg	NOUN
ajmsi-2312	98	33	once	once	ADV
ajmsi-2312	98	34	or	or	CCONJ
ajmsi-2312	98	35	twice	twice	ADV
ajmsi-2312	98	36	daily	daily	ADV
ajmsi-2312	98	37	)	)	PUNCT
ajmsi-2312	98	38	are	be	AUX
ajmsi-2312	98	39	first	first	ADJ
ajmsi-2312	98	40	-	-	PUNCT
ajmsi-2312	98	41	line	line	NOUN
ajmsi-2312	98	42	agents	agent	NOUN
ajmsi-2312	98	43	(	(	PUNCT
ajmsi-2312	98	44	tefferi	tefferi	ADJ
ajmsi-2312	98	45	&	&	CCONJ
ajmsi-2312	98	46	barbui	barbui	ADJ
ajmsi-2312	98	47	,	,	PUNCT
ajmsi-2312	98	48	2020	2020	NUM
ajmsi-2312	98	49	)	)	PUNCT
ajmsi-2312	98	50	.	.	PUNCT
ajmsi-2312	99	1	aspirin	aspirin	PROPN
ajmsi-2312	99	2	can	can	AUX
ajmsi-2312	99	3	reduce	reduce	VERB
ajmsi-2312	99	4	vasomotor	vasomotor	NOUN
ajmsi-2312	99	5	symptoms	symptom	NOUN
ajmsi-2312	99	6	and	and	CCONJ
ajmsi-2312	99	7	thrombo	thrombo	NOUN
ajmsi-2312	99	8	-	-	PUNCT
ajmsi-2312	99	9	hemorrhagic	hemorrhagic	NOUN
ajmsi-2312	99	10	complications	complication	NOUN
ajmsi-2312	99	11	in	in	ADP
ajmsi-2312	99	12	most	most	ADJ
ajmsi-2312	99	13	cases	case	NOUN
ajmsi-2312	99	14	of	of	ADP
ajmsi-2312	99	15	et	et	NOUN
ajmsi-2312	99	16	.	.	PUNCT
ajmsi-2312	100	1	higher	high	ADJ
ajmsi-2312	100	2	doses	dose	NOUN
ajmsi-2312	100	3	are	be	AUX
ajmsi-2312	100	4	associated	associate	VERB
ajmsi-2312	100	5	with	with	ADP
ajmsi-2312	100	6	increased	increase	VERB
ajmsi-2312	100	7	risks	risk	NOUN
ajmsi-2312	100	8	of	of	ADP
ajmsi-2312	100	9	gastritis	gastritis	NOUN
ajmsi-2312	100	10	and	and	CCONJ
ajmsi-2312	100	11	gastrointestinal	gastrointestinal	ADJ
ajmsi-2312	100	12	bleeding	bleeding	NOUN
ajmsi-2312	100	13	.	.	PUNCT
ajmsi-2312	101	1	hu	hu	PROPN
ajmsi-2312	101	2	is	be	AUX
ajmsi-2312	101	3	effective	effective	ADJ
ajmsi-2312	101	4	in	in	ADP
ajmsi-2312	101	5	reducing	reduce	VERB
ajmsi-2312	101	6	platelet	platelet	NOUN
ajmsi-2312	101	7	counts	count	NOUN
ajmsi-2312	101	8	,	,	PUNCT
ajmsi-2312	101	9	controlling	control	VERB
ajmsi-2312	101	10	splenomegaly	splenomegaly	ADJ
ajmsi-2312	101	11	,	,	PUNCT
ajmsi-2312	101	12	and	and	CCONJ
ajmsi-2312	101	13	reducing	reduce	VERB
ajmsi-2312	101	14	vasomotor	vasomotor	NOUN
ajmsi-2312	101	15	symptoms	symptom	NOUN
ajmsi-2312	101	16	in	in	ADP
ajmsi-2312	101	17	et	et	NOUN
ajmsi-2312	101	18	.	.	PUNCT
ajmsi-2312	102	1	the	the	DET
ajmsi-2312	102	2	dose	dose	PROPN
ajmsi-2312	102	3	of	of	ADP
ajmsi-2312	102	4	hu	hu	PROPN
ajmsi-2312	102	5	is	be	AUX
ajmsi-2312	102	6	adjusted	adjust	VERB
ajmsi-2312	102	7	to	to	ADP
ajmsi-2312	102	8	a	a	DET
ajmsi-2312	102	9	target	target	NOUN
ajmsi-2312	102	10	platelet	platelet	NOUN
ajmsi-2312	102	11	count	count	NOUN
ajmsi-2312	102	12	of	of	ADP
ajmsi-2312	102	13	100,000	100,000	NUM
ajmsi-2312	102	14	-	-	NUM
ajmsi-2312	102	15	450,000/µl	450,000/µl	NUM
ajmsi-2312	102	16	while	while	SCONJ
ajmsi-2312	102	17	limiting	limit	VERB
ajmsi-2312	102	18	leukocytopenia	leukocytopenia	NOUN
ajmsi-2312	102	19	and	and	CCONJ
ajmsi-2312	102	20	anemia	anemia	NOUN
ajmsi-2312	102	21	by	by	ADP
ajmsi-2312	102	22	doing	do	VERB
ajmsi-2312	102	23	weeklyto	weeklyto	VERB
ajmsi-2312	102	24	-	-	PUNCT
ajmsi-2312	102	25	monthly	monthly	ADJ
ajmsi-2312	102	26	complete	complete	ADJ
ajmsi-2312	102	27	blood	blood	NOUN
ajmsi-2312	102	28	count	count	NOUN
ajmsi-2312	102	29	monitoring	monitoring	NOUN
ajmsi-2312	102	30	(	(	PUNCT
ajmsi-2312	102	31	tefferi	tefferi	ADJ
ajmsi-2312	102	32	&	&	CCONJ
ajmsi-2312	102	33	barbui	barbui	ADJ
ajmsi-2312	102	34	,	,	PUNCT
ajmsi-2312	102	35	2020	2020	NUM
ajmsi-2312	102	36	)	)	PUNCT
ajmsi-2312	102	37	.	.	PUNCT
ajmsi-2312	103	1	the	the	DET
ajmsi-2312	103	2	response	response	NOUN
ajmsi-2312	103	3	rates	rate	NOUN
ajmsi-2312	103	4	of	of	ADP
ajmsi-2312	103	5	hu	hu	PROPN
ajmsi-2312	103	6	vary	vary	VERB
ajmsi-2312	103	7	from	from	ADP
ajmsi-2312	103	8	about	about	ADV
ajmsi-2312	103	9	80	80	NUM
ajmsi-2312	103	10	%	%	NOUN
ajmsi-2312	103	11	complete	complete	ADJ
ajmsi-2312	103	12	response	response	NOUN
ajmsi-2312	103	13	to	to	ADP
ajmsi-2312	103	14	15	15	NUM
ajmsi-2312	103	15	%	%	NOUN
ajmsi-2312	103	16	partial	partial	ADJ
ajmsi-2312	103	17	response	response	NOUN
ajmsi-2312	103	18	using	use	VERB
ajmsi-2312	103	19	the	the	DET
ajmsi-2312	103	20	international	international	ADJ
ajmsi-2312	103	21	working	working	NOUN
ajmsi-2312	103	22	group	group	NOUN
ajmsi-2312	103	23	-	-	PUNCT
ajmsi-2312	103	24	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	103	25	neoplasms	neoplasm	NOUN
ajmsi-2312	103	26	research	research	NOUN
ajmsi-2312	103	27	and	and	CCONJ
ajmsi-2312	103	28	treatment	treatment	NOUN
ajmsi-2312	103	29	(	(	PUNCT
ajmsi-2312	103	30	iwg	iwg	PROPN
ajmsi-2312	103	31	-	-	PUNCT
ajmsi-2312	103	32	nrt	nrt	NOUN
ajmsi-2312	103	33	)	)	PUNCT
ajmsi-2312	103	34	and	and	CCONJ
ajmsi-2312	103	35	the	the	DET
ajmsi-2312	103	36	european	european	ADJ
ajmsi-2312	103	37	leukemianet	leukemianet	PROPN
ajmsi-2312	103	38	(	(	PUNCT
ajmsi-2312	103	39	eln	eln	PROPN
ajmsi-2312	103	40	)	)	PUNCT
ajmsi-2312	103	41	criteria	criterion	NOUN
ajmsi-2312	103	42	(	(	PUNCT
ajmsi-2312	103	43	hernándezboluda	hernándezboluda	NOUN
ajmsi-2312	103	44	et	et	PROPN
ajmsi-2312	103	45	al	al	PROPN
ajmsi-2312	103	46	.	.	PROPN
ajmsi-2312	103	47	,	,	PUNCT
ajmsi-2312	103	48	2011	2011	NUM
ajmsi-2312	103	49	)	)	PUNCT
ajmsi-2312	103	50	.	.	PUNCT
ajmsi-2312	104	1	adverse	adverse	ADJ
ajmsi-2312	104	2	effects	effect	NOUN
ajmsi-2312	104	3	of	of	ADP
ajmsi-2312	104	4	hu	hu	PROPN
ajmsi-2312	104	5	include	include	VERB
ajmsi-2312	104	6	oral	oral	ADJ
ajmsi-2312	104	7	ulcers	ulcer	NOUN
ajmsi-2312	104	8	,	,	PUNCT
ajmsi-2312	104	9	skin	skin	NOUN
ajmsi-2312	104	10	rashes	rash	NOUN
ajmsi-2312	104	11	,	,	PUNCT
ajmsi-2312	104	12	hyperpigmentation	hyperpigmentation	NOUN
ajmsi-2312	104	13	,	,	PUNCT
ajmsi-2312	104	14	long	long	ADJ
ajmsi-2312	104	15	-	-	PUNCT
ajmsi-2312	104	16	term	term	NOUN
ajmsi-2312	104	17	lung	lung	NOUN
ajmsi-2312	104	18	and	and	CCONJ
ajmsi-2312	104	19	liver	liver	NOUN
ajmsi-2312	104	20	toxicities	toxicity	NOUN
ajmsi-2312	104	21	,	,	PUNCT
ajmsi-2312	104	22	etc	etc	X
ajmsi-2312	104	23	.	.	X
ajmsi-2312	104	24	hu	hu	PROPN
ajmsi-2312	104	25	is	be	AUX
ajmsi-2312	104	26	contraindicated	contraindicate	VERB
ajmsi-2312	104	27	in	in	ADP
ajmsi-2312	104	28	pregnancy	pregnancy	NOUN
ajmsi-2312	104	29	and	and	CCONJ
ajmsi-2312	104	30	lactation	lactation	NOUN
ajmsi-2312	104	31	.	.	PUNCT
ajmsi-2312	105	1	hu	hu	PROPN
ajmsi-2312	105	2	-	-	ADJ
ajmsi-2312	105	3	induced	induce	VERB
ajmsi-2312	105	4	neutropenia	neutropenia	NOUN
ajmsi-2312	105	5	due	due	ADP
ajmsi-2312	105	6	to	to	ADP
ajmsi-2312	105	7	myelosuppression	myelosuppression	NOUN
ajmsi-2312	105	8	may	may	AUX
ajmsi-2312	105	9	manifest	manifest	VERB
ajmsi-2312	105	10	as	as	ADP
ajmsi-2312	105	11	recurrent	recurrent	ADJ
ajmsi-2312	105	12	infections	infection	NOUN
ajmsi-2312	105	13	presenting	present	VERB
ajmsi-2312	105	14	with	with	ADP
ajmsi-2312	105	15	fever	fever	NOUN
ajmsi-2312	105	16	,	,	PUNCT
ajmsi-2312	105	17	sore	sore	ADJ
ajmsi-2312	105	18	throat	throat	NOUN
ajmsi-2312	105	19	,	,	PUNCT
ajmsi-2312	105	20	urinary	urinary	ADJ
ajmsi-2312	105	21	tract	tract	NOUN
ajmsi-2312	105	22	infections	infection	NOUN
ajmsi-2312	105	23	,	,	PUNCT
ajmsi-2312	105	24	etc	etc	X
ajmsi-2312	105	25	.	.	X
ajmsi-2312	106	1	(	(	PUNCT
ajmsi-2312	106	2	antonioli	antonioli	NOUN
ajmsi-2312	106	3	et	et	PROPN
ajmsi-2312	106	4	al	al	PROPN
ajmsi-2312	106	5	.	.	PROPN
ajmsi-2312	106	6	,	,	PUNCT
ajmsi-2312	106	7	2012	2012	NUM
ajmsi-2312	106	8	;	;	PUNCT
ajmsi-2312	106	9	luchtman	luchtman	NOUN
ajmsi-2312	106	10	-	-	PUNCT
ajmsi-2312	106	11	jones	jones	NOUN
ajmsi-2312	106	12	et	et	PROPN
ajmsi-2312	106	13	al	al	PROPN
ajmsi-2312	106	14	.	.	PROPN
ajmsi-2312	106	15	,	,	PUNCT
ajmsi-2312	106	16	2016	2016	NUM
ajmsi-2312	106	17	)	)	PUNCT
ajmsi-2312	106	18	.	.	PUNCT
ajmsi-2312	107	1	these	these	DET
ajmsi-2312	107	2	effects	effect	NOUN
ajmsi-2312	107	3	are	be	AUX
ajmsi-2312	107	4	reversible	reversible	ADJ
ajmsi-2312	107	5	by	by	ADP
ajmsi-2312	107	6	withholding	withhold	VERB
ajmsi-2312	107	7	hu	hu	PROPN
ajmsi-2312	107	8	for	for	ADP
ajmsi-2312	107	9	1	1	NUM
ajmsi-2312	107	10	to	to	PART
ajmsi-2312	107	11	2	2	NUM
ajmsi-2312	107	12	weeks	week	NOUN
ajmsi-2312	107	13	and	and	CCONJ
ajmsi-2312	107	14	then	then	ADV
ajmsi-2312	107	15	re	re	VERB
ajmsi-2312	107	16	-	-	VERB
ajmsi-2312	107	17	initiating	initiate	VERB
ajmsi-2312	107	18	at	at	ADP
ajmsi-2312	107	19	a	a	DET
ajmsi-2312	107	20	lower	low	ADJ
ajmsi-2312	107	21	dosage	dosage	NOUN
ajmsi-2312	107	22	(	(	PUNCT
ajmsi-2312	107	23	wang	wang	PROPN
ajmsi-2312	107	24	et	et	PROPN
ajmsi-2312	107	25	al	al	PROPN
ajmsi-2312	107	26	.	.	PROPN
ajmsi-2312	107	27	,	,	PUNCT
ajmsi-2312	107	28	2011	2011	NUM
ajmsi-2312	107	29	)	)	PUNCT
ajmsi-2312	107	30	.	.	PUNCT
ajmsi-2312	108	1	when	when	SCONJ
ajmsi-2312	108	2	our	our	PRON
ajmsi-2312	108	3	patient	patient	NOUN
ajmsi-2312	108	4	got	get	VERB
ajmsi-2312	108	5	recurrent	recurrent	ADJ
ajmsi-2312	108	6	hu	hu	PROPN
ajmsi-2312	108	7	-	-	ADJ
ajmsi-2312	108	8	induced	induce	VERB
ajmsi-2312	108	9	neutropenia	neutropenia	NOUN
ajmsi-2312	108	10	-	-	PUNCT
ajmsi-2312	108	11	related	relate	VERB
ajmsi-2312	108	12	infections	infection	NOUN
ajmsi-2312	108	13	,	,	PUNCT
ajmsi-2312	108	14	the	the	DET
ajmsi-2312	108	15	hu	hu	PROPN
ajmsi-2312	108	16	was	be	AUX
ajmsi-2312	108	17	withheld	withhold	VERB
ajmsi-2312	108	18	for	for	ADP
ajmsi-2312	108	19	one	one	NUM
ajmsi-2312	108	20	week	week	NOUN
ajmsi-2312	108	21	in	in	ADP
ajmsi-2312	108	22	each	each	DET
ajmsi-2312	108	23	case	case	NOUN
ajmsi-2312	108	24	and	and	CCONJ
ajmsi-2312	108	25	successfully	successfully	ADV
ajmsi-2312	108	26	re	re	VERB
ajmsi-2312	108	27	-	-	VERB
ajmsi-2312	108	28	started	start	VERB
ajmsi-2312	108	29	at	at	ADP
ajmsi-2312	108	30	lower	low	ADJ
ajmsi-2312	108	31	dosages	dosage	NOUN
ajmsi-2312	108	32	tailored	tailor	VERB
ajmsi-2312	108	33	to	to	ADP
ajmsi-2312	108	34	therapeutic	therapeutic	ADJ
ajmsi-2312	108	35	targets	target	NOUN
ajmsi-2312	108	36	.	.	PUNCT
ajmsi-2312	109	1	there	there	PRON
ajmsi-2312	109	2	are	be	VERB
ajmsi-2312	109	3	no	no	DET
ajmsi-2312	109	4	studies	study	NOUN
ajmsi-2312	109	5	that	that	PRON
ajmsi-2312	109	6	specifically	specifically	ADV
ajmsi-2312	109	7	address	address	VERB
ajmsi-2312	109	8	the	the	DET
ajmsi-2312	109	9	modification	modification	NOUN
ajmsi-2312	109	10	of	of	ADP
ajmsi-2312	109	11	doses	dose	NOUN
ajmsi-2312	109	12	of	of	ADP
ajmsi-2312	109	13	hu	hu	PROPN
ajmsi-2312	109	14	for	for	ADP
ajmsi-2312	109	15	et	et	PRON
ajmsi-2312	109	16	in	in	ADP
ajmsi-2312	109	17	cases	case	NOUN
ajmsi-2312	109	18	of	of	ADP
ajmsi-2312	109	19	severe	severe	ADJ
ajmsi-2312	109	20	hu	hu	PROPN
ajmsi-2312	109	21	-	-	ADJ
ajmsi-2312	109	22	induced	induced	ADJ
ajmsi-2312	109	23	neutropenia	neutropenia	NOUN
ajmsi-2312	109	24	.	.	PUNCT
ajmsi-2312	110	1	however	however	ADV
ajmsi-2312	110	2	,	,	PUNCT
ajmsi-2312	110	3	extrapolation	extrapolation	NOUN
ajmsi-2312	110	4	of	of	ADP
ajmsi-2312	110	5	expert	expert	ADJ
ajmsi-2312	110	6	consensus	consensus	NOUN
ajmsi-2312	110	7	recommendations	recommendation	NOUN
ajmsi-2312	110	8	from	from	ADP
ajmsi-2312	110	9	the	the	DET
ajmsi-2312	110	10	use	use	NOUN
ajmsi-2312	110	11	of	of	ADP
ajmsi-2312	110	12	hu	hu	PROPN
ajmsi-2312	110	13	in	in	ADP
ajmsi-2312	110	14	sickle	sickle	PROPN
ajmsi-2312	110	15	cell	cell	NOUN
ajmsi-2312	110	16	anemia	anemia	NOUN
ajmsi-2312	110	17	in	in	ADP
ajmsi-2312	110	18	children	child	NOUN
ajmsi-2312	110	19	may	may	AUX
ajmsi-2312	110	20	give	give	VERB
ajmsi-2312	110	21	guidance	guidance	NOUN
ajmsi-2312	110	22	on	on	ADP
ajmsi-2312	110	23	the	the	DET
ajmsi-2312	110	24	definition	definition	NOUN
ajmsi-2312	110	25	of	of	ADP
ajmsi-2312	110	26	hu	hu	PROPN
ajmsi-2312	110	27	-	-	PUNCT
ajmsi-2312	110	28	related	relate	VERB
ajmsi-2312	110	29	myelosuppression	myelosuppression	NOUN
ajmsi-2312	110	30	and	and	CCONJ
ajmsi-2312	110	31	toxicities	toxicity	NOUN
ajmsi-2312	110	32	,	,	PUNCT
ajmsi-2312	110	33	as	as	ADV
ajmsi-2312	110	34	well	well	ADV
ajmsi-2312	110	35	as	as	ADP
ajmsi-2312	110	36	dose	dose	VERB
ajmsi-2312	110	37	adjustments	adjustment	NOUN
ajmsi-2312	110	38	to	to	ADP
ajmsi-2312	110	39	the	the	DET
ajmsi-2312	110	40	maximum	maximum	ADJ
ajmsi-2312	110	41	tolerated	tolerate	VERB
ajmsi-2312	110	42	dosages	dosage	NOUN
ajmsi-2312	110	43	(	(	PUNCT
ajmsi-2312	110	44	mtd	mtd	NOUN
ajmsi-2312	110	45	)	)	PUNCT
ajmsi-2312	110	46	in	in	ADP
ajmsi-2312	110	47	such	such	ADJ
ajmsi-2312	110	48	cases	case	NOUN
ajmsi-2312	110	49	(	(	PUNCT
ajmsi-2312	110	50	mcgann	mcgann	PROPN
ajmsi-2312	110	51	et	et	PROPN
ajmsi-2312	110	52	al	al	PROPN
ajmsi-2312	110	53	.	.	PROPN
ajmsi-2312	110	54	,	,	PUNCT
ajmsi-2312	110	55	2016	2016	NUM
ajmsi-2312	110	56	;	;	PUNCT
ajmsi-2312	110	57	mcgann	mcgann	PROPN
ajmsi-2312	110	58	&	&	CCONJ
ajmsi-2312	110	59	ware	ware	PROPN
ajmsi-2312	110	60	,	,	PUNCT
ajmsi-2312	110	61	2015	2015	NUM
ajmsi-2312	110	62	)	)	PUNCT
ajmsi-2312	110	63	.	.	PUNCT
ajmsi-2312	111	1	this	this	PRON
ajmsi-2312	111	2	is	be	AUX
ajmsi-2312	111	3	demonstrated	demonstrate	VERB
ajmsi-2312	111	4	in	in	ADP
ajmsi-2312	111	5	table	table	NOUN
ajmsi-2312	111	6	3	3	NUM
ajmsi-2312	111	7	below	below	ADV
ajmsi-2312	111	8	.	.	PUNCT
ajmsi-2312	112	1	based	base	VERB
ajmsi-2312	112	2	on	on	ADP
ajmsi-2312	112	3	these	these	DET
ajmsi-2312	112	4	recommendations	recommendation	NOUN
ajmsi-2312	112	5	,	,	PUNCT
ajmsi-2312	112	6	an	an	DET
ajmsi-2312	112	7	absolute	absolute	ADJ
ajmsi-2312	112	8	neutrophil	neutrophil	ADJ
ajmsi-2312	112	9	count	count	NOUN
ajmsi-2312	112	10	of	of	ADP
ajmsi-2312	112	11	≥1500/µl	≥1500/µl	PRON
ajmsi-2312	112	12	was	be	AUX
ajmsi-2312	112	13	adopted	adopt	VERB
ajmsi-2312	112	14	for	for	ADP
ajmsi-2312	112	15	our	our	PRON
ajmsi-2312	112	16	patient	patient	NOUN
ajmsi-2312	112	17	as	as	ADP
ajmsi-2312	112	18	the	the	DET
ajmsi-2312	112	19	target	target	NOUN
ajmsi-2312	112	20	for	for	ADP
ajmsi-2312	112	21	defining	define	VERB
ajmsi-2312	112	22	the	the	DET
ajmsi-2312	112	23	maximum	maximum	ADJ
ajmsi-2312	112	24	tolerated	tolerate	VERB
ajmsi-2312	112	25	dosage	dosage	NOUN
ajmsi-2312	112	26	of	of	ADP
ajmsi-2312	112	27	the	the	DET
ajmsi-2312	112	28	hu	hu	PROPN
ajmsi-2312	112	29	,	,	PUNCT
ajmsi-2312	112	30	with	with	ADP
ajmsi-2312	112	31	the	the	DET
ajmsi-2312	112	32	uppermost	uppermost	ADJ
ajmsi-2312	112	33	dosage	dosage	NOUN
ajmsi-2312	112	34	of	of	ADP
ajmsi-2312	112	35	1.5	1.5	NUM
ajmsi-2312	112	36	g	g	NOUN
ajmsi-2312	112	37	/	/	SYM
ajmsi-2312	112	38	day	day	NOUN
ajmsi-2312	112	39	.	.	PUNCT
ajmsi-2312	113	1	so	so	ADV
ajmsi-2312	113	2	far	far	ADV
ajmsi-2312	113	3	,	,	PUNCT
ajmsi-2312	113	4	the	the	DET
ajmsi-2312	113	5	recommended	recommend	VERB
ajmsi-2312	113	6	target	target	NOUN
ajmsi-2312	113	7	platelet	platelet	NOUN
ajmsi-2312	113	8	count	count	NOUN
ajmsi-2312	113	9	of	of	ADP
ajmsi-2312	113	10	100,000	100,000	NUM
ajmsi-2312	113	11	-	-	SYM
ajmsi-2312	113	12	450	450	NUM
ajmsi-2312	113	13	,	,	PUNCT
ajmsi-2312	113	14	000/	000/	VERB
ajmsi-2312	113	15	µl	µl	SCONJ
ajmsi-2312	113	16	while	while	SCONJ
ajmsi-2312	113	17	on	on	ADP
ajmsi-2312	113	18	hu	hu	PROPN
ajmsi-2312	113	19	treatment	treatment	NOUN
ajmsi-2312	113	20	has	have	AUX
ajmsi-2312	113	21	not	not	PART
ajmsi-2312	113	22	been	be	AUX
ajmsi-2312	113	23	achieved	achieve	VERB
ajmsi-2312	113	24	due	due	ADP
ajmsi-2312	113	25	to	to	ADP
ajmsi-2312	113	26	the	the	DET
ajmsi-2312	113	27	concurrence	concurrence	NOUN
ajmsi-2312	113	28	of	of	ADP
ajmsi-2312	113	29	hu	hu	PROPN
ajmsi-2312	113	30	-	-	PUNCT
ajmsi-2312	113	31	related	relate	VERB
ajmsi-2312	113	32	neutropenia	neutropenia	NOUN
ajmsi-2312	113	33	,	,	PUNCT
ajmsi-2312	113	34	as	as	SCONJ
ajmsi-2312	113	35	highlighted	highlight	VERB
ajmsi-2312	113	36	.	.	PUNCT
ajmsi-2312	114	1	table	table	NOUN
ajmsi-2312	114	2	2	2	NUM
ajmsi-2312	114	3	:	:	PUNCT
ajmsi-2312	114	4	who	who	PRON
ajmsi-2312	114	5	diagnostic	diagnostic	ADJ
ajmsi-2312	114	6	criteria	criterion	NOUN
ajmsi-2312	114	7	for	for	ADP
ajmsi-2312	114	8	essential	essential	ADJ
ajmsi-2312	114	9	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	114	10	(	(	PUNCT
ajmsi-2312	114	11	arber	arber	PROPN
ajmsi-2312	114	12	et	et	PROPN
ajmsi-2312	114	13	al	al	PROPN
ajmsi-2312	114	14	.	.	PROPN
ajmsi-2312	114	15	,	,	PUNCT
ajmsi-2312	114	16	2022	2022	NUM
ajmsi-2312	114	17	)	)	PUNCT
ajmsi-2312	114	18	major	major	ADJ
ajmsi-2312	114	19	criteria	criterion	NOUN
ajmsi-2312	114	20	1	1	NUM
ajmsi-2312	114	21	.	.	PUNCT
ajmsi-2312	115	1	platelet	platelet	NOUN
ajmsi-2312	115	2	count	count	NOUN
ajmsi-2312	115	3	≥450	≥450	X
ajmsi-2312	115	4	×	×	NOUN
ajmsi-2312	115	5	109	109	NUM
ajmsi-2312	115	6	/	/	SYM
ajmsi-2312	115	7	l	l	NOUN
ajmsi-2312	115	8	2	2	NUM
ajmsi-2312	115	9	.	.	PUNCT
ajmsi-2312	115	10	bone	bone	NOUN
ajmsi-2312	115	11	marrow	marrow	PROPN
ajmsi-2312	115	12	biopsy	biopsy	NOUN
ajmsi-2312	115	13	showing	show	VERB
ajmsi-2312	115	14	proliferation	proliferation	NOUN
ajmsi-2312	115	15	mainly	mainly	ADV
ajmsi-2312	115	16	of	of	ADP
ajmsi-2312	115	17	the	the	DET
ajmsi-2312	115	18	megakaryocyte	megakaryocyte	ADJ
ajmsi-2312	115	19	lineage	lineage	NOUN
ajmsi-2312	115	20	with	with	ADP
ajmsi-2312	115	21	increased	increase	VERB
ajmsi-2312	115	22	numbers	number	NOUN
ajmsi-2312	115	23	of	of	ADP
ajmsi-2312	115	24	enlarged	enlarge	VERB
ajmsi-2312	115	25	,	,	PUNCT
ajmsi-2312	115	26	mature	mature	ADJ
ajmsi-2312	115	27	megakaryocytes	megakaryocyte	NOUN
ajmsi-2312	115	28	with	with	ADP
ajmsi-2312	115	29	hyper	hyper	NOUN
ajmsi-2312	115	30	-	-	ADJ
ajmsi-2312	115	31	lobulated	lobulate	VERB
ajmsi-2312	115	32	nuclei	nucleus	NOUN
ajmsi-2312	115	33	.	.	PUNCT
ajmsi-2312	116	1	no	no	DET
ajmsi-2312	116	2	significant	significant	ADJ
ajmsi-2312	116	3	increase	increase	NOUN
ajmsi-2312	116	4	or	or	CCONJ
ajmsi-2312	116	5	left	leave	VERB
ajmsi-2312	116	6	shift	shift	NOUN
ajmsi-2312	116	7	in	in	ADP
ajmsi-2312	116	8	neutrophil	neutrophil	ADJ
ajmsi-2312	116	9	granulopoiesis	granulopoiesis	NOUN
ajmsi-2312	116	10	or	or	CCONJ
ajmsi-2312	116	11	erythropoiesis	erythropoiesis	NOUN
ajmsi-2312	116	12	and	and	CCONJ
ajmsi-2312	116	13	very	very	ADV
ajmsi-2312	116	14	rarely	rarely	ADV
ajmsi-2312	116	15	minor	minor	ADJ
ajmsi-2312	116	16	(	(	PUNCT
ajmsi-2312	116	17	grade	grade	NOUN
ajmsi-2312	116	18	1	1	NUM
ajmsi-2312	116	19	)	)	PUNCT
ajmsi-2312	116	20	increase	increase	NOUN
ajmsi-2312	116	21	in	in	ADP
ajmsi-2312	116	22	reticulin	reticulin	ADJ
ajmsi-2312	116	23	fibers	fiber	NOUN
ajmsi-2312	116	24	3	3	NUM
ajmsi-2312	116	25	.	.	PUNCT
ajmsi-2312	116	26	not	not	PART
ajmsi-2312	116	27	meeting	meet	VERB
ajmsi-2312	116	28	who	who	PRON
ajmsi-2312	116	29	criteria	criteria	VERB
ajmsi-2312	116	30	for	for	ADP
ajmsi-2312	116	31	bcr	bcr	PROPN
ajmsi-2312	116	32	-	-	PUNCT
ajmsi-2312	116	33	abl1	abl1	PROPN
ajmsi-2312	116	34	+	+	NUM
ajmsi-2312	116	35	cml	cml	PROPN
ajmsi-2312	116	36	,	,	PUNCT
ajmsi-2312	116	37	pv	pv	NOUN
ajmsi-2312	116	38	,	,	PUNCT
ajmsi-2312	116	39	pmf	pmf	PROPN
ajmsi-2312	116	40	,	,	PUNCT
ajmsi-2312	116	41	myelodysplastic	myelodysplastic	ADJ
ajmsi-2312	116	42	syndromes	syndrome	NOUN
ajmsi-2312	116	43	,	,	PUNCT
ajmsi-2312	116	44	or	or	CCONJ
ajmsi-2312	116	45	other	other	ADJ
ajmsi-2312	116	46	myeloid	myeloid	ADJ
ajmsi-2312	116	47	neoplasms	neoplasm	NOUN
ajmsi-2312	116	48	4	4	NUM
ajmsi-2312	116	49	.	.	PUNCT
ajmsi-2312	116	50	presence	presence	NOUN
ajmsi-2312	116	51	of	of	ADP
ajmsi-2312	116	52	jak2	jak2	PROPN
ajmsi-2312	116	53	,	,	PUNCT
ajmsi-2312	116	54	calr	calr	PROPN
ajmsi-2312	116	55	,	,	PUNCT
ajmsi-2312	116	56	or	or	CCONJ
ajmsi-2312	116	57	mpl	mpl	NOUN
ajmsi-2312	116	58	mutation	mutation	VERB
ajmsi-2312	116	59	minor	minor	ADJ
ajmsi-2312	116	60	criterion	criterion	NOUN
ajmsi-2312	116	61	1	1	NUM
ajmsi-2312	116	62	.	.	PUNCT
ajmsi-2312	116	63	presence	presence	NOUN
ajmsi-2312	116	64	of	of	ADP
ajmsi-2312	116	65	a	a	DET
ajmsi-2312	116	66	clonal	clonal	ADJ
ajmsi-2312	116	67	marker	marker	NOUN
ajmsi-2312	116	68	or	or	CCONJ
ajmsi-2312	116	69	absence	absence	NOUN
ajmsi-2312	116	70	of	of	ADP
ajmsi-2312	116	71	evidence	evidence	NOUN
ajmsi-2312	116	72	for	for	ADP
ajmsi-2312	116	73	reactive	reactive	ADJ
ajmsi-2312	116	74	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	116	75	diagnosis	diagnosis	NOUN
ajmsi-2312	116	76	of	of	ADP
ajmsi-2312	116	77	et	et	NOUN
ajmsi-2312	116	78	requires	require	VERB
ajmsi-2312	116	79	meeting	meet	VERB
ajmsi-2312	116	80	all	all	DET
ajmsi-2312	116	81	4	4	NUM
ajmsi-2312	116	82	major	major	ADJ
ajmsi-2312	116	83	criteria	criterion	NOUN
ajmsi-2312	116	84	or	or	CCONJ
ajmsi-2312	116	85	the	the	DET
ajmsi-2312	116	86	first	first	ADJ
ajmsi-2312	116	87	3	3	NUM
ajmsi-2312	116	88	major	major	ADJ
ajmsi-2312	116	89	criteria	criterion	NOUN
ajmsi-2312	116	90	and	and	CCONJ
ajmsi-2312	116	91	the	the	DET
ajmsi-2312	116	92	minor	minor	ADJ
ajmsi-2312	116	93	criterion	criterion	NOUN
ajmsi-2312	116	94	.	.	PUNCT
ajmsi-2312	117	1	key	key	NOUN
ajmsi-2312	117	2	:	:	PUNCT
ajmsi-2312	117	3	cml	cml	PROPN
ajmsi-2312	117	4	:	:	PUNCT
ajmsi-2312	117	5	chronic	chronic	ADJ
ajmsi-2312	117	6	myeloid	myeloid	NOUN
ajmsi-2312	117	7	leukemia	leukemia	NOUN
ajmsi-2312	117	8	;	;	PUNCT
ajmsi-2312	117	9	et	et	NOUN
ajmsi-2312	117	10	:	:	PUNCT
ajmsi-2312	117	11	essential	essential	ADJ
ajmsi-2312	117	12	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	117	13	;	;	PUNCT
ajmsi-2312	117	14	pmf	pmf	NOUN
ajmsi-2312	117	15	:	:	PUNCT
ajmsi-2312	117	16	primary	primary	ADJ
ajmsi-2312	117	17	myelofibrosis	myelofibrosis	NOUN
ajmsi-2312	117	18	;	;	PUNCT
ajmsi-2312	117	19	pv	pv	X
ajmsi-2312	117	20	:	:	PUNCT
ajmsi-2312	117	21	polycythemia	polycythemia	NOUN
ajmsi-2312	117	22	vera	vera	NOUN
ajmsi-2312	117	23	;	;	PUNCT
ajmsi-2312	117	24	who	who	PRON
ajmsi-2312	117	25	:	:	PUNCT
ajmsi-2312	117	26	world	world	PROPN
ajmsi-2312	117	27	health	health	PROPN
ajmsi-2312	117	28	organization	organization	PROPN
ajmsi-2312	117	29	pa	pa	PROPN
ajmsi-2312	117	30	ge	ge	PROPN
ajmsi-2312	117	31	5	5	NUM
ajmsi-2312	117	32	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	117	33	am	be	AUX
ajmsi-2312	117	34	.	.	PUNCT
ajmsi-2312	118	1	j.	j.	PROPN
ajmsi-2312	118	2	med	med	PROPN
ajmsi-2312	118	3	.	.	PUNCT
ajmsi-2312	119	1	sci	sci	PROPN
ajmsi-2312	119	2	.	.	PUNCT
ajmsi-2312	119	3	innov	innov	PROPN
ajmsi-2312	119	4	.	.	PUNCT
ajmsi-2312	120	1	3(1	3(1	NUM
ajmsi-2312	120	2	)	)	PUNCT
ajmsi-2312	120	3	1	1	NUM
ajmsi-2312	120	4	-	-	SYM
ajmsi-2312	120	5	7	7	NUM
ajmsi-2312	120	6	,	,	PUNCT
ajmsi-2312	120	7	2024	2024	NUM
ajmsi-2312	120	8	interestingly	interestingly	ADV
ajmsi-2312	120	9	,	,	PUNCT
ajmsi-2312	120	10	the	the	DET
ajmsi-2312	120	11	patients	patient	NOUN
ajmsi-2312	120	12	’	’	PART
ajmsi-2312	120	13	subjective	subjective	ADJ
ajmsi-2312	120	14	symptoms	symptom	NOUN
ajmsi-2312	120	15	have	have	AUX
ajmsi-2312	120	16	almost	almost	ADV
ajmsi-2312	120	17	completely	completely	ADV
ajmsi-2312	120	18	resolved	resolve	VERB
ajmsi-2312	120	19	on	on	ADP
ajmsi-2312	120	20	hu	hu	PROPN
ajmsi-2312	120	21	and	and	CCONJ
ajmsi-2312	120	22	aspirin	aspirin	NOUN
ajmsi-2312	120	23	.	.	PUNCT
ajmsi-2312	121	1	therefore	therefore	ADV
ajmsi-2312	121	2	,	,	PUNCT
ajmsi-2312	121	3	in	in	ADP
ajmsi-2312	121	4	resource	resource	NOUN
ajmsi-2312	121	5	-	-	PUNCT
ajmsi-2312	121	6	limited	limit	VERB
ajmsi-2312	121	7	clinical	clinical	ADJ
ajmsi-2312	121	8	settings	setting	NOUN
ajmsi-2312	121	9	,	,	PUNCT
ajmsi-2312	121	10	we	we	PRON
ajmsi-2312	121	11	propose	propose	VERB
ajmsi-2312	121	12	a	a	DET
ajmsi-2312	121	13	practical	practical	ADJ
ajmsi-2312	121	14	and	and	CCONJ
ajmsi-2312	121	15	rational	rational	ADJ
ajmsi-2312	121	16	approach	approach	NOUN
ajmsi-2312	121	17	to	to	ADP
ajmsi-2312	121	18	the	the	DET
ajmsi-2312	121	19	diagnosis	diagnosis	NOUN
ajmsi-2312	121	20	and	and	CCONJ
ajmsi-2312	121	21	treatment	treatment	NOUN
ajmsi-2312	121	22	of	of	ADP
ajmsi-2312	121	23	et	et	NOUN
ajmsi-2312	121	24	,	,	PUNCT
ajmsi-2312	121	25	as	as	SCONJ
ajmsi-2312	121	26	summarized	summarize	VERB
ajmsi-2312	121	27	in	in	ADP
ajmsi-2312	121	28	the	the	DET
ajmsi-2312	121	29	algorithm	algorithm	NOUN
ajmsi-2312	121	30	shown	show	VERB
ajmsi-2312	121	31	in	in	ADP
ajmsi-2312	121	32	table	table	NOUN
ajmsi-2312	121	33	4	4	NUM
ajmsi-2312	121	34	below	below	ADV
ajmsi-2312	121	35	.	.	PUNCT
ajmsi-2312	122	1	table	table	NOUN
ajmsi-2312	122	2	3	3	NUM
ajmsi-2312	122	3	:	:	PUNCT
ajmsi-2312	123	1	hematological	hematological	ADJ
ajmsi-2312	123	2	parameters	parameter	NOUN
ajmsi-2312	123	3	used	use	VERB
ajmsi-2312	123	4	to	to	PART
ajmsi-2312	123	5	define	define	VERB
ajmsi-2312	123	6	the	the	DET
ajmsi-2312	123	7	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	123	8	maximum	maximum	PROPN
ajmsi-2312	123	9	tolerated	tolerate	VERB
ajmsi-2312	123	10	dose	dose	PROPN
ajmsi-2312	123	11	(	(	PUNCT
ajmsi-2312	123	12	mtd	mtd	PROPN
ajmsi-2312	123	13	)	)	PUNCT
ajmsi-2312	123	14	with	with	ADP
ajmsi-2312	123	15	mild	mild	ADJ
ajmsi-2312	123	16	marrow	marrow	NOUN
ajmsi-2312	123	17	suppression	suppression	NOUN
ajmsi-2312	123	18	(	(	PUNCT
ajmsi-2312	123	19	mcgann	mcgann	PROPN
ajmsi-2312	123	20	et	et	PROPN
ajmsi-2312	123	21	al	al	PROPN
ajmsi-2312	123	22	.	.	PROPN
ajmsi-2312	123	23	,	,	PUNCT
ajmsi-2312	123	24	2016	2016	NUM
ajmsi-2312	123	25	;	;	PUNCT
ajmsi-2312	123	26	mcgann	mcgann	PROPN
ajmsi-2312	123	27	&	&	CCONJ
ajmsi-2312	123	28	ware	ware	PROPN
ajmsi-2312	123	29	,	,	PUNCT
ajmsi-2312	123	30	2015	2015	NUM
ajmsi-2312	123	31	)	)	PUNCT
ajmsi-2312	123	32	parameter	parameter	NOUN
ajmsi-2312	123	33	toxicity	toxicity	NOUN
ajmsi-2312	123	34	criteria	criterion	NOUN
ajmsi-2312	123	35	escalation	escalation	NOUN
ajmsi-2312	123	36	criteria	criterion	NOUN
ajmsi-2312	123	37	target	target	PROPN
ajmsi-2312	123	38	mtd	mtd	PROPN
ajmsi-2312	123	39	value	value	NOUN
ajmsi-2312	123	40	absolute	absolute	ADJ
ajmsi-2312	123	41	neutrophil	neutrophil	ADJ
ajmsi-2312	123	42	count	count	NOUN
ajmsi-2312	123	43	(	(	PUNCT
ajmsi-2312	123	44	anc	anc	PROPN
ajmsi-2312	123	45	,	,	PUNCT
ajmsi-2312	123	46	x	x	PROPN
ajmsi-2312	123	47	109	109	NUM
ajmsi-2312	123	48	/	/	SYM
ajmsi-2312	123	49	l	l	NOUN
ajmsi-2312	123	50	)	)	PUNCT
ajmsi-2312	123	51	<	<	X
ajmsi-2312	123	52	1.0	1.0	NUM
ajmsi-2312	123	53	>	>	SYM
ajmsi-2312	123	54	3.0	3.0	NUM
ajmsi-2312	123	55	1.5–3.0	1.5–3.0	NUM
ajmsi-2312	123	56	absolute	absolute	ADJ
ajmsi-2312	123	57	reticulocyte	reticulocyte	NOUN
ajmsi-2312	123	58	count	count	NOUN
ajmsi-2312	123	59	(	(	PUNCT
ajmsi-2312	123	60	arc	arc	NOUN
ajmsi-2312	123	61	,	,	PUNCT
ajmsi-2312	123	62	x	x	PROPN
ajmsi-2312	123	63	109	109	NUM
ajmsi-2312	123	64	/	/	SYM
ajmsi-2312	123	65	l	l	NOUN
ajmsi-2312	123	66	)	)	PUNCT
ajmsi-2312	123	67	<	<	X
ajmsi-2312	123	68	80	80	NUM
ajmsi-2312	123	69	(	(	PUNCT
ajmsi-2312	123	70	unless	unless	SCONJ
ajmsi-2312	123	71	hb	hb	PROPN
ajmsi-2312	123	72	≥	≥	PROPN
ajmsi-2312	123	73	9.0	9.0	NUM
ajmsi-2312	123	74	)	)	PUNCT
ajmsi-2312	123	75	>	>	X
ajmsi-2312	123	76	200	200	NUM
ajmsi-2312	123	77	100–200	100–200	NUM
ajmsi-2312	123	78	platelets	platelet	NOUN
ajmsi-2312	123	79	(	(	PUNCT
ajmsi-2312	123	80	x	x	SYM
ajmsi-2312	123	81	109	109	NUM
ajmsi-2312	123	82	/	/	SYM
ajmsi-2312	123	83	l	l	NOUN
ajmsi-2312	123	84	)	)	PUNCT
ajmsi-2312	123	85	<	<	X
ajmsi-2312	123	86	80	80	NUM
ajmsi-2312	123	87	>	>	SYM
ajmsi-2312	123	88	150	150	NUM
ajmsi-2312	123	89	>	>	SYM
ajmsi-2312	123	90	80	80	NUM
ajmsi-2312	123	91	hemoglobin	hemoglobin	NOUN
ajmsi-2312	123	92	(	(	PUNCT
ajmsi-2312	123	93	hb	hb	PROPN
ajmsi-2312	123	94	gm	gm	PROPN
ajmsi-2312	123	95	/	/	SYM
ajmsi-2312	123	96	dl	dl	PROPN
ajmsi-2312	123	97	)	)	PUNCT
ajmsi-2312	123	98	hb	hb	X
ajmsi-2312	124	1	<	<	X
ajmsi-2312	124	2	4.0	4.0	NUM
ajmsi-2312	124	3	or	or	CCONJ
ajmsi-2312	124	4	hb	hb	X
ajmsi-2312	124	5	<	<	X
ajmsi-2312	124	6	6.0	6.0	NUM
ajmsi-2312	124	7	unless	unless	SCONJ
ajmsi-2312	124	8	arc	arc	NOUN
ajmsi-2312	124	9	>	>	X
ajmsi-2312	124	10	100	100	NUM
ajmsi-2312	124	11	>	>	SYM
ajmsi-2312	124	12	6.5	6.5	NUM
ajmsi-2312	124	13	table	table	NOUN
ajmsi-2312	124	14	4	4	NUM
ajmsi-2312	124	15	:	:	PUNCT
ajmsi-2312	124	16	an	an	DET
ajmsi-2312	124	17	algorithm	algorithm	NOUN
ajmsi-2312	124	18	for	for	ADP
ajmsi-2312	124	19	the	the	DET
ajmsi-2312	124	20	diagnosis	diagnosis	NOUN
ajmsi-2312	124	21	and	and	CCONJ
ajmsi-2312	124	22	management	management	NOUN
ajmsi-2312	124	23	of	of	ADP
ajmsi-2312	124	24	essential	essential	ADJ
ajmsi-2312	124	25	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	124	26	in	in	ADP
ajmsi-2312	124	27	a	a	DET
ajmsi-2312	124	28	resource	resource	NOUN
ajmsi-2312	124	29	-	-	PUNCT
ajmsi-2312	124	30	limited	limit	VERB
ajmsi-2312	124	31	setting	set	VERB
ajmsi-2312	124	32	a.	a.	NOUN
ajmsi-2312	124	33	platelet	platelet	NOUN
ajmsi-2312	124	34	count	count	NOUN
ajmsi-2312	124	35	:	:	PUNCT
ajmsi-2312	125	1	450	450	NUM
ajmsi-2312	125	2	-	-	SYM
ajmsi-2312	125	3	1000	1000	NUM
ajmsi-2312	125	4	x	x	SYM
ajmsi-2312	125	5	103/µl	103/µl	NUM
ajmsi-2312	125	6	1	1	X
ajmsi-2312	125	7	.	.	PUNCT
ajmsi-2312	125	8	rule	rule	VERB
ajmsi-2312	125	9	out	out	ADP
ajmsi-2312	125	10	rt	rt	NOUN
ajmsi-2312	125	11	:	:	PUNCT
ajmsi-2312	125	12	inflammatory	inflammatory	ADJ
ajmsi-2312	125	13	conditions	condition	NOUN
ajmsi-2312	125	14	,	,	PUNCT
ajmsi-2312	125	15	trauma	trauma	NOUN
ajmsi-2312	125	16	,	,	PUNCT
ajmsi-2312	125	17	iron	iron	NOUN
ajmsi-2312	125	18	deficiency	deficiency	NOUN
ajmsi-2312	125	19	anemia	anemia	NOUN
ajmsi-2312	125	20	,	,	PUNCT
ajmsi-2312	125	21	etc	etc	X
ajmsi-2312	125	22	.	.	X
ajmsi-2312	125	23	,	,	PUNCT
ajmsi-2312	125	24	elevated	elevated	ADJ
ajmsi-2312	125	25	crp	crp	PROPN
ajmsi-2312	125	26	,	,	PUNCT
ajmsi-2312	125	27	esr	esr	PROPN
ajmsi-2312	125	28	,	,	PUNCT
ajmsi-2312	125	29	procalcitonin	procalcitonin	ADJ
ajmsi-2312	125	30	,	,	PUNCT
ajmsi-2312	125	31	and	and	CCONJ
ajmsi-2312	125	32	other	other	ADJ
ajmsi-2312	125	33	acute	acute	NOUN
ajmsi-2312	125	34	phase	phase	NOUN
ajmsi-2312	125	35	reactants	reactant	VERB
ajmsi-2312	125	36	.	.	PUNCT
ajmsi-2312	126	1	2	2	X
ajmsi-2312	126	2	.	.	X
ajmsi-2312	126	3	if	if	SCONJ
ajmsi-2312	126	4	no	no	DET
ajmsi-2312	126	5	evidence	evidence	NOUN
ajmsi-2312	126	6	of	of	ADP
ajmsi-2312	126	7	rt	rt	PROPN
ajmsi-2312	126	8	,	,	PUNCT
ajmsi-2312	126	9	go	go	VERB
ajmsi-2312	126	10	to	to	ADP
ajmsi-2312	126	11	b.	b.	PROPN
ajmsi-2312	126	12	b.	b.	PROPN
ajmsi-2312	126	13	platelet	platelet	PROPN
ajmsi-2312	126	14	count	count	PROPN
ajmsi-2312	126	15	:	:	PUNCT
ajmsi-2312	126	16	>	>	PUNCT
ajmsi-2312	126	17	1000	1000	NUM
ajmsi-2312	126	18	x	x	SYM
ajmsi-2312	126	19	103/µl	103/µl	NUM
ajmsi-2312	126	20	1	1	X
ajmsi-2312	126	21	.	.	PUNCT
ajmsi-2312	127	1	clinically	clinically	ADV
ajmsi-2312	127	2	:	:	PUNCT
ajmsi-2312	127	3	vasomotor	vasomotor	NOUN
ajmsi-2312	127	4	symptoms	symptom	NOUN
ajmsi-2312	127	5	,	,	PUNCT
ajmsi-2312	127	6	thrombotic	thrombotic	ADJ
ajmsi-2312	127	7	and/or	and/or	CCONJ
ajmsi-2312	127	8	hemorrhagic	hemorrhagic	ADJ
ajmsi-2312	127	9	complications	complication	NOUN
ajmsi-2312	127	10	.	.	PUNCT
ajmsi-2312	128	1	2	2	X
ajmsi-2312	128	2	.	.	X
ajmsi-2312	128	3	peripheral	peripheral	ADJ
ajmsi-2312	128	4	blood	blood	NOUN
ajmsi-2312	128	5	film	film	NOUN
ajmsi-2312	128	6	:	:	PUNCT
ajmsi-2312	128	7	presence	presence	NOUN
ajmsi-2312	128	8	of	of	ADP
ajmsi-2312	128	9	marked	mark	VERB
ajmsi-2312	128	10	/	/	SYM
ajmsi-2312	128	11	severe	severe	ADJ
ajmsi-2312	128	12	/	/	SYM
ajmsi-2312	128	13	extreme	extreme	ADJ
ajmsi-2312	128	14	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	128	15	with	with	ADP
ajmsi-2312	128	16	platelet	platelet	NOUN
ajmsi-2312	128	17	anisocytosis	anisocytosis	NOUN
ajmsi-2312	128	18	.	.	PUNCT
ajmsi-2312	129	1	3	3	X
ajmsi-2312	129	2	.	.	X
ajmsi-2312	129	3	clinically	clinically	ADV
ajmsi-2312	129	4	rule	rule	VERB
ajmsi-2312	129	5	out	out	ADP
ajmsi-2312	129	6	other	other	ADJ
ajmsi-2312	129	7	mpns	mpns	NOUN
ajmsi-2312	129	8	using	use	VERB
ajmsi-2312	129	9	a	a	DET
ajmsi-2312	129	10	complete	complete	ADJ
ajmsi-2312	129	11	blood	blood	NOUN
ajmsi-2312	129	12	count	count	NOUN
ajmsi-2312	129	13	,	,	PUNCT
ajmsi-2312	129	14	targeted	target	VERB
ajmsi-2312	129	15	clinical	clinical	ADJ
ajmsi-2312	129	16	examination	examination	NOUN
ajmsi-2312	129	17	,	,	PUNCT
ajmsi-2312	129	18	and	and	CCONJ
ajmsi-2312	129	19	peripheral	peripheral	ADJ
ajmsi-2312	129	20	blood	blood	NOUN
ajmsi-2312	129	21	film	film	NOUN
ajmsi-2312	129	22	.	.	PUNCT
ajmsi-2312	130	1	4	4	X
ajmsi-2312	130	2	.	.	X
ajmsi-2312	130	3	bone	bone	NOUN
ajmsi-2312	130	4	marrow	marrow	NOUN
ajmsi-2312	130	5	aspirate	aspirate	NOUN
ajmsi-2312	130	6	and	and	CCONJ
ajmsi-2312	130	7	trephine	trephine	ADJ
ajmsi-2312	130	8	biopsy	biopsy	NOUN
ajmsi-2312	130	9	,	,	PUNCT
ajmsi-2312	130	10	where	where	SCONJ
ajmsi-2312	130	11	possible	possible	ADJ
ajmsi-2312	130	12	:	:	PUNCT
ajmsi-2312	130	13	findings	finding	NOUN
ajmsi-2312	130	14	meeting	meet	VERB
ajmsi-2312	130	15	the	the	DET
ajmsi-2312	130	16	major	major	ADJ
ajmsi-2312	130	17	criteria	criterion	NOUN
ajmsi-2312	130	18	for	for	ADP
ajmsi-2312	130	19	et	et	NOUN
ajmsi-2312	130	20	diagnosis	diagnosis	NOUN
ajmsi-2312	130	21	.	.	PUNCT
ajmsi-2312	131	1	5	5	X
ajmsi-2312	131	2	.	.	X
ajmsi-2312	131	3	make	make	VERB
ajmsi-2312	131	4	a	a	DET
ajmsi-2312	131	5	presumed	presumed	ADJ
ajmsi-2312	131	6	or	or	CCONJ
ajmsi-2312	131	7	definitive	definitive	ADJ
ajmsi-2312	131	8	diagnosis	diagnosis	NOUN
ajmsi-2312	131	9	of	of	ADP
ajmsi-2312	131	10	et	et	NOUN
ajmsi-2312	131	11	and	and	CCONJ
ajmsi-2312	131	12	go	go	VERB
ajmsi-2312	131	13	to	to	ADP
ajmsi-2312	131	14	c.	c.	PROPN
ajmsi-2312	131	15	c.	c.	PROPN
ajmsi-2312	131	16	diagnosis	diagnosis	NOUN
ajmsi-2312	131	17	of	of	ADP
ajmsi-2312	131	18	et	et	PROPN
ajmsi-2312	131	19	1	1	NUM
ajmsi-2312	131	20	.	.	PUNCT
ajmsi-2312	132	1	start	start	VERB
ajmsi-2312	132	2	on	on	ADP
ajmsi-2312	132	3	low	low	ADJ
ajmsi-2312	132	4	-	-	PUNCT
ajmsi-2312	132	5	dose	dose	NOUN
ajmsi-2312	132	6	aspirin	aspirin	NOUN
ajmsi-2312	132	7	and	and	CCONJ
ajmsi-2312	132	8	hydroxyurea	hydroxyurea	ADJ
ajmsi-2312	132	9	.	.	PUNCT
ajmsi-2312	133	1	2	2	X
ajmsi-2312	133	2	.	.	X
ajmsi-2312	133	3	therapeutic	therapeutic	ADJ
ajmsi-2312	133	4	target	target	NOUN
ajmsi-2312	133	5	platelet	platelet	NOUN
ajmsi-2312	133	6	counts	count	NOUN
ajmsi-2312	133	7	of	of	ADP
ajmsi-2312	133	8	150	150	NUM
ajmsi-2312	133	9	-	-	SYM
ajmsi-2312	133	10	450	450	NUM
ajmsi-2312	133	11	x	x	SYM
ajmsi-2312	133	12	103/µl	103/µl	NUM
ajmsi-2312	133	13	,	,	PUNCT
ajmsi-2312	133	14	and	and	CCONJ
ajmsi-2312	133	15	an	an	DET
ajmsi-2312	133	16	absolute	absolute	ADJ
ajmsi-2312	133	17	neutrophil	neutrophil	ADJ
ajmsi-2312	133	18	count	count	NOUN
ajmsi-2312	133	19	of	of	ADP
ajmsi-2312	133	20	≥	≥	NOUN
ajmsi-2312	133	21	1.5	1.5	NUM
ajmsi-2312	133	22	x	x	SYM
ajmsi-2312	133	23	103/µl	103/µl	NUM
ajmsi-2312	133	24	.	.	NOUN
ajmsi-2312	134	1	3	3	X
ajmsi-2312	134	2	.	.	X
ajmsi-2312	134	3	individualize	individualize	VERB
ajmsi-2312	134	4	therapeutic	therapeutic	ADJ
ajmsi-2312	134	5	targets	target	NOUN
ajmsi-2312	134	6	.	.	PUNCT
ajmsi-2312	135	1	4	4	X
ajmsi-2312	135	2	.	.	X
ajmsi-2312	135	3	monthly	monthly	ADJ
ajmsi-2312	135	4	follow	follow	NOUN
ajmsi-2312	135	5	-	-	PUNCT
ajmsi-2312	135	6	ups	up	NOUN
ajmsi-2312	135	7	with	with	ADP
ajmsi-2312	135	8	complete	complete	ADJ
ajmsi-2312	135	9	blood	blood	NOUN
ajmsi-2312	135	10	counts	count	NOUN
ajmsi-2312	135	11	(	(	PUNCT
ajmsi-2312	135	12	and	and	CCONJ
ajmsi-2312	135	13	any	any	DET
ajmsi-2312	135	14	other	other	ADJ
ajmsi-2312	135	15	relevant	relevant	ADJ
ajmsi-2312	135	16	tests	test	NOUN
ajmsi-2312	135	17	)	)	PUNCT
ajmsi-2312	135	18	.	.	PUNCT
ajmsi-2312	136	1	5	5	X
ajmsi-2312	136	2	.	.	X
ajmsi-2312	136	3	monitor	monitor	VERB
ajmsi-2312	136	4	for	for	ADP
ajmsi-2312	136	5	therapeutic	therapeutic	ADJ
ajmsi-2312	136	6	targets	target	NOUN
ajmsi-2312	136	7	,	,	PUNCT
ajmsi-2312	136	8	drug	drug	NOUN
ajmsi-2312	136	9	adverse	adverse	ADJ
ajmsi-2312	136	10	effects	effect	NOUN
ajmsi-2312	136	11	,	,	PUNCT
ajmsi-2312	136	12	and	and	CCONJ
ajmsi-2312	136	13	disease	disease	NOUN
ajmsi-2312	136	14	transformations	transformation	NOUN
ajmsi-2312	136	15	(	(	PUNCT
ajmsi-2312	136	16	e.g.	e.g.	ADV
ajmsi-2312	136	17	,	,	PUNCT
ajmsi-2312	136	18	into	into	ADP
ajmsi-2312	136	19	leukemias	leukemias	PROPN
ajmsi-2312	136	20	)	)	PUNCT
ajmsi-2312	136	21	.	.	PUNCT
ajmsi-2312	137	1	key	key	ADJ
ajmsi-2312	137	2	:	:	PUNCT
ajmsi-2312	137	3	et	et	X
ajmsi-2312	137	4	=	=	NOUN
ajmsi-2312	137	5	essential	essential	ADJ
ajmsi-2312	137	6	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	137	7	,	,	PUNCT
ajmsi-2312	137	8	rt	rt	NOUN
ajmsi-2312	137	9	=	=	NOUN
ajmsi-2312	137	10	reactive	reactive	ADJ
ajmsi-2312	137	11	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	137	12	,	,	PUNCT
ajmsi-2312	137	13	crp	crp	PROPN
ajmsi-2312	137	14	=	=	SYM
ajmsi-2312	137	15	c	c	NOUN
ajmsi-2312	137	16	-	-	PUNCT
ajmsi-2312	137	17	reactive	reactive	ADJ
ajmsi-2312	137	18	protein	protein	NOUN
ajmsi-2312	137	19	,	,	PUNCT
ajmsi-2312	137	20	esr	esr	NOUN
ajmsi-2312	137	21	=	=	PROPN
ajmsi-2312	137	22	erythrocyte	erythrocyte	ADJ
ajmsi-2312	137	23	sedimentation	sedimentation	NOUN
ajmsi-2312	137	24	rate	rate	NOUN
ajmsi-2312	137	25	,	,	PUNCT
ajmsi-2312	137	26	and	and	CCONJ
ajmsi-2312	137	27	mpns	mpns	ADJ
ajmsi-2312	137	28	=	=	ADJ
ajmsi-2312	137	29	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	137	30	neoplasms	neoplasm	NOUN
ajmsi-2312	137	31	.	.	PUNCT
ajmsi-2312	138	1	conclusion	conclusion	NOUN
ajmsi-2312	138	2	in	in	ADP
ajmsi-2312	138	3	resource	resource	NOUN
ajmsi-2312	138	4	-	-	PUNCT
ajmsi-2312	138	5	limited	limit	VERB
ajmsi-2312	138	6	settings	setting	NOUN
ajmsi-2312	138	7	,	,	PUNCT
ajmsi-2312	138	8	a	a	DET
ajmsi-2312	138	9	diagnosis	diagnosis	NOUN
ajmsi-2312	138	10	of	of	ADP
ajmsi-2312	138	11	et	et	NOUN
ajmsi-2312	138	12	must	must	AUX
ajmsi-2312	138	13	still	still	ADV
ajmsi-2312	138	14	be	be	AUX
ajmsi-2312	138	15	made	make	VERB
ajmsi-2312	138	16	through	through	ADP
ajmsi-2312	138	17	a	a	DET
ajmsi-2312	138	18	high	high	ADJ
ajmsi-2312	138	19	index	index	NOUN
ajmsi-2312	138	20	of	of	ADP
ajmsi-2312	138	21	suspicion	suspicion	NOUN
ajmsi-2312	138	22	and	and	CCONJ
ajmsi-2312	138	23	a	a	DET
ajmsi-2312	138	24	nuanced	nuanced	ADJ
ajmsi-2312	138	25	approach	approach	NOUN
ajmsi-2312	138	26	that	that	PRON
ajmsi-2312	138	27	incorporates	incorporate	VERB
ajmsi-2312	138	28	compatible	compatible	ADJ
ajmsi-2312	138	29	clinical	clinical	ADJ
ajmsi-2312	138	30	features	feature	NOUN
ajmsi-2312	138	31	,	,	PUNCT
ajmsi-2312	138	32	persistent	persistent	ADJ
ajmsi-2312	138	33	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	138	34	(	(	PUNCT
ajmsi-2312	138	35	especially	especially	ADV
ajmsi-2312	138	36	with	with	ADP
ajmsi-2312	138	37	platelet	platelet	NOUN
ajmsi-2312	138	38	counts	count	NOUN
ajmsi-2312	138	39	>	>	PUNCT
ajmsi-2312	138	40	1000	1000	NUM
ajmsi-2312	138	41	x	x	SYM
ajmsi-2312	138	42	103/µl	103/µl	NUM
ajmsi-2312	138	43	)	)	PUNCT
ajmsi-2312	138	44	,	,	PUNCT
ajmsi-2312	138	45	and	and	CCONJ
ajmsi-2312	138	46	a	a	DET
ajmsi-2312	138	47	simple	simple	ADJ
ajmsi-2312	138	48	peripheral	peripheral	ADJ
ajmsi-2312	138	49	blood	blood	NOUN
ajmsi-2312	138	50	smear	smear	NOUN
ajmsi-2312	138	51	that	that	PRON
ajmsi-2312	138	52	shows	show	VERB
ajmsi-2312	138	53	extreme	extreme	ADJ
ajmsi-2312	138	54	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	138	55	with	with	ADP
ajmsi-2312	138	56	platelet	platelet	NOUN
ajmsi-2312	138	57	anisocytosis	anisocytosis	NOUN
ajmsi-2312	138	58	.	.	PUNCT
ajmsi-2312	139	1	this	this	PRON
ajmsi-2312	139	2	is	be	AUX
ajmsi-2312	139	3	followed	follow	VERB
ajmsi-2312	139	4	by	by	ADP
ajmsi-2312	139	5	a	a	DET
ajmsi-2312	139	6	meticulous	meticulous	ADJ
ajmsi-2312	139	7	,	,	PUNCT
ajmsi-2312	139	8	targeted	targeted	ADJ
ajmsi-2312	139	9	evaluation	evaluation	NOUN
ajmsi-2312	139	10	to	to	PART
ajmsi-2312	139	11	rule	rule	VERB
ajmsi-2312	139	12	out	out	ADP
ajmsi-2312	139	13	reactive	reactive	ADJ
ajmsi-2312	139	14	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	139	15	and	and	CCONJ
ajmsi-2312	139	16	other	other	ADJ
ajmsi-2312	139	17	mpns	mpns	NOUN
ajmsi-2312	139	18	.	.	PUNCT
ajmsi-2312	140	1	a	a	DET
ajmsi-2312	140	2	bmat	bmat	ADJ
ajmsi-2312	140	3	biopsy	biopsy	NOUN
ajmsi-2312	140	4	and	and	CCONJ
ajmsi-2312	140	5	genetic	genetic	ADJ
ajmsi-2312	140	6	testing	testing	NOUN
ajmsi-2312	140	7	for	for	ADP
ajmsi-2312	140	8	jak2	jak2	PROPN
ajmsi-2312	140	9	,	,	PUNCT
ajmsi-2312	140	10	calr	calr	ADJ
ajmsi-2312	140	11	,	,	PUNCT
ajmsi-2312	140	12	or	or	CCONJ
ajmsi-2312	140	13	mpl	mpl	NOUN
ajmsi-2312	140	14	mutations	mutation	NOUN
ajmsi-2312	140	15	are	be	AUX
ajmsi-2312	140	16	ideally	ideally	ADV
ajmsi-2312	140	17	required	require	VERB
ajmsi-2312	140	18	for	for	ADP
ajmsi-2312	140	19	proving	prove	VERB
ajmsi-2312	140	20	a	a	DET
ajmsi-2312	140	21	diagnosis	diagnosis	NOUN
ajmsi-2312	140	22	of	of	ADP
ajmsi-2312	140	23	et	et	NOUN
ajmsi-2312	140	24	,	,	PUNCT
ajmsi-2312	140	25	but	but	CCONJ
ajmsi-2312	140	26	in	in	ADP
ajmsi-2312	140	27	resource	resource	NOUN
ajmsi-2312	140	28	-	-	PUNCT
ajmsi-2312	140	29	limited	limit	VERB
ajmsi-2312	140	30	settings	setting	NOUN
ajmsi-2312	140	31	,	,	PUNCT
ajmsi-2312	140	32	obtaining	obtain	VERB
ajmsi-2312	140	33	these	these	DET
ajmsi-2312	140	34	tests	test	NOUN
ajmsi-2312	140	35	is	be	AUX
ajmsi-2312	140	36	usually	usually	ADV
ajmsi-2312	140	37	hopelessly	hopelessly	ADV
ajmsi-2312	140	38	vetoed	veto	VERB
ajmsi-2312	140	39	by	by	ADP
ajmsi-2312	140	40	their	their	PRON
ajmsi-2312	140	41	inaccessibility	inaccessibility	NOUN
ajmsi-2312	140	42	and	and	CCONJ
ajmsi-2312	140	43	prohibitive	prohibitive	ADJ
ajmsi-2312	140	44	costs	cost	NOUN
ajmsi-2312	140	45	.	.	PUNCT
ajmsi-2312	141	1	hu	hu	PROPN
ajmsi-2312	141	2	and	and	CCONJ
ajmsi-2312	141	3	aspirin	aspirin	NOUN
ajmsi-2312	141	4	are	be	AUX
ajmsi-2312	141	5	widely	widely	ADV
ajmsi-2312	141	6	available	available	ADJ
ajmsi-2312	141	7	in	in	ADP
ajmsi-2312	141	8	most	most	ADJ
ajmsi-2312	141	9	clinical	clinical	ADJ
ajmsi-2312	141	10	settings	setting	NOUN
ajmsi-2312	141	11	and	and	CCONJ
ajmsi-2312	141	12	should	should	AUX
ajmsi-2312	141	13	judiciously	judiciously	ADV
ajmsi-2312	141	14	be	be	AUX
ajmsi-2312	141	15	used	use	VERB
ajmsi-2312	141	16	to	to	PART
ajmsi-2312	141	17	treat	treat	VERB
ajmsi-2312	141	18	et	et	NOUN
ajmsi-2312	141	19	with	with	ADP
ajmsi-2312	141	20	careful	careful	ADJ
ajmsi-2312	141	21	monitoring	monitoring	NOUN
ajmsi-2312	141	22	based	base	VERB
ajmsi-2312	141	23	on	on	ADP
ajmsi-2312	141	24	individualized	individualized	ADJ
ajmsi-2312	141	25	treatment	treatment	NOUN
ajmsi-2312	141	26	targets	target	NOUN
ajmsi-2312	141	27	.	.	PUNCT
ajmsi-2312	142	1	recommendations	recommendation	NOUN
ajmsi-2312	142	2	hu	hu	ADJ
ajmsi-2312	142	3	-	-	ADJ
ajmsi-2312	142	4	induced	induced	ADJ
ajmsi-2312	142	5	neutropenia	neutropenia	NOUN
ajmsi-2312	142	6	is	be	AUX
ajmsi-2312	142	7	a	a	DET
ajmsi-2312	142	8	dose	dose	NOUN
ajmsi-2312	142	9	-	-	PUNCT
ajmsi-2312	142	10	limiting	limit	VERB
ajmsi-2312	142	11	adverse	adverse	ADJ
ajmsi-2312	142	12	effect	effect	NOUN
ajmsi-2312	142	13	of	of	ADP
ajmsi-2312	142	14	hu	hu	PROPN
ajmsi-2312	142	15	therapy	therapy	NOUN
ajmsi-2312	142	16	that	that	PRON
ajmsi-2312	142	17	may	may	AUX
ajmsi-2312	142	18	complicate	complicate	VERB
ajmsi-2312	142	19	et	et	NOUN
ajmsi-2312	142	20	treatment	treatment	NOUN
ajmsi-2312	142	21	and	and	CCONJ
ajmsi-2312	142	22	hinder	hinder	VERB
ajmsi-2312	142	23	the	the	DET
ajmsi-2312	142	24	attainment	attainment	NOUN
ajmsi-2312	142	25	of	of	ADP
ajmsi-2312	142	26	target	target	NOUN
ajmsi-2312	142	27	platelet	platelet	NOUN
ajmsi-2312	142	28	levels	level	NOUN
ajmsi-2312	142	29	.	.	PUNCT
ajmsi-2312	143	1	unfortunately	unfortunately	ADV
ajmsi-2312	143	2	,	,	PUNCT
ajmsi-2312	143	3	no	no	DET
ajmsi-2312	143	4	robust	robust	ADJ
ajmsi-2312	143	5	data	datum	NOUN
ajmsi-2312	143	6	currently	currently	ADV
ajmsi-2312	143	7	exists	exist	VERB
ajmsi-2312	143	8	in	in	ADP
ajmsi-2312	143	9	the	the	DET
ajmsi-2312	143	10	literature	literature	NOUN
ajmsi-2312	143	11	that	that	PRON
ajmsi-2312	143	12	would	would	AUX
ajmsi-2312	143	13	give	give	VERB
ajmsi-2312	143	14	guidance	guidance	NOUN
ajmsi-2312	143	15	on	on	ADP
ajmsi-2312	143	16	dose	dose	NOUN
ajmsi-2312	143	17	adjustments	adjustment	NOUN
ajmsi-2312	143	18	in	in	ADP
ajmsi-2312	143	19	such	such	ADJ
ajmsi-2312	143	20	cases	case	NOUN
ajmsi-2312	143	21	.	.	PUNCT
ajmsi-2312	144	1	more	more	ADJ
ajmsi-2312	144	2	clinical	clinical	ADJ
ajmsi-2312	144	3	trials	trial	NOUN
ajmsi-2312	144	4	and	and	CCONJ
ajmsi-2312	144	5	expert	expert	ADJ
ajmsi-2312	144	6	consensus	consensus	NOUN
ajmsi-2312	144	7	recommendations	recommendation	NOUN
ajmsi-2312	144	8	are	be	AUX
ajmsi-2312	144	9	necessary	necessary	ADJ
ajmsi-2312	144	10	to	to	PART
ajmsi-2312	144	11	bridge	bridge	VERB
ajmsi-2312	144	12	this	this	DET
ajmsi-2312	144	13	gap	gap	NOUN
ajmsi-2312	144	14	,	,	PUNCT
ajmsi-2312	144	15	especially	especially	ADV
ajmsi-2312	144	16	with	with	ADP
ajmsi-2312	144	17	a	a	DET
ajmsi-2312	144	18	focus	focus	NOUN
ajmsi-2312	144	19	on	on	ADP
ajmsi-2312	144	20	resource	resource	NOUN
ajmsi-2312	144	21	-	-	PUNCT
ajmsi-2312	144	22	limited	limit	VERB
ajmsi-2312	144	23	clinical	clinical	ADJ
ajmsi-2312	144	24	contexts	contexts	NOUN
ajmsi-2312	144	25	.	.	PUNCT
ajmsi-2312	145	1	acknowledgement	acknowledgement	NOUN
ajmsi-2312	145	2	the	the	DET
ajmsi-2312	145	3	authors	author	NOUN
ajmsi-2312	145	4	acknowledge	acknowledge	VERB
ajmsi-2312	145	5	nurse	nurse	PROPN
ajmsi-2312	145	6	pauline	pauline	PROPN
ajmsi-2312	145	7	nyagah	nyagah	PROPN
ajmsi-2312	145	8	,	,	PUNCT
ajmsi-2312	145	9	laboratory	laboratory	NOUN
ajmsi-2312	145	10	technicians	technician	NOUN
ajmsi-2312	145	11	paul	paul	PROPN
ajmsi-2312	145	12	njuguna	njuguna	PROPN
ajmsi-2312	145	13	,	,	PUNCT
ajmsi-2312	145	14	peter	peter	PROPN
ajmsi-2312	145	15	kibet	kibet	PROPN
ajmsi-2312	145	16	,	,	PUNCT
ajmsi-2312	145	17	and	and	CCONJ
ajmsi-2312	145	18	zebedeo	zebedeo	PROPN
ajmsi-2312	145	19	machuka	machuka	PROPN
ajmsi-2312	145	20	,	,	PUNCT
ajmsi-2312	145	21	as	as	ADV
ajmsi-2312	145	22	well	well	ADV
ajmsi-2312	145	23	as	as	ADP
ajmsi-2312	145	24	hospital	hospital	NOUN
ajmsi-2312	145	25	administrators	administrator	NOUN
ajmsi-2312	145	26	seth	seth	PROPN
ajmsi-2312	145	27	manera	manera	PROPN
ajmsi-2312	145	28	and	and	CCONJ
ajmsi-2312	145	29	steve	steve	PROPN
ajmsi-2312	145	30	nyagah	nyagah	PROPN
ajmsi-2312	145	31	,	,	PUNCT
ajmsi-2312	145	32	for	for	ADP
ajmsi-2312	145	33	their	their	PRON
ajmsi-2312	145	34	direct	direct	ADJ
ajmsi-2312	145	35	involvement	involvement	NOUN
ajmsi-2312	145	36	in	in	ADP
ajmsi-2312	145	37	the	the	DET
ajmsi-2312	145	38	management	management	NOUN
ajmsi-2312	145	39	of	of	ADP
ajmsi-2312	145	40	the	the	DET
ajmsi-2312	145	41	patient	patient	NOUN
ajmsi-2312	145	42	.	.	PUNCT
ajmsi-2312	146	1	references	reference	NOUN
ajmsi-2312	146	2	antonioli	antonioli	PROPN
ajmsi-2312	146	3	,	,	PUNCT
ajmsi-2312	146	4	e.	e.	PROPN
ajmsi-2312	146	5	,	,	PUNCT
ajmsi-2312	146	6	guglielmelli	guglielmelli	PROPN
ajmsi-2312	146	7	,	,	PUNCT
ajmsi-2312	146	8	p.	p.	NOUN
ajmsi-2312	146	9	,	,	PUNCT
ajmsi-2312	146	10	pieri	pieri	PROPN
ajmsi-2312	146	11	,	,	PUNCT
ajmsi-2312	146	12	l.	l.	PROPN
ajmsi-2312	146	13	,	,	PUNCT
ajmsi-2312	146	14	finazzi	finazzi	NOUN
ajmsi-2312	146	15	,	,	PUNCT
ajmsi-2312	146	16	m.	m.	NOUN
ajmsi-2312	146	17	,	,	PUNCT
ajmsi-2312	146	18	rumi	rumi	PROPN
ajmsi-2312	146	19	,	,	PUNCT
ajmsi-2312	146	20	e.	e.	PROPN
ajmsi-2312	146	21	,	,	PUNCT
ajmsi-2312	146	22	martinelli	martinelli	PROPN
ajmsi-2312	146	23	,	,	PUNCT
ajmsi-2312	146	24	v.	v.	PROPN
ajmsi-2312	146	25	,	,	PUNCT
ajmsi-2312	146	26	vianelli	vianelli	ADV
ajmsi-2312	146	27	,	,	PUNCT
ajmsi-2312	146	28	n.	n.	PROPN
ajmsi-2312	146	29	,	,	PUNCT
ajmsi-2312	146	30	luigia	luigia	PROPN
ajmsi-2312	146	31	randi	randi	PROPN
ajmsi-2312	146	32	,	,	PUNCT
ajmsi-2312	146	33	m.	m.	NOUN
ajmsi-2312	146	34	,	,	PUNCT
ajmsi-2312	146	35	bertozzi	bertozzi	NOUN
ajmsi-2312	146	36	,	,	PUNCT
ajmsi-2312	146	37	i.	i.	NOUN
ajmsi-2312	146	38	,	,	PUNCT
ajmsi-2312	146	39	de	de	PROPN
ajmsi-2312	146	40	stefano	stefano	PROPN
ajmsi-2312	146	41	,	,	PUNCT
ajmsi-2312	146	42	v.	v.	PROPN
ajmsi-2312	146	43	,	,	PUNCT
ajmsi-2312	146	44	za	za	PROPN
ajmsi-2312	146	45	,	,	PUNCT
ajmsi-2312	146	46	t.	t.	PROPN
ajmsi-2312	146	47	,	,	PUNCT
ajmsi-2312	146	48	rossi	rossi	PROPN
ajmsi-2312	146	49	,	,	PUNCT
ajmsi-2312	146	50	e.	e.	PROPN
ajmsi-2312	146	51	,	,	PUNCT
ajmsi-2312	146	52	ruggeri	ruggeri	PROPN
ajmsi-2312	146	53	,	,	PUNCT
ajmsi-2312	146	54	m.	m.	NOUN
ajmsi-2312	146	55	,	,	PUNCT
ajmsi-2312	146	56	elli	elli	PROPN
ajmsi-2312	146	57	,	,	PUNCT
ajmsi-2312	146	58	e.	e.	PROPN
ajmsi-2312	146	59	,	,	PUNCT
ajmsi-2312	146	60	cacciola	cacciola	PROPN
ajmsi-2312	146	61	,	,	PUNCT
ajmsi-2312	146	62	r.	r.	PROPN
ajmsi-2312	146	63	,	,	PUNCT
ajmsi-2312	146	64	cacciola	cacciola	PROPN
ajmsi-2312	146	65	,	,	PUNCT
ajmsi-2312	146	66	e.	e.	PROPN
ajmsi-2312	146	67	,	,	PUNCT
ajmsi-2312	146	68	pogliani	pogliani	PROPN
ajmsi-2312	146	69	,	,	PUNCT
ajmsi-2312	146	70	e.	e.	PROPN
ajmsi-2312	146	71	,	,	PUNCT
ajmsi-2312	146	72	rodeghiero	rodeghiero	PROPN
ajmsi-2312	146	73	,	,	PUNCT
ajmsi-2312	146	74	f.	f.	PROPN
ajmsi-2312	146	75	,	,	PUNCT
ajmsi-2312	146	76	baccarani	baccarani	PROPN
ajmsi-2312	146	77	,	,	PUNCT
ajmsi-2312	146	78	m.	m.	NOUN
ajmsi-2312	146	79	,	,	PUNCT
ajmsi-2312	146	80	.	.	PUNCT
ajmsi-2312	146	81	.	.	PUNCT
ajmsi-2312	146	82	.	.	PUNCT
ajmsi-2312	147	1	vannucchi	vannucchi	PROPN
ajmsi-2312	147	2	,	,	PUNCT
ajmsi-2312	147	3	a.	a.	NOUN
ajmsi-2312	147	4	m.	m.	NOUN
ajmsi-2312	147	5	pa	pa	PROPN
ajmsi-2312	147	6	ge	ge	PROPN
ajmsi-2312	147	7	6	6	NUM
ajmsi-2312	147	8	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	147	9	am	be	AUX
ajmsi-2312	147	10	.	.	PUNCT
ajmsi-2312	148	1	j.	j.	PROPN
ajmsi-2312	148	2	med	med	PROPN
ajmsi-2312	148	3	.	.	PUNCT
ajmsi-2312	149	1	sci	sci	PROPN
ajmsi-2312	149	2	.	.	PUNCT
ajmsi-2312	149	3	innov	innov	PROPN
ajmsi-2312	149	4	.	.	PUNCT
ajmsi-2312	150	1	3(1	3(1	NUM
ajmsi-2312	150	2	)	)	PUNCT
ajmsi-2312	151	1	1	1	NUM
ajmsi-2312	151	2	-	-	SYM
ajmsi-2312	151	3	7	7	NUM
ajmsi-2312	151	4	,	,	PUNCT
ajmsi-2312	151	5	2024	2024	NUM
ajmsi-2312	151	6	(	(	PUNCT
ajmsi-2312	151	7	2012	2012	NUM
ajmsi-2312	151	8	)	)	PUNCT
ajmsi-2312	151	9	.	.	PUNCT
ajmsi-2312	152	1	hydroxyurea	hydroxyurea	ADV
ajmsi-2312	152	2	-	-	PUNCT
ajmsi-2312	152	3	related	relate	VERB
ajmsi-2312	152	4	toxicity	toxicity	NOUN
ajmsi-2312	152	5	in	in	ADP
ajmsi-2312	152	6	3,411	3,411	NUM
ajmsi-2312	152	7	patients	patient	NOUN
ajmsi-2312	152	8	with	with	ADP
ajmsi-2312	152	9	ph’-negative	ph’-negative	ADJ
ajmsi-2312	152	10	mpn	mpn	NOUN
ajmsi-2312	152	11	.	.	PUNCT
ajmsi-2312	153	1	am	be	AUX
ajmsi-2312	153	2	j	j	PROPN
ajmsi-2312	153	3	hematol	hematol	NOUN
ajmsi-2312	153	4	,	,	PUNCT
ajmsi-2312	153	5	87(5	87(5	NUM
ajmsi-2312	153	6	)	)	PUNCT
ajmsi-2312	153	7	,	,	PUNCT
ajmsi-2312	153	8	552554	552554	NUM
ajmsi-2312	153	9	.	.	PUNCT
ajmsi-2312	154	1	https://doi.org/10.1002/ajh.23160	https://doi.org/10.1002/ajh.23160	PROPN
ajmsi-2312	154	2	arber	arber	PROPN
ajmsi-2312	154	3	,	,	PUNCT
ajmsi-2312	154	4	d.	d.	PROPN
ajmsi-2312	154	5	a.	a.	PROPN
ajmsi-2312	154	6	,	,	PUNCT
ajmsi-2312	154	7	orazi	orazi	PROPN
ajmsi-2312	154	8	,	,	PUNCT
ajmsi-2312	154	9	a.	a.	NOUN
ajmsi-2312	154	10	,	,	PUNCT
ajmsi-2312	154	11	hasserjian	hasserjian	PROPN
ajmsi-2312	154	12	,	,	PUNCT
ajmsi-2312	154	13	r.	r.	PROPN
ajmsi-2312	154	14	,	,	PUNCT
ajmsi-2312	154	15	thiele	thiele	PROPN
ajmsi-2312	154	16	,	,	PUNCT
ajmsi-2312	154	17	j.	j.	PROPN
ajmsi-2312	154	18	,	,	PUNCT
ajmsi-2312	154	19	borowitz	borowitz	NOUN
ajmsi-2312	154	20	,	,	PUNCT
ajmsi-2312	154	21	m.	m.	NOUN
ajmsi-2312	154	22	j.	j.	PROPN
ajmsi-2312	154	23	,	,	PUNCT
ajmsi-2312	154	24	le	le	X
ajmsi-2312	154	25	beau	beau	PROPN
ajmsi-2312	154	26	,	,	PUNCT
ajmsi-2312	154	27	m.	m.	NOUN
ajmsi-2312	154	28	m.	m.	NOUN
ajmsi-2312	154	29	,	,	PUNCT
ajmsi-2312	154	30	bloomfield	bloomfield	PROPN
ajmsi-2312	154	31	,	,	PUNCT
ajmsi-2312	154	32	c.	c.	PROPN
ajmsi-2312	154	33	d.	d.	PROPN
ajmsi-2312	154	34	,	,	PUNCT
ajmsi-2312	154	35	cazzola	cazzola	PROPN
ajmsi-2312	154	36	,	,	PUNCT
ajmsi-2312	154	37	m.	m.	NOUN
ajmsi-2312	154	38	,	,	PUNCT
ajmsi-2312	154	39	&	&	CCONJ
ajmsi-2312	154	40	vardiman	vardiman	PROPN
ajmsi-2312	154	41	,	,	PUNCT
ajmsi-2312	154	42	j.	j.	PROPN
ajmsi-2312	154	43	w.	w.	PROPN
ajmsi-2312	154	44	(	(	PUNCT
ajmsi-2312	154	45	2016	2016	NUM
ajmsi-2312	154	46	)	)	PUNCT
ajmsi-2312	154	47	.	.	PUNCT
ajmsi-2312	155	1	the	the	DET
ajmsi-2312	155	2	2016	2016	NUM
ajmsi-2312	155	3	revision	revision	NOUN
ajmsi-2312	155	4	to	to	ADP
ajmsi-2312	155	5	the	the	DET
ajmsi-2312	155	6	world	world	PROPN
ajmsi-2312	155	7	health	health	PROPN
ajmsi-2312	155	8	organization	organization	PROPN
ajmsi-2312	155	9	classification	classification	NOUN
ajmsi-2312	155	10	of	of	ADP
ajmsi-2312	155	11	myeloid	myeloid	ADJ
ajmsi-2312	155	12	neoplasms	neoplasm	NOUN
ajmsi-2312	155	13	and	and	CCONJ
ajmsi-2312	155	14	acute	acute	ADJ
ajmsi-2312	155	15	leukemia	leukemia	NOUN
ajmsi-2312	155	16	.	.	PUNCT
ajmsi-2312	156	1	blood	blood	NOUN
ajmsi-2312	156	2	,	,	PUNCT
ajmsi-2312	156	3	127(20	127(20	NUM
ajmsi-2312	156	4	)	)	PUNCT
ajmsi-2312	156	5	,	,	PUNCT
ajmsi-2312	156	6	2391	2391	NUM
ajmsi-2312	156	7	-	-	SYM
ajmsi-2312	156	8	2405	2405	NUM
ajmsi-2312	156	9	.	.	PUNCT
ajmsi-2312	157	1	https://doi.org/10.1182/	https://doi.org/10.1182/	NOUN
ajmsi-2312	157	2	blood-2016	blood-2016	PROPN
ajmsi-2312	157	3	-	-	PUNCT
ajmsi-2312	157	4	03	03	NUM
ajmsi-2312	157	5	-	-	PUNCT
ajmsi-2312	157	6	643544	643544	NUM
ajmsi-2312	157	7	arber	arber	PROPN
ajmsi-2312	157	8	,	,	PUNCT
ajmsi-2312	157	9	d.	d.	PROPN
ajmsi-2312	157	10	a.	a.	PROPN
ajmsi-2312	157	11	,	,	PUNCT
ajmsi-2312	157	12	orazi	orazi	PROPN
ajmsi-2312	157	13	,	,	PUNCT
ajmsi-2312	157	14	a.	a.	NOUN
ajmsi-2312	157	15	,	,	PUNCT
ajmsi-2312	157	16	hasserjian	hasserjian	PROPN
ajmsi-2312	157	17	,	,	PUNCT
ajmsi-2312	157	18	r.	r.	PROPN
ajmsi-2312	157	19	p.	p.	PROPN
ajmsi-2312	157	20	,	,	PUNCT
ajmsi-2312	157	21	borowitz	borowitz	NOUN
ajmsi-2312	157	22	,	,	PUNCT
ajmsi-2312	157	23	m.	m.	NOUN
ajmsi-2312	157	24	j.	j.	PROPN
ajmsi-2312	157	25	,	,	PUNCT
ajmsi-2312	157	26	calvo	calvo	PROPN
ajmsi-2312	157	27	,	,	PUNCT
ajmsi-2312	157	28	k.	k.	PROPN
ajmsi-2312	157	29	r.	r.	PROPN
ajmsi-2312	157	30	,	,	PUNCT
ajmsi-2312	157	31	kvasnicka	kvasnicka	PROPN
ajmsi-2312	157	32	,	,	PUNCT
ajmsi-2312	157	33	h.	h.	PROPN
ajmsi-2312	157	34	m.	m.	PROPN
ajmsi-2312	157	35	,	,	PUNCT
ajmsi-2312	157	36	wang	wang	PROPN
ajmsi-2312	157	37	,	,	PUNCT
ajmsi-2312	157	38	s.	s.	PROPN
ajmsi-2312	157	39	a.	a.	PROPN
ajmsi-2312	157	40	,	,	PUNCT
ajmsi-2312	157	41	bagg	bagg	PROPN
ajmsi-2312	157	42	,	,	PUNCT
ajmsi-2312	157	43	a.	a.	NOUN
ajmsi-2312	157	44	,	,	PUNCT
ajmsi-2312	157	45	barbui	barbui	ADJ
ajmsi-2312	157	46	,	,	PUNCT
ajmsi-2312	157	47	t.	t.	PROPN
ajmsi-2312	157	48	,	,	PUNCT
ajmsi-2312	157	49	branford	branford	PROPN
ajmsi-2312	157	50	,	,	PUNCT
ajmsi-2312	157	51	s.	s.	PROPN
ajmsi-2312	157	52	,	,	PUNCT
ajmsi-2312	157	53	bueso	bueso	NOUN
ajmsi-2312	157	54	-	-	PUNCT
ajmsi-2312	157	55	ramos	ramos	PROPN
ajmsi-2312	157	56	,	,	PUNCT
ajmsi-2312	157	57	c.	c.	PROPN
ajmsi-2312	157	58	e.	e.	PROPN
ajmsi-2312	157	59	,	,	PUNCT
ajmsi-2312	157	60	cortes	corte	VERB
ajmsi-2312	157	61	,	,	PUNCT
ajmsi-2312	157	62	j.	j.	PROPN
ajmsi-2312	157	63	e.	e.	PROPN
ajmsi-2312	157	64	,	,	PUNCT
ajmsi-2312	157	65	dal	dal	NOUN
ajmsi-2312	157	66	cin	cin	PROPN
ajmsi-2312	157	67	,	,	PUNCT
ajmsi-2312	157	68	p.	p.	PROPN
ajmsi-2312	157	69	,	,	PUNCT
ajmsi-2312	157	70	dinardo	dinardo	PROPN
ajmsi-2312	157	71	,	,	PUNCT
ajmsi-2312	157	72	c.	c.	PROPN
ajmsi-2312	157	73	d.	d.	PROPN
ajmsi-2312	157	74	,	,	PUNCT
ajmsi-2312	157	75	dombret	dombret	PROPN
ajmsi-2312	157	76	,	,	PUNCT
ajmsi-2312	157	77	h.	h.	PROPN
ajmsi-2312	157	78	,	,	PUNCT
ajmsi-2312	157	79	duncavage	duncavage	PROPN
ajmsi-2312	157	80	,	,	PUNCT
ajmsi-2312	157	81	e.	e.	PROPN
ajmsi-2312	157	82	j.	j.	PROPN
ajmsi-2312	157	83	,	,	PUNCT
ajmsi-2312	157	84	ebert	ebert	PROPN
ajmsi-2312	157	85	,	,	PUNCT
ajmsi-2312	157	86	b.	b.	PROPN
ajmsi-2312	157	87	l.	l.	PROPN
ajmsi-2312	157	88	,	,	PUNCT
ajmsi-2312	157	89	estey	estey	PROPN
ajmsi-2312	157	90	,	,	PUNCT
ajmsi-2312	157	91	e.	e.	PROPN
ajmsi-2312	157	92	h.	h.	PROPN
ajmsi-2312	157	93	,	,	PUNCT
ajmsi-2312	157	94	facchetti	facchetti	PROPN
ajmsi-2312	157	95	,	,	PUNCT
ajmsi-2312	157	96	f.	f.	PROPN
ajmsi-2312	157	97	,	,	PUNCT
ajmsi-2312	157	98	.	.	PUNCT
ajmsi-2312	157	99	.	.	PUNCT
ajmsi-2312	157	100	.	.	PUNCT
ajmsi-2312	158	1	tefferi	tefferi	ADV
ajmsi-2312	158	2	,	,	PUNCT
ajmsi-2312	158	3	a.	a.	NOUN
ajmsi-2312	158	4	(	(	PUNCT
ajmsi-2312	158	5	2022	2022	NUM
ajmsi-2312	158	6	)	)	PUNCT
ajmsi-2312	158	7	.	.	PUNCT
ajmsi-2312	159	1	international	international	ADJ
ajmsi-2312	159	2	consensus	consensus	NOUN
ajmsi-2312	159	3	classification	classification	NOUN
ajmsi-2312	159	4	of	of	ADP
ajmsi-2312	159	5	myeloid	myeloid	ADJ
ajmsi-2312	159	6	neoplasms	neoplasm	NOUN
ajmsi-2312	159	7	and	and	CCONJ
ajmsi-2312	159	8	acute	acute	ADJ
ajmsi-2312	159	9	leukemias	leukemia	NOUN
ajmsi-2312	159	10	:	:	PUNCT
ajmsi-2312	159	11	integrating	integrate	VERB
ajmsi-2312	159	12	morphologic	morphologic	ADJ
ajmsi-2312	159	13	,	,	PUNCT
ajmsi-2312	159	14	clinical	clinical	ADJ
ajmsi-2312	159	15	,	,	PUNCT
ajmsi-2312	159	16	and	and	CCONJ
ajmsi-2312	159	17	genomic	genomic	ADJ
ajmsi-2312	159	18	data	datum	NOUN
ajmsi-2312	159	19	.	.	PUNCT
ajmsi-2312	160	1	blood	blood	NOUN
ajmsi-2312	160	2	,	,	PUNCT
ajmsi-2312	160	3	140(11	140(11	NUM
ajmsi-2312	160	4	)	)	PUNCT
ajmsi-2312	160	5	,	,	PUNCT
ajmsi-2312	160	6	1200	1200	NUM
ajmsi-2312	160	7	-	-	SYM
ajmsi-2312	160	8	1228	1228	NUM
ajmsi-2312	160	9	.	.	PUNCT
ajmsi-2312	161	1	https://doi	https://doi	PROPN
ajmsi-2312	161	2	.	.	PUNCT
ajmsi-2312	161	3	org/10.1182	org/10.1182	PROPN
ajmsi-2312	161	4	/	/	SYM
ajmsi-2312	161	5	blood.2022015850	blood.2022015850	PROPN
ajmsi-2312	161	6	barbui	barbui	NOUN
ajmsi-2312	161	7	,	,	PUNCT
ajmsi-2312	161	8	t.	t.	PROPN
ajmsi-2312	161	9	,	,	PUNCT
ajmsi-2312	161	10	vannucchi	vannucchi	PROPN
ajmsi-2312	161	11	,	,	PUNCT
ajmsi-2312	161	12	a.	a.	NOUN
ajmsi-2312	161	13	m.	m.	NOUN
ajmsi-2312	161	14	,	,	PUNCT
ajmsi-2312	161	15	buxhofer	buxhofer	NOUN
ajmsi-2312	161	16	-	-	PUNCT
ajmsi-2312	161	17	ausch	ausch	X
ajmsi-2312	161	18	,	,	PUNCT
ajmsi-2312	161	19	v.	v.	ADV
ajmsi-2312	161	20	,	,	PUNCT
ajmsi-2312	161	21	de	de	X
ajmsi-2312	161	22	stefano	stefano	PROPN
ajmsi-2312	161	23	,	,	PUNCT
ajmsi-2312	161	24	v.	v.	PROPN
ajmsi-2312	161	25	,	,	PUNCT
ajmsi-2312	161	26	betti	betti	PROPN
ajmsi-2312	161	27	,	,	PUNCT
ajmsi-2312	161	28	s.	s.	PROPN
ajmsi-2312	161	29	,	,	PUNCT
ajmsi-2312	161	30	rambaldi	rambaldi	PROPN
ajmsi-2312	161	31	,	,	PUNCT
ajmsi-2312	161	32	a.	a.	NOUN
ajmsi-2312	161	33	,	,	PUNCT
ajmsi-2312	161	34	rumi	rumi	PROPN
ajmsi-2312	161	35	,	,	PUNCT
ajmsi-2312	161	36	e.	e.	PROPN
ajmsi-2312	161	37	,	,	PUNCT
ajmsi-2312	161	38	ruggeri	ruggeri	PROPN
ajmsi-2312	161	39	,	,	PUNCT
ajmsi-2312	161	40	m.	m.	NOUN
ajmsi-2312	161	41	,	,	PUNCT
ajmsi-2312	161	42	rodeghiero	rodeghiero	PROPN
ajmsi-2312	161	43	,	,	PUNCT
ajmsi-2312	161	44	f.	f.	PROPN
ajmsi-2312	161	45	,	,	PUNCT
ajmsi-2312	161	46	randi	randi	PROPN
ajmsi-2312	161	47	,	,	PUNCT
ajmsi-2312	161	48	m.	m.	PROPN
ajmsi-2312	161	49	l.	l.	PROPN
ajmsi-2312	161	50	,	,	PUNCT
ajmsi-2312	161	51	bertozzi	bertozzi	NOUN
ajmsi-2312	161	52	,	,	PUNCT
ajmsi-2312	161	53	i.	i.	NOUN
ajmsi-2312	161	54	,	,	PUNCT
ajmsi-2312	161	55	gisslinger	gisslinger	NOUN
ajmsi-2312	161	56	,	,	PUNCT
ajmsi-2312	161	57	h.	h.	PROPN
ajmsi-2312	161	58	,	,	PUNCT
ajmsi-2312	161	59	finazzi	finazzi	NOUN
ajmsi-2312	161	60	,	,	PUNCT
ajmsi-2312	161	61	g.	g.	PROPN
ajmsi-2312	161	62	,	,	PUNCT
ajmsi-2312	161	63	carobbio	carobbio	PROPN
ajmsi-2312	161	64	,	,	PUNCT
ajmsi-2312	161	65	a.	a.	PROPN
ajmsi-2312	161	66	,	,	PUNCT
ajmsi-2312	161	67	thiele	thiele	PROPN
ajmsi-2312	161	68	,	,	PUNCT
ajmsi-2312	161	69	j.	j.	PROPN
ajmsi-2312	161	70	,	,	PUNCT
ajmsi-2312	161	71	passamonti	passamonti	PROPN
ajmsi-2312	161	72	,	,	PUNCT
ajmsi-2312	161	73	f.	f.	PROPN
ajmsi-2312	161	74	,	,	PUNCT
ajmsi-2312	161	75	falcone	falcone	PROPN
ajmsi-2312	161	76	,	,	PUNCT
ajmsi-2312	161	77	c.	c.	PROPN
ajmsi-2312	161	78	,	,	PUNCT
ajmsi-2312	161	79	&	&	CCONJ
ajmsi-2312	161	80	tefferi	tefferi	ADJ
ajmsi-2312	161	81	,	,	PUNCT
ajmsi-2312	161	82	a.	a.	NOUN
ajmsi-2312	161	83	(	(	PUNCT
ajmsi-2312	161	84	2015	2015	NUM
ajmsi-2312	161	85	)	)	PUNCT
ajmsi-2312	161	86	.	.	PUNCT
ajmsi-2312	162	1	practice	practice	NOUN
ajmsi-2312	162	2	-	-	PUNCT
ajmsi-2312	162	3	relevant	relevant	ADJ
ajmsi-2312	162	4	revision	revision	NOUN
ajmsi-2312	162	5	of	of	ADP
ajmsi-2312	162	6	ipset	ipset	NOUN
ajmsi-2312	162	7	-	-	PUNCT
ajmsi-2312	162	8	thrombosis	thrombosis	NOUN
ajmsi-2312	162	9	based	base	VERB
ajmsi-2312	162	10	on	on	ADP
ajmsi-2312	162	11	1019	1019	NUM
ajmsi-2312	162	12	patients	patient	NOUN
ajmsi-2312	162	13	with	with	ADP
ajmsi-2312	162	14	who	who	PRON
ajmsi-2312	162	15	-	-	PUNCT
ajmsi-2312	162	16	defined	define	VERB
ajmsi-2312	162	17	essential	essential	ADJ
ajmsi-2312	162	18	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	162	19	.	.	PUNCT
ajmsi-2312	163	1	blood	blood	NOUN
ajmsi-2312	163	2	cancer	cancer	PROPN
ajmsi-2312	163	3	j	j	PROPN
ajmsi-2312	163	4	,	,	PUNCT
ajmsi-2312	163	5	5(11	5(11	NUM
ajmsi-2312	163	6	)	)	PUNCT
ajmsi-2312	163	7	,	,	PUNCT
ajmsi-2312	163	8	e369	e369	PROPN
ajmsi-2312	163	9	.	.	PUNCT
ajmsi-2312	164	1	https://	https://	PROPN
ajmsi-2312	164	2	doi.org/10.1038/bcj.2015.94	doi.org/10.1038/bcj.2015.94	PROPN
ajmsi-2312	164	3	bellucci	bellucci	PROPN
ajmsi-2312	164	4	,	,	PUNCT
ajmsi-2312	164	5	s.	s.	PROPN
ajmsi-2312	164	6	,	,	PUNCT
ajmsi-2312	164	7	janvier	janvier	NOUN
ajmsi-2312	164	8	,	,	PUNCT
ajmsi-2312	164	9	m.	m.	NOUN
ajmsi-2312	164	10	,	,	PUNCT
ajmsi-2312	164	11	tobelem	tobelem	NOUN
ajmsi-2312	164	12	,	,	PUNCT
ajmsi-2312	164	13	g.	g.	PROPN
ajmsi-2312	164	14	,	,	PUNCT
ajmsi-2312	164	15	flandrin	flandrin	PROPN
ajmsi-2312	164	16	,	,	PUNCT
ajmsi-2312	164	17	g.	g.	PROPN
ajmsi-2312	164	18	,	,	PUNCT
ajmsi-2312	164	19	charpak	charpak	PROPN
ajmsi-2312	164	20	,	,	PUNCT
ajmsi-2312	164	21	y.	y.	PROPN
ajmsi-2312	164	22	,	,	PUNCT
ajmsi-2312	164	23	berger	berger	PROPN
ajmsi-2312	164	24	,	,	PUNCT
ajmsi-2312	164	25	r.	r.	PROPN
ajmsi-2312	164	26	,	,	PUNCT
ajmsi-2312	164	27	&	&	CCONJ
ajmsi-2312	164	28	boiron	boiron	PROPN
ajmsi-2312	164	29	,	,	PUNCT
ajmsi-2312	164	30	m.	m.	NOUN
ajmsi-2312	164	31	(	(	PUNCT
ajmsi-2312	164	32	1986	1986	NUM
ajmsi-2312	164	33	)	)	PUNCT
ajmsi-2312	164	34	.	.	PUNCT
ajmsi-2312	165	1	essential	essential	ADJ
ajmsi-2312	165	2	thrombocythemias	thrombocythemia	NOUN
ajmsi-2312	165	3	.	.	PUNCT
ajmsi-2312	166	1	clinical	clinical	ADJ
ajmsi-2312	166	2	evolutionary	evolutionary	ADJ
ajmsi-2312	166	3	and	and	CCONJ
ajmsi-2312	166	4	biological	biological	ADJ
ajmsi-2312	166	5	data	datum	NOUN
ajmsi-2312	166	6	.	.	PUNCT
ajmsi-2312	167	1	cancer	cancer	NOUN
ajmsi-2312	167	2	,	,	PUNCT
ajmsi-2312	167	3	58(11	58(11	NUM
ajmsi-2312	167	4	)	)	PUNCT
ajmsi-2312	167	5	,	,	PUNCT
ajmsi-2312	167	6	2440	2440	NUM
ajmsi-2312	167	7	-	-	SYM
ajmsi-2312	167	8	2447	2447	NUM
ajmsi-2312	167	9	.	.	PUNCT
ajmsi-2312	168	1	birgegård	birgegård	ADV
ajmsi-2312	168	2	,	,	PUNCT
ajmsi-2312	168	3	g.	g.	PROPN
ajmsi-2312	168	4	(	(	PUNCT
ajmsi-2312	168	5	2016	2016	NUM
ajmsi-2312	168	6	)	)	PUNCT
ajmsi-2312	168	7	.	.	PUNCT
ajmsi-2312	169	1	the	the	DET
ajmsi-2312	169	2	use	use	NOUN
ajmsi-2312	169	3	of	of	ADP
ajmsi-2312	169	4	anagrelide	anagrelide	ADJ
ajmsi-2312	169	5	in	in	ADP
ajmsi-2312	169	6	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	169	7	neoplasms	neoplasm	NOUN
ajmsi-2312	169	8	,	,	PUNCT
ajmsi-2312	169	9	with	with	ADP
ajmsi-2312	169	10	focus	focus	NOUN
ajmsi-2312	169	11	on	on	ADP
ajmsi-2312	169	12	essential	essential	ADJ
ajmsi-2312	169	13	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	169	14	.	.	PUNCT
ajmsi-2312	170	1	curr	curr	PROPN
ajmsi-2312	170	2	hematol	hematol	PROPN
ajmsi-2312	170	3	malig	malig	PROPN
ajmsi-2312	170	4	rep	rep	PROPN
ajmsi-2312	170	5	,	,	PUNCT
ajmsi-2312	170	6	11(5	11(5	NUM
ajmsi-2312	170	7	)	)	PUNCT
ajmsi-2312	170	8	,	,	PUNCT
ajmsi-2312	170	9	348	348	NUM
ajmsi-2312	170	10	-	-	SYM
ajmsi-2312	170	11	355	355	NUM
ajmsi-2312	170	12	.	.	PUNCT
ajmsi-2312	171	1	https://doi.org/10.1007/s11899016-0335-0	https://doi.org/10.1007/s11899016-0335-0	PROPN
ajmsi-2312	171	2	cazzola	cazzola	PROPN
ajmsi-2312	171	3	,	,	PUNCT
ajmsi-2312	171	4	m.	m.	NOUN
ajmsi-2312	171	5	,	,	PUNCT
ajmsi-2312	171	6	&	&	CCONJ
ajmsi-2312	171	7	kralovics	kralovics	PROPN
ajmsi-2312	171	8	,	,	PUNCT
ajmsi-2312	171	9	r.	r.	PROPN
ajmsi-2312	171	10	(	(	PUNCT
ajmsi-2312	171	11	2014	2014	NUM
ajmsi-2312	171	12	)	)	PUNCT
ajmsi-2312	171	13	.	.	PUNCT
ajmsi-2312	172	1	from	from	ADP
ajmsi-2312	172	2	janus	janus	PROPN
ajmsi-2312	172	3	kinase	kinase	PROPN
ajmsi-2312	172	4	2	2	NUM
ajmsi-2312	172	5	to	to	ADP
ajmsi-2312	172	6	calreticulin	calreticulin	NOUN
ajmsi-2312	172	7	:	:	PUNCT
ajmsi-2312	172	8	the	the	DET
ajmsi-2312	172	9	clinically	clinically	ADV
ajmsi-2312	172	10	relevant	relevant	ADJ
ajmsi-2312	172	11	genomic	genomic	ADJ
ajmsi-2312	172	12	landscape	landscape	NOUN
ajmsi-2312	172	13	of	of	ADP
ajmsi-2312	172	14	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	172	15	neoplasms	neoplasm	NOUN
ajmsi-2312	172	16	.	.	PUNCT
ajmsi-2312	173	1	blood	blood	NOUN
ajmsi-2312	173	2	,	,	PUNCT
ajmsi-2312	173	3	123(24	123(24	NUM
ajmsi-2312	173	4	)	)	PUNCT
ajmsi-2312	173	5	,	,	PUNCT
ajmsi-2312	173	6	3714	3714	NUM
ajmsi-2312	173	7	-	-	SYM
ajmsi-2312	173	8	3719	3719	NUM
ajmsi-2312	173	9	.	.	PUNCT
ajmsi-2312	174	1	https://doi.org/10.1182/	https://doi.org/10.1182/	PROPN
ajmsi-2312	174	2	blood-2014	blood-2014	ADJ
ajmsi-2312	174	3	-	-	PUNCT
ajmsi-2312	174	4	03	03	NUM
ajmsi-2312	174	5	-	-	PUNCT
ajmsi-2312	174	6	530865	530865	NUM
ajmsi-2312	174	7	finazzi	finazzi	NOUN
ajmsi-2312	174	8	,	,	PUNCT
ajmsi-2312	174	9	g.	g.	PROPN
ajmsi-2312	174	10	,	,	PUNCT
ajmsi-2312	174	11	caruso	caruso	PROPN
ajmsi-2312	174	12	,	,	PUNCT
ajmsi-2312	174	13	v.	v.	PROPN
ajmsi-2312	174	14	,	,	PUNCT
ajmsi-2312	174	15	marchioli	marchioli	PROPN
ajmsi-2312	174	16	,	,	PUNCT
ajmsi-2312	174	17	r.	r.	PROPN
ajmsi-2312	174	18	,	,	PUNCT
ajmsi-2312	174	19	capnist	capnist	NOUN
ajmsi-2312	174	20	,	,	PUNCT
ajmsi-2312	174	21	g.	g.	PROPN
ajmsi-2312	174	22	,	,	PUNCT
ajmsi-2312	174	23	chisesi	chisesi	NOUN
ajmsi-2312	174	24	,	,	PUNCT
ajmsi-2312	174	25	t.	t.	PROPN
ajmsi-2312	174	26	,	,	PUNCT
ajmsi-2312	174	27	finelli	finelli	PROPN
ajmsi-2312	174	28	,	,	PUNCT
ajmsi-2312	174	29	c.	c.	PROPN
ajmsi-2312	174	30	,	,	PUNCT
ajmsi-2312	174	31	gugliotta	gugliotta	NOUN
ajmsi-2312	174	32	,	,	PUNCT
ajmsi-2312	174	33	l.	l.	PROPN
ajmsi-2312	174	34	,	,	PUNCT
ajmsi-2312	174	35	landolfi	landolfi	PROPN
ajmsi-2312	174	36	,	,	PUNCT
ajmsi-2312	174	37	r.	r.	PROPN
ajmsi-2312	174	38	,	,	PUNCT
ajmsi-2312	174	39	kutti	kutti	PROPN
ajmsi-2312	174	40	,	,	PUNCT
ajmsi-2312	174	41	j.	j.	PROPN
ajmsi-2312	174	42	,	,	PUNCT
ajmsi-2312	174	43	gisslinger	gisslinger	NOUN
ajmsi-2312	174	44	,	,	PUNCT
ajmsi-2312	174	45	h.	h.	PROPN
ajmsi-2312	174	46	,	,	PUNCT
ajmsi-2312	174	47	marilus	marilus	PROPN
ajmsi-2312	174	48	,	,	PUNCT
ajmsi-2312	174	49	r.	r.	PROPN
ajmsi-2312	174	50	,	,	PUNCT
ajmsi-2312	174	51	patrono	patrono	PROPN
ajmsi-2312	174	52	,	,	PUNCT
ajmsi-2312	174	53	c.	c.	NOUN
ajmsi-2312	174	54	,	,	PUNCT
ajmsi-2312	174	55	pogliani	pogliani	PROPN
ajmsi-2312	174	56	,	,	PUNCT
ajmsi-2312	174	57	e.	e.	PROPN
ajmsi-2312	174	58	m.	m.	PROPN
ajmsi-2312	174	59	,	,	PUNCT
ajmsi-2312	174	60	randi	randi	PROPN
ajmsi-2312	174	61	,	,	PUNCT
ajmsi-2312	174	62	m.	m.	PROPN
ajmsi-2312	174	63	l.	l.	PROPN
ajmsi-2312	174	64	,	,	PUNCT
ajmsi-2312	174	65	villegas	villegas	PROPN
ajmsi-2312	174	66	,	,	PUNCT
ajmsi-2312	174	67	a.	a.	PROPN
ajmsi-2312	174	68	,	,	PUNCT
ajmsi-2312	174	69	tognoni	tognoni	PROPN
ajmsi-2312	174	70	,	,	PUNCT
ajmsi-2312	174	71	g.	g.	PROPN
ajmsi-2312	174	72	,	,	PUNCT
ajmsi-2312	174	73	&	&	CCONJ
ajmsi-2312	174	74	barbui	barbui	ADJ
ajmsi-2312	174	75	,	,	PUNCT
ajmsi-2312	174	76	t.	t.	PROPN
ajmsi-2312	174	77	(	(	PUNCT
ajmsi-2312	174	78	2005	2005	NUM
ajmsi-2312	174	79	)	)	PUNCT
ajmsi-2312	174	80	.	.	PUNCT
ajmsi-2312	175	1	acute	acute	PROPN
ajmsi-2312	175	2	leukemia	leukemia	PROPN
ajmsi-2312	175	3	in	in	ADP
ajmsi-2312	175	4	polycythemia	polycythemia	NOUN
ajmsi-2312	175	5	vera	vera	NOUN
ajmsi-2312	175	6	:	:	PUNCT
ajmsi-2312	175	7	an	an	DET
ajmsi-2312	175	8	analysis	analysis	NOUN
ajmsi-2312	175	9	of	of	ADP
ajmsi-2312	175	10	1638	1638	NUM
ajmsi-2312	175	11	patients	patient	NOUN
ajmsi-2312	175	12	enrolled	enrol	VERB
ajmsi-2312	175	13	in	in	ADP
ajmsi-2312	175	14	a	a	DET
ajmsi-2312	175	15	prospective	prospective	ADJ
ajmsi-2312	175	16	observational	observational	ADJ
ajmsi-2312	175	17	study	study	NOUN
ajmsi-2312	175	18	.	.	PUNCT
ajmsi-2312	176	1	blood	blood	NOUN
ajmsi-2312	176	2	,	,	PUNCT
ajmsi-2312	176	3	105(7	105(7	NUM
ajmsi-2312	176	4	)	)	PUNCT
ajmsi-2312	176	5	,	,	PUNCT
ajmsi-2312	176	6	2664	2664	NUM
ajmsi-2312	176	7	-	-	SYM
ajmsi-2312	176	8	2670	2670	NUM
ajmsi-2312	176	9	.	.	PUNCT
ajmsi-2312	177	1	https://	https://	PROPN
ajmsi-2312	177	2	doi.org/10.1182/blood-2004-09-3426	doi.org/10.1182/blood-2004-09-3426	PROPN
ajmsi-2312	177	3	hernández	hernández	NOUN
ajmsi-2312	177	4	-	-	PUNCT
ajmsi-2312	177	5	boluda	boluda	NOUN
ajmsi-2312	177	6	,	,	PUNCT
ajmsi-2312	177	7	j.	j.	PROPN
ajmsi-2312	177	8	c.	c.	PROPN
ajmsi-2312	177	9	,	,	PUNCT
ajmsi-2312	177	10	alvarez	alvarez	PROPN
ajmsi-2312	177	11	-	-	PUNCT
ajmsi-2312	177	12	larrán	larrán	PROPN
ajmsi-2312	177	13	,	,	PUNCT
ajmsi-2312	177	14	a.	a.	NOUN
ajmsi-2312	177	15	,	,	PUNCT
ajmsi-2312	177	16	gómez	gómez	NOUN
ajmsi-2312	177	17	,	,	PUNCT
ajmsi-2312	177	18	m.	m.	NOUN
ajmsi-2312	177	19	,	,	PUNCT
ajmsi-2312	177	20	angona	angona	PROPN
ajmsi-2312	177	21	,	,	PUNCT
ajmsi-2312	177	22	a.	a.	NOUN
ajmsi-2312	177	23	,	,	PUNCT
ajmsi-2312	177	24	amat	amat	PROPN
ajmsi-2312	177	25	,	,	PUNCT
ajmsi-2312	177	26	p.	p.	PROPN
ajmsi-2312	177	27	,	,	PUNCT
ajmsi-2312	177	28	bellosillo	bellosillo	PROPN
ajmsi-2312	177	29	,	,	PUNCT
ajmsi-2312	177	30	b.	b.	PROPN
ajmsi-2312	177	31	,	,	PUNCT
ajmsi-2312	177	32	martínez	martínez	NOUN
ajmsi-2312	177	33	-	-	PUNCT
ajmsi-2312	177	34	avilés	avilés	PROPN
ajmsi-2312	177	35	,	,	PUNCT
ajmsi-2312	177	36	l.	l.	PROPN
ajmsi-2312	177	37	,	,	PUNCT
ajmsi-2312	177	38	navarro	navarro	PROPN
ajmsi-2312	177	39	,	,	PUNCT
ajmsi-2312	177	40	b.	b.	PROPN
ajmsi-2312	177	41	,	,	PUNCT
ajmsi-2312	177	42	teruel	teruel	PROPN
ajmsi-2312	177	43	,	,	PUNCT
ajmsi-2312	177	44	a.	a.	PROPN
ajmsi-2312	177	45	,	,	PUNCT
ajmsi-2312	177	46	martínez	martínez	NOUN
ajmsi-2312	177	47	-	-	PUNCT
ajmsi-2312	177	48	ruiz	ruiz	NOUN
ajmsi-2312	177	49	,	,	PUNCT
ajmsi-2312	177	50	f.	f.	PROPN
ajmsi-2312	177	51	,	,	PUNCT
ajmsi-2312	177	52	&	&	CCONJ
ajmsi-2312	177	53	besses	besse	NOUN
ajmsi-2312	177	54	,	,	PUNCT
ajmsi-2312	177	55	c.	c.	PROPN
ajmsi-2312	177	56	(	(	PUNCT
ajmsi-2312	177	57	2011	2011	NUM
ajmsi-2312	177	58	)	)	PUNCT
ajmsi-2312	177	59	.	.	PUNCT
ajmsi-2312	178	1	clinical	clinical	ADJ
ajmsi-2312	178	2	evaluation	evaluation	NOUN
ajmsi-2312	178	3	of	of	ADP
ajmsi-2312	178	4	the	the	DET
ajmsi-2312	178	5	european	european	PROPN
ajmsi-2312	178	6	leukaemianet	leukaemianet	PROPN
ajmsi-2312	178	7	criteria	criterion	NOUN
ajmsi-2312	178	8	for	for	ADP
ajmsi-2312	178	9	clinicohaematological	clinicohaematological	ADJ
ajmsi-2312	178	10	response	response	NOUN
ajmsi-2312	178	11	and	and	CCONJ
ajmsi-2312	178	12	resistance	resistance	NOUN
ajmsi-2312	178	13	/	/	SYM
ajmsi-2312	178	14	intolerance	intolerance	NOUN
ajmsi-2312	178	15	to	to	ADP
ajmsi-2312	178	16	hydroxycarbamide	hydroxycarbamide	NOUN
ajmsi-2312	178	17	in	in	ADP
ajmsi-2312	178	18	essential	essential	ADJ
ajmsi-2312	178	19	thrombocythaemia	thrombocythaemia	NOUN
ajmsi-2312	178	20	.	.	PUNCT
ajmsi-2312	179	1	br	br	PROPN
ajmsi-2312	180	1	j	j	PROPN
ajmsi-2312	180	2	haematol	haematol	NOUN
ajmsi-2312	180	3	,	,	PUNCT
ajmsi-2312	180	4	152(1	152(1	NUM
ajmsi-2312	180	5	)	)	PUNCT
ajmsi-2312	180	6	,	,	PUNCT
ajmsi-2312	180	7	81	81	NUM
ajmsi-2312	180	8	-	-	SYM
ajmsi-2312	180	9	88	88	NUM
ajmsi-2312	180	10	.	.	PUNCT
ajmsi-2312	181	1	https://doi.org/10.1111/j.1365-2141.2010.08430.x	https://doi.org/10.1111/j.1365-2141.2010.08430.x	PROPN
ajmsi-2312	181	2	hultcrantz	hultcrantz	PROPN
ajmsi-2312	181	3	,	,	PUNCT
ajmsi-2312	181	4	m.	m.	NOUN
ajmsi-2312	181	5	,	,	PUNCT
ajmsi-2312	181	6	wilkes	wilkes	PROPN
ajmsi-2312	181	7	,	,	PUNCT
ajmsi-2312	181	8	s.	s.	PROPN
ajmsi-2312	181	9	r.	r.	PROPN
ajmsi-2312	181	10	,	,	PUNCT
ajmsi-2312	181	11	kristinsson	kristinsson	PROPN
ajmsi-2312	181	12	,	,	PUNCT
ajmsi-2312	181	13	s.	s.	PROPN
ajmsi-2312	181	14	y.	y.	PROPN
ajmsi-2312	181	15	,	,	PUNCT
ajmsi-2312	181	16	andersson	andersson	PROPN
ajmsi-2312	181	17	,	,	PUNCT
ajmsi-2312	181	18	t.	t.	NOUN
ajmsi-2312	181	19	m.	m.	NOUN
ajmsi-2312	181	20	,	,	PUNCT
ajmsi-2312	181	21	derolf	derolf	PROPN
ajmsi-2312	181	22	å	å	PROPN
ajmsi-2312	181	23	,	,	PUNCT
ajmsi-2312	181	24	r.	r.	PROPN
ajmsi-2312	181	25	,	,	PUNCT
ajmsi-2312	181	26	eloranta	eloranta	PROPN
ajmsi-2312	181	27	,	,	PUNCT
ajmsi-2312	181	28	s.	s.	PROPN
ajmsi-2312	181	29	,	,	PUNCT
ajmsi-2312	181	30	samuelsson	samuelsson	PROPN
ajmsi-2312	181	31	,	,	PUNCT
ajmsi-2312	181	32	j.	j.	PROPN
ajmsi-2312	181	33	,	,	PUNCT
ajmsi-2312	181	34	landgren	landgren	PROPN
ajmsi-2312	181	35	,	,	PUNCT
ajmsi-2312	181	36	o.	o.	PROPN
ajmsi-2312	181	37	,	,	PUNCT
ajmsi-2312	181	38	dickman	dickman	PROPN
ajmsi-2312	181	39	,	,	PUNCT
ajmsi-2312	181	40	p.	p.	PROPN
ajmsi-2312	181	41	w.	w.	PROPN
ajmsi-2312	181	42	,	,	PUNCT
ajmsi-2312	181	43	lambert	lambert	PROPN
ajmsi-2312	181	44	,	,	PUNCT
ajmsi-2312	181	45	p.	p.	PROPN
ajmsi-2312	181	46	c.	c.	PROPN
ajmsi-2312	181	47	,	,	PUNCT
ajmsi-2312	181	48	&	&	CCONJ
ajmsi-2312	181	49	björkholm	björkholm	PROPN
ajmsi-2312	181	50	,	,	PUNCT
ajmsi-2312	181	51	m.	m.	NOUN
ajmsi-2312	181	52	(	(	PUNCT
ajmsi-2312	181	53	2015	2015	NUM
ajmsi-2312	181	54	)	)	PUNCT
ajmsi-2312	181	55	.	.	PUNCT
ajmsi-2312	182	1	risk	risk	NOUN
ajmsi-2312	182	2	and	and	CCONJ
ajmsi-2312	182	3	cause	cause	NOUN
ajmsi-2312	182	4	of	of	ADP
ajmsi-2312	182	5	death	death	NOUN
ajmsi-2312	182	6	in	in	ADP
ajmsi-2312	182	7	patients	patient	NOUN
ajmsi-2312	182	8	diagnosed	diagnose	VERB
ajmsi-2312	182	9	with	with	ADP
ajmsi-2312	182	10	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	182	11	neoplasms	neoplasm	NOUN
ajmsi-2312	182	12	in	in	ADP
ajmsi-2312	182	13	sweden	sweden	PROPN
ajmsi-2312	182	14	between	between	ADP
ajmsi-2312	182	15	1973	1973	NUM
ajmsi-2312	182	16	and	and	CCONJ
ajmsi-2312	182	17	2005	2005	NUM
ajmsi-2312	182	18	:	:	PUNCT
ajmsi-2312	182	19	a	a	DET
ajmsi-2312	182	20	population	population	NOUN
ajmsi-2312	182	21	-	-	PUNCT
ajmsi-2312	182	22	based	base	VERB
ajmsi-2312	182	23	study	study	NOUN
ajmsi-2312	182	24	.	.	PUNCT
ajmsi-2312	183	1	j	j	PROPN
ajmsi-2312	183	2	clin	clin	PROPN
ajmsi-2312	183	3	oncol	oncol	PROPN
ajmsi-2312	183	4	,	,	PUNCT
ajmsi-2312	183	5	33(20	33(20	NUM
ajmsi-2312	183	6	)	)	PUNCT
ajmsi-2312	183	7	,	,	PUNCT
ajmsi-2312	183	8	22882295	22882295	NUM
ajmsi-2312	183	9	.	.	PUNCT
ajmsi-2312	184	1	https://doi.org/10.1200/jco.2014.57.6652	https://doi.org/10.1200/jco.2014.57.6652	NOUN
ajmsi-2312	184	2	klampfl	klampfl	VERB
ajmsi-2312	184	3	,	,	PUNCT
ajmsi-2312	184	4	t.	t.	NOUN
ajmsi-2312	184	5	,	,	PUNCT
ajmsi-2312	184	6	gisslinger	gisslinger	NOUN
ajmsi-2312	184	7	,	,	PUNCT
ajmsi-2312	184	8	h.	h.	PROPN
ajmsi-2312	184	9	,	,	PUNCT
ajmsi-2312	184	10	harutyunyan	harutyunyan	PROPN
ajmsi-2312	184	11	,	,	PUNCT
ajmsi-2312	184	12	a.	a.	PROPN
ajmsi-2312	184	13	s.	s.	PROPN
ajmsi-2312	184	14	,	,	PUNCT
ajmsi-2312	184	15	nivarthi	nivarthi	PROPN
ajmsi-2312	184	16	,	,	PUNCT
ajmsi-2312	184	17	h.	h.	PROPN
ajmsi-2312	184	18	,	,	PUNCT
ajmsi-2312	184	19	rumi	rumi	PROPN
ajmsi-2312	184	20	,	,	PUNCT
ajmsi-2312	184	21	e.	e.	PROPN
ajmsi-2312	184	22	,	,	PUNCT
ajmsi-2312	184	23	milosevic	milosevic	PROPN
ajmsi-2312	184	24	,	,	PUNCT
ajmsi-2312	184	25	j.	j.	PROPN
ajmsi-2312	184	26	d.	d.	PROPN
ajmsi-2312	184	27	,	,	PUNCT
ajmsi-2312	184	28	them	they	PRON
ajmsi-2312	184	29	,	,	PUNCT
ajmsi-2312	184	30	n.	n.	PROPN
ajmsi-2312	184	31	c.	c.	PROPN
ajmsi-2312	184	32	,	,	PUNCT
ajmsi-2312	184	33	berg	berg	PROPN
ajmsi-2312	184	34	,	,	PUNCT
ajmsi-2312	184	35	t.	t.	PROPN
ajmsi-2312	184	36	,	,	PUNCT
ajmsi-2312	184	37	gisslinger	gisslinger	NOUN
ajmsi-2312	184	38	,	,	PUNCT
ajmsi-2312	184	39	b.	b.	PROPN
ajmsi-2312	184	40	,	,	PUNCT
ajmsi-2312	184	41	pietra	pietra	PROPN
ajmsi-2312	184	42	,	,	PUNCT
ajmsi-2312	184	43	d.	d.	PROPN
ajmsi-2312	184	44	,	,	PUNCT
ajmsi-2312	184	45	chen	chen	PROPN
ajmsi-2312	184	46	,	,	PUNCT
ajmsi-2312	184	47	d.	d.	PROPN
ajmsi-2312	184	48	,	,	PUNCT
ajmsi-2312	184	49	vladimer	vladimer	PROPN
ajmsi-2312	184	50	,	,	PUNCT
ajmsi-2312	184	51	g.	g.	PROPN
ajmsi-2312	184	52	i.	i.	PROPN
ajmsi-2312	184	53	,	,	PUNCT
ajmsi-2312	184	54	bagienski	bagienski	PROPN
ajmsi-2312	184	55	,	,	PUNCT
ajmsi-2312	184	56	k.	k.	PROPN
ajmsi-2312	184	57	,	,	PUNCT
ajmsi-2312	184	58	milanesi	milanesi	PROPN
ajmsi-2312	184	59	,	,	PUNCT
ajmsi-2312	184	60	c.	c.	PROPN
ajmsi-2312	184	61	,	,	PUNCT
ajmsi-2312	184	62	casetti	casetti	PROPN
ajmsi-2312	184	63	,	,	PUNCT
ajmsi-2312	184	64	i.	i.	PROPN
ajmsi-2312	184	65	c.	c.	PROPN
ajmsi-2312	184	66	,	,	PUNCT
ajmsi-2312	184	67	sant’antonio	sant’antonio	NOUN
ajmsi-2312	184	68	,	,	PUNCT
ajmsi-2312	184	69	e.	e.	PROPN
ajmsi-2312	184	70	,	,	PUNCT
ajmsi-2312	184	71	ferretti	ferretti	PROPN
ajmsi-2312	184	72	,	,	PUNCT
ajmsi-2312	184	73	v.	v.	PROPN
ajmsi-2312	184	74	,	,	PUNCT
ajmsi-2312	184	75	elena	elena	PROPN
ajmsi-2312	184	76	,	,	PUNCT
ajmsi-2312	184	77	c.	c.	PROPN
ajmsi-2312	184	78	,	,	PUNCT
ajmsi-2312	184	79	schischlik	schischlik	PROPN
ajmsi-2312	184	80	,	,	PUNCT
ajmsi-2312	184	81	f.	f.	PROPN
ajmsi-2312	184	82	,	,	PUNCT
ajmsi-2312	184	83	.	.	PUNCT
ajmsi-2312	184	84	.	.	PUNCT
ajmsi-2312	184	85	.	.	PUNCT
ajmsi-2312	185	1	kralovics	kralovic	NOUN
ajmsi-2312	185	2	,	,	PUNCT
ajmsi-2312	185	3	r.	r.	PROPN
ajmsi-2312	185	4	(	(	PUNCT
ajmsi-2312	185	5	2013	2013	NUM
ajmsi-2312	185	6	)	)	PUNCT
ajmsi-2312	185	7	.	.	PUNCT
ajmsi-2312	186	1	somatic	somatic	ADJ
ajmsi-2312	186	2	mutations	mutation	NOUN
ajmsi-2312	186	3	of	of	ADP
ajmsi-2312	186	4	calreticulin	calreticulin	PROPN
ajmsi-2312	186	5	in	in	ADP
ajmsi-2312	186	6	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	186	7	neoplasms	neoplasm	NOUN
ajmsi-2312	186	8	.	.	PUNCT
ajmsi-2312	187	1	n	n	PROPN
ajmsi-2312	187	2	engl	engl	PROPN
ajmsi-2312	187	3	j	j	PROPN
ajmsi-2312	187	4	med	med	PROPN
ajmsi-2312	187	5	,	,	PUNCT
ajmsi-2312	187	6	369(25	369(25	NUM
ajmsi-2312	187	7	)	)	PUNCT
ajmsi-2312	187	8	,	,	PUNCT
ajmsi-2312	187	9	2379	2379	NUM
ajmsi-2312	187	10	-	-	SYM
ajmsi-2312	187	11	2390	2390	NUM
ajmsi-2312	187	12	.	.	PUNCT
ajmsi-2312	188	1	https://doi.org/10.1056/	https://doi.org/10.1056/	PROPN
ajmsi-2312	188	2	nejmoa1311347	nejmoa1311347	PROPN
ajmsi-2312	188	3	landolfi	landolfi	PROPN
ajmsi-2312	188	4	,	,	PUNCT
ajmsi-2312	188	5	r.	r.	PROPN
ajmsi-2312	188	6	,	,	PUNCT
ajmsi-2312	188	7	cipriani	cipriani	PROPN
ajmsi-2312	188	8	,	,	PUNCT
ajmsi-2312	188	9	m.	m.	PROPN
ajmsi-2312	188	10	c.	c.	PROPN
ajmsi-2312	188	11	,	,	PUNCT
ajmsi-2312	188	12	&	&	CCONJ
ajmsi-2312	188	13	novarese	novarese	PROPN
ajmsi-2312	188	14	,	,	PUNCT
ajmsi-2312	188	15	l.	l.	PROPN
ajmsi-2312	188	16	(	(	PUNCT
ajmsi-2312	188	17	2006	2006	NUM
ajmsi-2312	188	18	)	)	PUNCT
ajmsi-2312	188	19	.	.	PUNCT
ajmsi-2312	189	1	thrombosis	thrombosis	NOUN
ajmsi-2312	189	2	and	and	CCONJ
ajmsi-2312	189	3	bleeding	bleed	VERB
ajmsi-2312	189	4	in	in	ADP
ajmsi-2312	189	5	polycythemia	polycythemia	NOUN
ajmsi-2312	189	6	vera	vera	NOUN
ajmsi-2312	189	7	and	and	CCONJ
ajmsi-2312	189	8	essential	essential	ADJ
ajmsi-2312	189	9	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	189	10	:	:	PUNCT
ajmsi-2312	189	11	pathogenetic	pathogenetic	ADJ
ajmsi-2312	189	12	mechanisms	mechanism	NOUN
ajmsi-2312	189	13	and	and	CCONJ
ajmsi-2312	189	14	prevention	prevention	NOUN
ajmsi-2312	189	15	.	.	PUNCT
ajmsi-2312	190	1	best	good	ADJ
ajmsi-2312	190	2	pract	pract	PROPN
ajmsi-2312	190	3	res	res	PROPN
ajmsi-2312	190	4	clin	clin	PROPN
ajmsi-2312	190	5	haematol	haematol	NOUN
ajmsi-2312	190	6	,	,	PUNCT
ajmsi-2312	190	7	19(3	19(3	NUM
ajmsi-2312	190	8	)	)	PUNCT
ajmsi-2312	190	9	,	,	PUNCT
ajmsi-2312	190	10	617633	617633	NUM
ajmsi-2312	190	11	.	.	PUNCT
ajmsi-2312	191	1	https://doi.org/10.1016/j.beha.2005.07.011	https://doi.org/10.1016/j.beha.2005.07.011	NUM
ajmsi-2312	191	2	luchtman	luchtman	NOUN
ajmsi-2312	191	3	-	-	PUNCT
ajmsi-2312	191	4	jones	jones	NOUN
ajmsi-2312	191	5	,	,	PUNCT
ajmsi-2312	191	6	l.	l.	PROPN
ajmsi-2312	191	7	,	,	PUNCT
ajmsi-2312	191	8	pressel	pressel	PROPN
ajmsi-2312	191	9	,	,	PUNCT
ajmsi-2312	191	10	s.	s.	PROPN
ajmsi-2312	191	11	,	,	PUNCT
ajmsi-2312	191	12	hilliard	hilliard	PROPN
ajmsi-2312	191	13	,	,	PUNCT
ajmsi-2312	191	14	l.	l.	PROPN
ajmsi-2312	191	15	,	,	PUNCT
ajmsi-2312	191	16	brown	brown	PROPN
ajmsi-2312	191	17	,	,	PUNCT
ajmsi-2312	191	18	r.	r.	PROPN
ajmsi-2312	191	19	c.	c.	PROPN
ajmsi-2312	191	20	,	,	PUNCT
ajmsi-2312	191	21	smith	smith	PROPN
ajmsi-2312	191	22	,	,	PUNCT
ajmsi-2312	191	23	m.	m.	NOUN
ajmsi-2312	191	24	g.	g.	PROPN
ajmsi-2312	191	25	,	,	PUNCT
ajmsi-2312	191	26	thompson	thompson	PROPN
ajmsi-2312	191	27	,	,	PUNCT
ajmsi-2312	191	28	a.	a.	NOUN
ajmsi-2312	191	29	a.	a.	PROPN
ajmsi-2312	191	30	,	,	PUNCT
ajmsi-2312	191	31	lee	lee	PROPN
ajmsi-2312	191	32	,	,	PUNCT
ajmsi-2312	191	33	m.	m.	PROPN
ajmsi-2312	191	34	t.	t.	PROPN
ajmsi-2312	191	35	,	,	PUNCT
ajmsi-2312	191	36	rothman	rothman	PROPN
ajmsi-2312	191	37	,	,	PUNCT
ajmsi-2312	191	38	j.	j.	PROPN
ajmsi-2312	191	39	,	,	PUNCT
ajmsi-2312	191	40	rogers	rogers	PROPN
ajmsi-2312	191	41	,	,	PUNCT
ajmsi-2312	191	42	z.	z.	PROPN
ajmsi-2312	191	43	r.	r.	PROPN
ajmsi-2312	191	44	,	,	PUNCT
ajmsi-2312	191	45	owen	owen	PROPN
ajmsi-2312	191	46	,	,	PUNCT
ajmsi-2312	191	47	w.	w.	PROPN
ajmsi-2312	191	48	,	,	PUNCT
ajmsi-2312	191	49	imran	imran	PROPN
ajmsi-2312	191	50	,	,	PUNCT
ajmsi-2312	191	51	h.	h.	PROPN
ajmsi-2312	191	52	,	,	PUNCT
ajmsi-2312	191	53	thornburg	thornburg	PROPN
ajmsi-2312	191	54	,	,	PUNCT
ajmsi-2312	191	55	c.	c.	PROPN
ajmsi-2312	191	56	,	,	PUNCT
ajmsi-2312	191	57	kwiatkowski	kwiatkowski	PROPN
ajmsi-2312	191	58	,	,	PUNCT
ajmsi-2312	191	59	j.	j.	PROPN
ajmsi-2312	191	60	l.	l.	PROPN
ajmsi-2312	191	61	,	,	PUNCT
ajmsi-2312	191	62	aygun	aygun	PROPN
ajmsi-2312	191	63	,	,	PUNCT
ajmsi-2312	191	64	b.	b.	PROPN
ajmsi-2312	191	65	,	,	PUNCT
ajmsi-2312	191	66	nelson	nelson	PROPN
ajmsi-2312	191	67	,	,	PUNCT
ajmsi-2312	191	68	s.	s.	PROPN
ajmsi-2312	191	69	,	,	PUNCT
ajmsi-2312	191	70	roberts	roberts	PROPN
ajmsi-2312	191	71	,	,	PUNCT
ajmsi-2312	191	72	c.	c.	PROPN
ajmsi-2312	191	73	,	,	PUNCT
ajmsi-2312	191	74	gauger	gauger	PROPN
ajmsi-2312	191	75	,	,	PUNCT
ajmsi-2312	191	76	c.	c.	PROPN
ajmsi-2312	191	77	,	,	PUNCT
ajmsi-2312	191	78	piccone	piccone	NOUN
ajmsi-2312	191	79	,	,	PUNCT
ajmsi-2312	191	80	c.	c.	PROPN
ajmsi-2312	191	81	,	,	PUNCT
ajmsi-2312	191	82	kalfa	kalfa	PROPN
ajmsi-2312	191	83	,	,	PUNCT
ajmsi-2312	191	84	t.	t.	PROPN
ajmsi-2312	191	85	,	,	PUNCT
ajmsi-2312	191	86	.	.	PUNCT
ajmsi-2312	191	87	.	.	PUNCT
ajmsi-2312	192	1	.	.	PUNCT
ajmsi-2312	193	1	ware	ware	PROPN
ajmsi-2312	193	2	,	,	PUNCT
ajmsi-2312	193	3	r.	r.	PROPN
ajmsi-2312	193	4	e.	e.	PROPN
ajmsi-2312	193	5	(	(	PUNCT
ajmsi-2312	193	6	2016	2016	NUM
ajmsi-2312	193	7	)	)	PUNCT
ajmsi-2312	193	8	.	.	PUNCT
ajmsi-2312	194	1	effects	effect	NOUN
ajmsi-2312	194	2	of	of	ADP
ajmsi-2312	194	3	hydroxyurea	hydroxyurea	ADJ
ajmsi-2312	194	4	treatment	treatment	NOUN
ajmsi-2312	194	5	for	for	ADP
ajmsi-2312	194	6	patients	patient	NOUN
ajmsi-2312	194	7	with	with	ADP
ajmsi-2312	194	8	hemoglobin	hemoglobin	PROPN
ajmsi-2312	194	9	sc	sc	PROPN
ajmsi-2312	194	10	disease	disease	PROPN
ajmsi-2312	194	11	.	.	PUNCT
ajmsi-2312	195	1	am	be	AUX
ajmsi-2312	195	2	j	j	PROPN
ajmsi-2312	195	3	hematol	hematol	NOUN
ajmsi-2312	195	4	,	,	PUNCT
ajmsi-2312	195	5	91(2	91(2	NUM
ajmsi-2312	195	6	)	)	PUNCT
ajmsi-2312	195	7	,	,	PUNCT
ajmsi-2312	195	8	238	238	NUM
ajmsi-2312	195	9	-	-	SYM
ajmsi-2312	195	10	242	242	NUM
ajmsi-2312	195	11	.	.	PUNCT
ajmsi-2312	196	1	https://doi.org/10.1002/ajh.24255	https://doi.org/10.1002/ajh.24255	PROPN
ajmsi-2312	196	2	mcgann	mcgann	PROPN
ajmsi-2312	196	3	,	,	PUNCT
ajmsi-2312	196	4	p.	p.	PROPN
ajmsi-2312	196	5	t.	t.	PROPN
ajmsi-2312	196	6	,	,	PUNCT
ajmsi-2312	196	7	tshilolo	tshilolo	PROPN
ajmsi-2312	196	8	,	,	PUNCT
ajmsi-2312	196	9	l.	l.	PROPN
ajmsi-2312	196	10	,	,	PUNCT
ajmsi-2312	196	11	santos	santos	PROPN
ajmsi-2312	196	12	,	,	PUNCT
ajmsi-2312	196	13	b.	b.	PROPN
ajmsi-2312	196	14	,	,	PUNCT
ajmsi-2312	196	15	tomlinson	tomlinson	PROPN
ajmsi-2312	196	16	,	,	PUNCT
ajmsi-2312	196	17	g.	g.	PROPN
ajmsi-2312	196	18	a.	a.	PROPN
ajmsi-2312	196	19	,	,	PUNCT
ajmsi-2312	196	20	stuber	stuber	PROPN
ajmsi-2312	196	21	,	,	PUNCT
ajmsi-2312	196	22	s.	s.	PROPN
ajmsi-2312	196	23	,	,	PUNCT
ajmsi-2312	196	24	latham	latham	PROPN
ajmsi-2312	196	25	,	,	PUNCT
ajmsi-2312	196	26	t.	t.	PROPN
ajmsi-2312	196	27	,	,	PUNCT
ajmsi-2312	196	28	aygun	aygun	PROPN
ajmsi-2312	196	29	,	,	PUNCT
ajmsi-2312	196	30	b.	b.	PROPN
ajmsi-2312	196	31	,	,	PUNCT
ajmsi-2312	196	32	obaro	obaro	NOUN
ajmsi-2312	196	33	,	,	PUNCT
ajmsi-2312	196	34	s.	s.	PROPN
ajmsi-2312	196	35	k.	k.	PROPN
ajmsi-2312	196	36	,	,	PUNCT
ajmsi-2312	196	37	olupot	olupot	NOUN
ajmsi-2312	196	38	-	-	PUNCT
ajmsi-2312	196	39	olupot	olupot	NOUN
ajmsi-2312	196	40	,	,	PUNCT
ajmsi-2312	196	41	p.	p.	NOUN
ajmsi-2312	196	42	,	,	PUNCT
ajmsi-2312	196	43	williams	williams	PROPN
ajmsi-2312	196	44	,	,	PUNCT
ajmsi-2312	196	45	t.	t.	PROPN
ajmsi-2312	196	46	n.	n.	PROPN
ajmsi-2312	196	47	,	,	PUNCT
ajmsi-2312	196	48	odame	odame	PROPN
ajmsi-2312	196	49	,	,	PUNCT
ajmsi-2312	196	50	i.	i.	NOUN
ajmsi-2312	196	51	,	,	PUNCT
ajmsi-2312	196	52	&	&	CCONJ
ajmsi-2312	196	53	ware	ware	PROPN
ajmsi-2312	196	54	,	,	PUNCT
ajmsi-2312	196	55	r.	r.	PROPN
ajmsi-2312	196	56	e.	e.	PROPN
ajmsi-2312	196	57	(	(	PUNCT
ajmsi-2312	196	58	2016	2016	NUM
ajmsi-2312	196	59	)	)	PUNCT
ajmsi-2312	196	60	.	.	PUNCT
ajmsi-2312	197	1	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	197	2	therapy	therapy	NOUN
ajmsi-2312	197	3	for	for	ADP
ajmsi-2312	197	4	children	child	NOUN
ajmsi-2312	197	5	with	with	ADP
ajmsi-2312	197	6	sickle	sickle	PROPN
ajmsi-2312	197	7	cell	cell	NOUN
ajmsi-2312	197	8	anemia	anemia	NOUN
ajmsi-2312	197	9	in	in	ADP
ajmsi-2312	197	10	sub	sub	ADJ
ajmsi-2312	197	11	-	-	ADJ
ajmsi-2312	197	12	saharan	saharan	ADJ
ajmsi-2312	197	13	africa	africa	PROPN
ajmsi-2312	197	14	:	:	PUNCT
ajmsi-2312	197	15	rationale	rationale	NOUN
ajmsi-2312	197	16	and	and	CCONJ
ajmsi-2312	197	17	design	design	NOUN
ajmsi-2312	197	18	of	of	ADP
ajmsi-2312	197	19	the	the	DET
ajmsi-2312	197	20	reach	reach	NOUN
ajmsi-2312	197	21	trial	trial	NOUN
ajmsi-2312	197	22	.	.	PUNCT
ajmsi-2312	198	1	pediatr	pediatr	ADJ
ajmsi-2312	198	2	blood	blood	NOUN
ajmsi-2312	198	3	cancer	cancer	NOUN
ajmsi-2312	198	4	,	,	PUNCT
ajmsi-2312	198	5	63(1	63(1	NUM
ajmsi-2312	198	6	)	)	PUNCT
ajmsi-2312	198	7	,	,	PUNCT
ajmsi-2312	198	8	98	98	NUM
ajmsi-2312	198	9	-	-	SYM
ajmsi-2312	198	10	104	104	NUM
ajmsi-2312	198	11	.	.	PUNCT
ajmsi-2312	199	1	https://doi.org/10.1002/pbc.25705	https://doi.org/10.1002/pbc.25705	PROPN
ajmsi-2312	199	2	mcgann	mcgann	PROPN
ajmsi-2312	199	3	,	,	PUNCT
ajmsi-2312	199	4	p.	p.	PROPN
ajmsi-2312	199	5	t.	t.	PROPN
ajmsi-2312	199	6	,	,	PUNCT
ajmsi-2312	199	7	&	&	CCONJ
ajmsi-2312	199	8	ware	ware	PROPN
ajmsi-2312	199	9	,	,	PUNCT
ajmsi-2312	199	10	r.	r.	PROPN
ajmsi-2312	199	11	e.	e.	PROPN
ajmsi-2312	199	12	(	(	PUNCT
ajmsi-2312	199	13	2015	2015	NUM
ajmsi-2312	199	14	)	)	PUNCT
ajmsi-2312	199	15	.	.	PUNCT
ajmsi-2312	200	1	hydroxyurea	hydroxyurea	PROPN
ajmsi-2312	200	2	therapy	therapy	NOUN
ajmsi-2312	200	3	for	for	ADP
ajmsi-2312	200	4	sickle	sickle	NOUN
ajmsi-2312	200	5	cell	cell	NOUN
ajmsi-2312	200	6	anemia	anemia	NOUN
ajmsi-2312	200	7	.	.	PUNCT
ajmsi-2312	201	1	expert	expert	NOUN
ajmsi-2312	201	2	opin	opin	NOUN
ajmsi-2312	201	3	drug	drug	NOUN
ajmsi-2312	201	4	saf	saf	PROPN
ajmsi-2312	201	5	,	,	PUNCT
ajmsi-2312	201	6	14(11	14(11	NUM
ajmsi-2312	201	7	)	)	PUNCT
ajmsi-2312	201	8	,	,	PUNCT
ajmsi-2312	201	9	1749	1749	NUM
ajmsi-2312	201	10	-	-	SYM
ajmsi-2312	201	11	1758	1758	NUM
ajmsi-2312	201	12	.	.	PUNCT
ajmsi-2312	202	1	https://doi.org/10.1517/147403	https://doi.org/10.1517/147403	ADP
ajmsi-2312	202	2	38.2015.1088827	38.2015.1088827	NUM
ajmsi-2312	202	3	nielsen	nielsen	PROPN
ajmsi-2312	202	4	,	,	PUNCT
ajmsi-2312	202	5	c.	c.	PROPN
ajmsi-2312	202	6	,	,	PUNCT
ajmsi-2312	202	7	birgens	birgen	NOUN
ajmsi-2312	202	8	,	,	PUNCT
ajmsi-2312	202	9	h.	h.	PROPN
ajmsi-2312	202	10	s.	s.	PROPN
ajmsi-2312	202	11	,	,	PUNCT
ajmsi-2312	202	12	nordestgaard	nordestgaard	PROPN
ajmsi-2312	202	13	,	,	PUNCT
ajmsi-2312	202	14	b.	b.	PROPN
ajmsi-2312	202	15	g.	g.	PROPN
ajmsi-2312	202	16	,	,	PUNCT
ajmsi-2312	202	17	&	&	CCONJ
ajmsi-2312	202	18	bojesen	bojesen	PROPN
ajmsi-2312	202	19	,	,	PUNCT
ajmsi-2312	202	20	s.	s.	PROPN
ajmsi-2312	202	21	e.	e.	PROPN
ajmsi-2312	202	22	(	(	PUNCT
ajmsi-2312	202	23	2013	2013	NUM
ajmsi-2312	202	24	)	)	PUNCT
ajmsi-2312	202	25	.	.	PUNCT
ajmsi-2312	203	1	diagnostic	diagnostic	ADJ
ajmsi-2312	203	2	value	value	NOUN
ajmsi-2312	203	3	of	of	ADP
ajmsi-2312	203	4	jak2	jak2	PROPN
ajmsi-2312	203	5	v617f	v617f	ADJ
ajmsi-2312	203	6	somatic	somatic	ADJ
ajmsi-2312	203	7	mutation	mutation	NOUN
ajmsi-2312	203	8	for	for	ADP
ajmsi-2312	203	9	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	203	10	cancer	cancer	NOUN
ajmsi-2312	203	11	in	in	ADP
ajmsi-2312	203	12	49	49	NUM
ajmsi-2312	203	13	488	488	NUM
ajmsi-2312	203	14	individuals	individual	NOUN
ajmsi-2312	203	15	from	from	ADP
ajmsi-2312	203	16	the	the	DET
ajmsi-2312	203	17	general	general	ADJ
ajmsi-2312	203	18	population	population	NOUN
ajmsi-2312	203	19	.	.	PUNCT
ajmsi-2312	204	1	br	br	PROPN
ajmsi-2312	205	1	j	j	PROPN
ajmsi-2312	205	2	haematol	haematol	NOUN
ajmsi-2312	205	3	,	,	PUNCT
ajmsi-2312	205	4	160(1	160(1	NUM
ajmsi-2312	205	5	)	)	PUNCT
ajmsi-2312	205	6	,	,	PUNCT
ajmsi-2312	205	7	70	70	NUM
ajmsi-2312	205	8	-	-	SYM
ajmsi-2312	205	9	79	79	NUM
ajmsi-2312	205	10	.	.	PUNCT
ajmsi-2312	206	1	https://doi.org/10.1111/	https://doi.org/10.1111/	PROPN
ajmsi-2312	206	2	bjh.12099	bjh.12099	NOUN
ajmsi-2312	206	3	roaldsnes	roaldsne	NOUN
ajmsi-2312	206	4	,	,	PUNCT
ajmsi-2312	206	5	c.	c.	NOUN
ajmsi-2312	206	6	,	,	PUNCT
ajmsi-2312	206	7	holst	holst	NOUN
ajmsi-2312	206	8	,	,	PUNCT
ajmsi-2312	206	9	r.	r.	PROPN
ajmsi-2312	206	10	,	,	PUNCT
ajmsi-2312	206	11	frederiksen	frederiksen	PROPN
ajmsi-2312	206	12	,	,	PUNCT
ajmsi-2312	206	13	h.	h.	PROPN
ajmsi-2312	206	14	,	,	PUNCT
ajmsi-2312	206	15	&	&	CCONJ
ajmsi-2312	206	16	ghanima	ghanima	PROPN
ajmsi-2312	206	17	,	,	PUNCT
ajmsi-2312	206	18	w.	w.	PROPN
ajmsi-2312	206	19	(	(	PUNCT
ajmsi-2312	206	20	2017	2017	NUM
ajmsi-2312	206	21	)	)	PUNCT
ajmsi-2312	206	22	.	.	PUNCT
ajmsi-2312	207	1	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	207	2	neoplasms	neoplasm	NOUN
ajmsi-2312	207	3	:	:	PUNCT
ajmsi-2312	207	4	trends	trend	NOUN
ajmsi-2312	207	5	in	in	ADP
ajmsi-2312	207	6	incidence	incidence	NOUN
ajmsi-2312	207	7	,	,	PUNCT
ajmsi-2312	207	8	prevalence	prevalence	NOUN
ajmsi-2312	207	9	and	and	CCONJ
ajmsi-2312	207	10	survival	survival	NOUN
ajmsi-2312	207	11	in	in	ADP
ajmsi-2312	207	12	norway	norway	PROPN
ajmsi-2312	207	13	.	.	PUNCT
ajmsi-2312	208	1	eur	eur	PROPN
ajmsi-2312	208	2	j	j	PROPN
ajmsi-2312	208	3	haematol	haematol	NOUN
ajmsi-2312	208	4	,	,	PUNCT
ajmsi-2312	208	5	98(1	98(1	NOUN
ajmsi-2312	208	6	)	)	PUNCT
ajmsi-2312	208	7	,	,	PUNCT
ajmsi-2312	208	8	85	85	NUM
ajmsi-2312	208	9	-	-	SYM
ajmsi-2312	208	10	93	93	NUM
ajmsi-2312	208	11	.	.	PUNCT
ajmsi-2312	209	1	https://doi.org/10.1111/	https://doi.org/10.1111/	PROPN
ajmsi-2312	209	2	ejh.12788	ejh.12788	PRON
ajmsi-2312	209	3	rocca	rocca	PROPN
ajmsi-2312	209	4	,	,	PUNCT
ajmsi-2312	209	5	b.	b.	PROPN
ajmsi-2312	209	6	,	,	PUNCT
ajmsi-2312	209	7	tosetto	tosetto	PROPN
ajmsi-2312	209	8	,	,	PUNCT
ajmsi-2312	209	9	a.	a.	NOUN
ajmsi-2312	209	10	,	,	PUNCT
ajmsi-2312	209	11	betti	betti	PROPN
ajmsi-2312	209	12	,	,	PUNCT
ajmsi-2312	209	13	s.	s.	PROPN
ajmsi-2312	209	14	,	,	PUNCT
ajmsi-2312	209	15	soldati	soldati	NOUN
ajmsi-2312	209	16	,	,	PUNCT
ajmsi-2312	209	17	d.	d.	PROPN
ajmsi-2312	209	18	,	,	PUNCT
ajmsi-2312	209	19	petrucci	petrucci	PROPN
ajmsi-2312	209	20	,	,	PUNCT
ajmsi-2312	209	21	g.	g.	PROPN
ajmsi-2312	209	22	,	,	PUNCT
ajmsi-2312	209	23	rossi	rossi	PROPN
ajmsi-2312	209	24	,	,	PUNCT
ajmsi-2312	209	25	e.	e.	PROPN
ajmsi-2312	209	26	,	,	PUNCT
ajmsi-2312	209	27	timillero	timillero	PROPN
ajmsi-2312	209	28	,	,	PUNCT
ajmsi-2312	209	29	a.	a.	NOUN
ajmsi-2312	209	30	,	,	PUNCT
ajmsi-2312	209	31	cavalca	cavalca	PROPN
ajmsi-2312	209	32	,	,	PUNCT
ajmsi-2312	209	33	v.	v.	PROPN
ajmsi-2312	209	34	,	,	PUNCT
ajmsi-2312	209	35	porro	porro	PROPN
ajmsi-2312	209	36	,	,	PUNCT
ajmsi-2312	209	37	b.	b.	PROPN
ajmsi-2312	209	38	,	,	PUNCT
ajmsi-2312	209	39	iurlo	iurlo	NOUN
ajmsi-2312	209	40	,	,	PUNCT
ajmsi-2312	209	41	a.	a.	NOUN
ajmsi-2312	209	42	,	,	PUNCT
ajmsi-2312	209	43	cattaneo	cattaneo	PROPN
ajmsi-2312	209	44	,	,	PUNCT
ajmsi-2312	209	45	d.	d.	PROPN
ajmsi-2312	209	46	,	,	PUNCT
ajmsi-2312	209	47	bucelli	bucelli	PROPN
ajmsi-2312	209	48	,	,	PUNCT
ajmsi-2312	209	49	c.	c.	PROPN
ajmsi-2312	209	50	,	,	PUNCT
ajmsi-2312	209	51	dragani	dragani	PROPN
ajmsi-2312	209	52	,	,	PUNCT
ajmsi-2312	209	53	a.	a.	PROPN
ajmsi-2312	209	54	,	,	PUNCT
ajmsi-2312	209	55	di	di	X
ajmsi-2312	209	56	ianni	ianni	PROPN
ajmsi-2312	209	57	,	,	PUNCT
ajmsi-2312	209	58	m.	m.	NOUN
ajmsi-2312	209	59	,	,	PUNCT
ajmsi-2312	209	60	ranalli	ranalli	NOUN
ajmsi-2312	209	61	,	,	PUNCT
ajmsi-2312	209	62	p.	p.	NOUN
ajmsi-2312	209	63	,	,	PUNCT
ajmsi-2312	209	64	palandri	palandri	PROPN
ajmsi-2312	209	65	,	,	PUNCT
ajmsi-2312	209	66	f.	f.	PROPN
ajmsi-2312	209	67	,	,	PUNCT
ajmsi-2312	209	68	vianelli	vianelli	ADV
ajmsi-2312	209	69	,	,	PUNCT
ajmsi-2312	209	70	n.	n.	NOUN
ajmsi-2312	209	71	,	,	PUNCT
ajmsi-2312	209	72	beggiato	beggiato	NOUN
ajmsi-2312	209	73	,	,	PUNCT
ajmsi-2312	209	74	e.	e.	PROPN
ajmsi-2312	209	75	,	,	PUNCT
ajmsi-2312	209	76	lanzarone	lanzarone	NOUN
ajmsi-2312	209	77	,	,	PUNCT
ajmsi-2312	209	78	g.	g.	PROPN
ajmsi-2312	209	79	,	,	PUNCT
ajmsi-2312	209	80	.	.	PUNCT
ajmsi-2312	209	81	.	.	PUNCT
ajmsi-2312	209	82	.	.	PUNCT
ajmsi-2312	210	1	de	de	PROPN
ajmsi-2312	210	2	stefano	stefano	PROPN
ajmsi-2312	210	3	,	,	PUNCT
ajmsi-2312	210	4	v.	v.	PROPN
ajmsi-2312	210	5	(	(	PUNCT
ajmsi-2312	210	6	2020	2020	NUM
ajmsi-2312	210	7	)	)	PUNCT
ajmsi-2312	210	8	.	.	PUNCT
ajmsi-2312	211	1	a	a	DET
ajmsi-2312	211	2	randomized	randomize	VERB
ajmsi-2312	211	3	pa	pa	PROPN
ajmsi-2312	211	4	ge	ge	PROPN
ajmsi-2312	211	5	7	7	NUM
ajmsi-2312	211	6	https://journals.e-palli.com/home/index.php/ajmsi	https://journals.e-palli.com/home/index.php/ajmsi	PROPN
ajmsi-2312	211	7	am	be	AUX
ajmsi-2312	211	8	.	.	PUNCT
ajmsi-2312	212	1	j.	j.	PROPN
ajmsi-2312	212	2	med	med	PROPN
ajmsi-2312	212	3	.	.	PUNCT
ajmsi-2312	213	1	sci	sci	PROPN
ajmsi-2312	213	2	.	.	PUNCT
ajmsi-2312	213	3	innov	innov	PROPN
ajmsi-2312	213	4	.	.	PUNCT
ajmsi-2312	214	1	3(1	3(1	NUM
ajmsi-2312	214	2	)	)	PUNCT
ajmsi-2312	214	3	1	1	NUM
ajmsi-2312	214	4	-	-	SYM
ajmsi-2312	214	5	7	7	NUM
ajmsi-2312	214	6	,	,	PUNCT
ajmsi-2312	214	7	2024	2024	NUM
ajmsi-2312	214	8	double	double	ADJ
ajmsi-2312	214	9	-	-	PUNCT
ajmsi-2312	214	10	blind	blind	ADJ
ajmsi-2312	214	11	trial	trial	NOUN
ajmsi-2312	214	12	of	of	ADP
ajmsi-2312	214	13	3	3	NUM
ajmsi-2312	214	14	aspirin	aspirin	NOUN
ajmsi-2312	214	15	regimens	regimen	NOUN
ajmsi-2312	214	16	to	to	PART
ajmsi-2312	214	17	optimize	optimize	VERB
ajmsi-2312	214	18	antiplatelet	antiplatelet	NOUN
ajmsi-2312	214	19	therapy	therapy	NOUN
ajmsi-2312	214	20	in	in	ADP
ajmsi-2312	214	21	essential	essential	ADJ
ajmsi-2312	214	22	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	214	23	.	.	PUNCT
ajmsi-2312	215	1	blood	blood	NOUN
ajmsi-2312	215	2	,	,	PUNCT
ajmsi-2312	215	3	136(2	136(2	NUM
ajmsi-2312	215	4	)	)	PUNCT
ajmsi-2312	215	5	,	,	PUNCT
ajmsi-2312	215	6	171	171	NUM
ajmsi-2312	215	7	-	-	SYM
ajmsi-2312	215	8	182	182	NUM
ajmsi-2312	215	9	.	.	PUNCT
ajmsi-2312	216	1	https://doi.org/10.1182/	https://doi.org/10.1182/	PROPN
ajmsi-2312	216	2	blood.2019004596	blood.2019004596	PROPN
ajmsi-2312	216	3	schafer	schafer	PROPN
ajmsi-2312	216	4	,	,	PUNCT
ajmsi-2312	216	5	a.	a.	PROPN
ajmsi-2312	216	6	i.	i.	PROPN
ajmsi-2312	216	7	(	(	PUNCT
ajmsi-2312	216	8	2004	2004	NUM
ajmsi-2312	216	9	)	)	PUNCT
ajmsi-2312	216	10	.	.	PUNCT
ajmsi-2312	217	1	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	217	2	.	.	PUNCT
ajmsi-2312	218	1	n	n	PROPN
ajmsi-2312	218	2	engl	engl	PROPN
ajmsi-2312	218	3	j	j	PROPN
ajmsi-2312	218	4	med	med	PROPN
ajmsi-2312	218	5	,	,	PUNCT
ajmsi-2312	218	6	350(12	350(12	NUM
ajmsi-2312	218	7	)	)	PUNCT
ajmsi-2312	218	8	,	,	PUNCT
ajmsi-2312	218	9	1211	1211	NUM
ajmsi-2312	218	10	-	-	SYM
ajmsi-2312	218	11	1219	1219	NUM
ajmsi-2312	218	12	.	.	PUNCT
ajmsi-2312	219	1	https://doi.org/10.1056/nejmra035363	https://doi.org/10.1056/nejmra035363	PROPN
ajmsi-2312	219	2	shen	shen	PROPN
ajmsi-2312	219	3	,	,	PUNCT
ajmsi-2312	219	4	c.	c.	PROPN
ajmsi-2312	219	5	l.	l.	PROPN
ajmsi-2312	219	6	,	,	PUNCT
ajmsi-2312	219	7	hsieh	hsieh	PROPN
ajmsi-2312	219	8	,	,	PUNCT
ajmsi-2312	219	9	t.	t.	PROPN
ajmsi-2312	219	10	c.	c.	PROPN
ajmsi-2312	219	11	,	,	PUNCT
ajmsi-2312	219	12	wang	wang	PROPN
ajmsi-2312	219	13	,	,	PUNCT
ajmsi-2312	219	14	t.	t.	PROPN
ajmsi-2312	219	15	f.	f.	PROPN
ajmsi-2312	219	16	,	,	PUNCT
ajmsi-2312	219	17	huang	huang	PROPN
ajmsi-2312	219	18	,	,	PUNCT
ajmsi-2312	219	19	w.	w.	PROPN
ajmsi-2312	219	20	h.	h.	PROPN
ajmsi-2312	219	21	,	,	PUNCT
ajmsi-2312	219	22	chu	chu	PROPN
ajmsi-2312	219	23	,	,	PUNCT
ajmsi-2312	219	24	s.	s.	PROPN
ajmsi-2312	219	25	c.	c.	PROPN
ajmsi-2312	219	26	,	,	PUNCT
ajmsi-2312	219	27	&	&	CCONJ
ajmsi-2312	219	28	wu	wu	PROPN
ajmsi-2312	219	29	,	,	PUNCT
ajmsi-2312	219	30	y.	y.	PROPN
ajmsi-2312	219	31	f.	f.	PROPN
ajmsi-2312	219	32	(	(	PUNCT
ajmsi-2312	219	33	2021	2021	NUM
ajmsi-2312	219	34	)	)	PUNCT
ajmsi-2312	219	35	.	.	PUNCT
ajmsi-2312	220	1	designing	design	VERB
ajmsi-2312	220	2	a	a	DET
ajmsi-2312	220	3	scoring	scoring	NOUN
ajmsi-2312	220	4	system	system	NOUN
ajmsi-2312	220	5	for	for	ADP
ajmsi-2312	220	6	differential	differential	ADJ
ajmsi-2312	220	7	diagnosis	diagnosis	NOUN
ajmsi-2312	220	8	from	from	ADP
ajmsi-2312	220	9	reactive	reactive	ADJ
ajmsi-2312	220	10	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	220	11	and	and	CCONJ
ajmsi-2312	220	12	essential	essential	ADJ
ajmsi-2312	220	13	thrombocytosis	thrombocytosis	NOUN
ajmsi-2312	220	14	.	.	PUNCT
ajmsi-2312	221	1	front	front	ADJ
ajmsi-2312	221	2	med	med	PROPN
ajmsi-2312	221	3	(	(	PUNCT
ajmsi-2312	221	4	lausanne	lausanne	PROPN
ajmsi-2312	221	5	)	)	PUNCT
ajmsi-2312	221	6	,	,	PUNCT
ajmsi-2312	221	7	8	8	NUM
ajmsi-2312	221	8	,	,	PUNCT
ajmsi-2312	221	9	736150	736150	NUM
ajmsi-2312	221	10	.	.	PUNCT
ajmsi-2312	222	1	https://doi.org/10.3389/	https://doi.org/10.3389/	PROPN
ajmsi-2312	222	2	fmed.2021.736150	fmed.2021.736150	PROPN
ajmsi-2312	222	3	srour	srour	NOUN
ajmsi-2312	222	4	,	,	PUNCT
ajmsi-2312	222	5	s.	s.	PROPN
ajmsi-2312	222	6	a.	a.	PROPN
ajmsi-2312	222	7	,	,	PUNCT
ajmsi-2312	222	8	devesa	devesa	PROPN
ajmsi-2312	222	9	,	,	PUNCT
ajmsi-2312	222	10	s.	s.	PROPN
ajmsi-2312	222	11	s.	s.	PROPN
ajmsi-2312	222	12	,	,	PUNCT
ajmsi-2312	222	13	morton	morton	PROPN
ajmsi-2312	222	14	,	,	PUNCT
ajmsi-2312	222	15	l.	l.	PROPN
ajmsi-2312	222	16	m.	m.	PROPN
ajmsi-2312	222	17	,	,	PUNCT
ajmsi-2312	222	18	check	check	NOUN
ajmsi-2312	222	19	,	,	PUNCT
ajmsi-2312	222	20	d.	d.	PROPN
ajmsi-2312	222	21	p.	p.	PROPN
ajmsi-2312	222	22	,	,	PUNCT
ajmsi-2312	222	23	curtis	curtis	PROPN
ajmsi-2312	222	24	,	,	PUNCT
ajmsi-2312	222	25	r.	r.	PROPN
ajmsi-2312	222	26	e.	e.	PROPN
ajmsi-2312	222	27	,	,	PUNCT
ajmsi-2312	222	28	linet	linet	PROPN
ajmsi-2312	222	29	,	,	PUNCT
ajmsi-2312	222	30	m.	m.	NOUN
ajmsi-2312	222	31	s.	s.	PROPN
ajmsi-2312	222	32	,	,	PUNCT
ajmsi-2312	222	33	&	&	CCONJ
ajmsi-2312	222	34	dores	dores	PROPN
ajmsi-2312	222	35	,	,	PUNCT
ajmsi-2312	222	36	g.	g.	PROPN
ajmsi-2312	222	37	m.	m.	PROPN
ajmsi-2312	222	38	(	(	PUNCT
ajmsi-2312	222	39	2016	2016	NUM
ajmsi-2312	222	40	)	)	PUNCT
ajmsi-2312	222	41	.	.	PUNCT
ajmsi-2312	223	1	incidence	incidence	NOUN
ajmsi-2312	223	2	and	and	CCONJ
ajmsi-2312	223	3	patient	patient	ADJ
ajmsi-2312	223	4	survival	survival	NOUN
ajmsi-2312	223	5	of	of	ADP
ajmsi-2312	223	6	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	223	7	neoplasms	neoplasm	NOUN
ajmsi-2312	223	8	and	and	CCONJ
ajmsi-2312	223	9	myelodysplastic	myelodysplastic	ADJ
ajmsi-2312	223	10	/	/	SYM
ajmsi-2312	223	11	myeloproliferative	myeloproliferative	ADJ
ajmsi-2312	223	12	neoplasms	neoplasm	NOUN
ajmsi-2312	223	13	in	in	ADP
ajmsi-2312	223	14	the	the	DET
ajmsi-2312	223	15	united	united	PROPN
ajmsi-2312	223	16	states	states	PROPN
ajmsi-2312	223	17	,	,	PUNCT
ajmsi-2312	223	18	2001	2001	NUM
ajmsi-2312	223	19	-	-	SYM
ajmsi-2312	223	20	12	12	NUM
ajmsi-2312	223	21	.	.	PUNCT
ajmsi-2312	224	1	br	br	PROPN
ajmsi-2312	224	2	j	j	PROPN
ajmsi-2312	224	3	haematol	haematol	NOUN
ajmsi-2312	224	4	,	,	PUNCT
ajmsi-2312	224	5	174(3	174(3	NUM
ajmsi-2312	224	6	)	)	PUNCT
ajmsi-2312	224	7	,	,	PUNCT
ajmsi-2312	224	8	382	382	NUM
ajmsi-2312	224	9	-	-	SYM
ajmsi-2312	224	10	396	396	NUM
ajmsi-2312	224	11	.	.	PUNCT
ajmsi-2312	225	1	https://doi.org/10.1111/bjh.14061	https://doi.org/10.1111/bjh.14061	PROPN
ajmsi-2312	225	2	tefferi	tefferi	PROPN
ajmsi-2312	225	3	,	,	PUNCT
ajmsi-2312	225	4	a.	a.	NOUN
ajmsi-2312	225	5	,	,	PUNCT
ajmsi-2312	225	6	&	&	CCONJ
ajmsi-2312	225	7	barbui	barbui	ADJ
ajmsi-2312	225	8	,	,	PUNCT
ajmsi-2312	225	9	t.	t.	PROPN
ajmsi-2312	225	10	(	(	PUNCT
ajmsi-2312	225	11	2017	2017	NUM
ajmsi-2312	225	12	)	)	PUNCT
ajmsi-2312	225	13	.	.	PUNCT
ajmsi-2312	226	1	polycythemia	polycythemia	NOUN
ajmsi-2312	226	2	vera	vera	NOUN
ajmsi-2312	226	3	and	and	CCONJ
ajmsi-2312	226	4	essential	essential	ADJ
ajmsi-2312	226	5	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	226	6	:	:	PUNCT
ajmsi-2312	226	7	2017	2017	NUM
ajmsi-2312	226	8	update	update	NOUN
ajmsi-2312	226	9	on	on	ADP
ajmsi-2312	226	10	diagnosis	diagnosis	NOUN
ajmsi-2312	226	11	,	,	PUNCT
ajmsi-2312	226	12	risk	risk	NOUN
ajmsi-2312	226	13	-	-	PUNCT
ajmsi-2312	226	14	stratification	stratification	NOUN
ajmsi-2312	226	15	,	,	PUNCT
ajmsi-2312	226	16	and	and	CCONJ
ajmsi-2312	226	17	management	management	NOUN
ajmsi-2312	226	18	.	.	PUNCT
ajmsi-2312	226	19	am	be	AUX
ajmsi-2312	226	20	j	j	PROPN
ajmsi-2312	226	21	hematol	hematol	NOUN
ajmsi-2312	226	22	,	,	PUNCT
ajmsi-2312	226	23	92(1	92(1	NOUN
ajmsi-2312	226	24	)	)	PUNCT
ajmsi-2312	226	25	,	,	PUNCT
ajmsi-2312	226	26	94	94	NUM
ajmsi-2312	226	27	-	-	SYM
ajmsi-2312	226	28	108	108	NUM
ajmsi-2312	226	29	.	.	PUNCT
ajmsi-2312	227	1	https://doi.org/10.1002/ajh.24607	https://doi.org/10.1002/ajh.24607	PROPN
ajmsi-2312	227	2	tefferi	tefferi	PROPN
ajmsi-2312	227	3	,	,	PUNCT
ajmsi-2312	227	4	a.	a.	NOUN
ajmsi-2312	227	5	,	,	PUNCT
ajmsi-2312	227	6	&	&	CCONJ
ajmsi-2312	227	7	barbui	barbui	ADJ
ajmsi-2312	227	8	,	,	PUNCT
ajmsi-2312	227	9	t.	t.	PROPN
ajmsi-2312	227	10	(	(	PUNCT
ajmsi-2312	227	11	2020	2020	NUM
ajmsi-2312	227	12	)	)	PUNCT
ajmsi-2312	227	13	.	.	PUNCT
ajmsi-2312	228	1	polycythemia	polycythemia	NOUN
ajmsi-2312	228	2	vera	vera	NOUN
ajmsi-2312	228	3	and	and	CCONJ
ajmsi-2312	228	4	essential	essential	ADJ
ajmsi-2312	228	5	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	228	6	:	:	PUNCT
ajmsi-2312	228	7	2021	2021	NUM
ajmsi-2312	228	8	update	update	NOUN
ajmsi-2312	228	9	on	on	ADP
ajmsi-2312	228	10	diagnosis	diagnosis	NOUN
ajmsi-2312	228	11	,	,	PUNCT
ajmsi-2312	228	12	risk	risk	NOUN
ajmsi-2312	228	13	-	-	PUNCT
ajmsi-2312	228	14	stratification	stratification	NOUN
ajmsi-2312	228	15	and	and	CCONJ
ajmsi-2312	228	16	management	management	NOUN
ajmsi-2312	228	17	.	.	PUNCT
ajmsi-2312	229	1	am	be	AUX
ajmsi-2312	229	2	j	j	PROPN
ajmsi-2312	229	3	hematol	hematol	NOUN
ajmsi-2312	229	4	,	,	PUNCT
ajmsi-2312	229	5	95(12	95(12	NUM
ajmsi-2312	229	6	)	)	PUNCT
ajmsi-2312	229	7	,	,	PUNCT
ajmsi-2312	229	8	1599	1599	NUM
ajmsi-2312	229	9	-	-	SYM
ajmsi-2312	229	10	1613	1613	NUM
ajmsi-2312	229	11	.	.	PUNCT
ajmsi-2312	230	1	https://doi.org/10.1002/	https://doi.org/10.1002/	PROPN
ajmsi-2312	230	2	ajh.26008	ajh.26008	PRON
ajmsi-2312	230	3	tefferi	tefferi	ADJ
ajmsi-2312	230	4	,	,	PUNCT
ajmsi-2312	230	5	a.	a.	NOUN
ajmsi-2312	230	6	,	,	PUNCT
ajmsi-2312	230	7	lasho	lasho	VERB
ajmsi-2312	230	8	,	,	PUNCT
ajmsi-2312	230	9	t.	t.	PROPN
ajmsi-2312	230	10	l.	l.	PROPN
ajmsi-2312	230	11	,	,	PUNCT
ajmsi-2312	230	12	finke	finke	PROPN
ajmsi-2312	230	13	,	,	PUNCT
ajmsi-2312	230	14	c.	c.	PROPN
ajmsi-2312	230	15	m.	m.	PROPN
ajmsi-2312	230	16	,	,	PUNCT
ajmsi-2312	230	17	knudson	knudson	PROPN
ajmsi-2312	230	18	,	,	PUNCT
ajmsi-2312	230	19	r.	r.	PROPN
ajmsi-2312	230	20	a.	a.	PROPN
ajmsi-2312	230	21	,	,	PUNCT
ajmsi-2312	230	22	ketterling	ketterling	PROPN
ajmsi-2312	230	23	,	,	PUNCT
ajmsi-2312	230	24	r.	r.	PROPN
ajmsi-2312	230	25	,	,	PUNCT
ajmsi-2312	230	26	hanson	hanson	PROPN
ajmsi-2312	230	27	,	,	PUNCT
ajmsi-2312	230	28	c.	c.	PROPN
ajmsi-2312	230	29	h.	h.	PROPN
ajmsi-2312	230	30	,	,	PUNCT
ajmsi-2312	230	31	maffioli	maffioli	PROPN
ajmsi-2312	230	32	,	,	PUNCT
ajmsi-2312	230	33	m.	m.	NOUN
ajmsi-2312	230	34	,	,	PUNCT
ajmsi-2312	230	35	caramazza	caramazza	PROPN
ajmsi-2312	230	36	,	,	PUNCT
ajmsi-2312	230	37	d.	d.	PROPN
ajmsi-2312	230	38	,	,	PUNCT
ajmsi-2312	230	39	passamonti	passamonti	PROPN
ajmsi-2312	230	40	,	,	PUNCT
ajmsi-2312	230	41	f.	f.	PROPN
ajmsi-2312	230	42	,	,	PUNCT
ajmsi-2312	230	43	&	&	CCONJ
ajmsi-2312	230	44	pardanani	pardanani	PROPN
ajmsi-2312	230	45	,	,	PUNCT
ajmsi-2312	230	46	a.	a.	NOUN
ajmsi-2312	230	47	(	(	PUNCT
ajmsi-2312	230	48	2014	2014	NUM
ajmsi-2312	230	49	)	)	PUNCT
ajmsi-2312	230	50	.	.	PUNCT
ajmsi-2312	231	1	calr	calr	PROPN
ajmsi-2312	231	2	vs	vs	ADP
ajmsi-2312	231	3	jak2	jak2	PROPN
ajmsi-2312	231	4	vs	vs	ADP
ajmsi-2312	231	5	mpl	mpl	PROPN
ajmsi-2312	231	6	-	-	PUNCT
ajmsi-2312	231	7	mutated	mutate	VERB
ajmsi-2312	231	8	or	or	CCONJ
ajmsi-2312	231	9	triplenegative	triplenegative	VERB
ajmsi-2312	231	10	myelofibrosis	myelofibrosis	NOUN
ajmsi-2312	231	11	:	:	PUNCT
ajmsi-2312	231	12	clinical	clinical	ADJ
ajmsi-2312	231	13	,	,	PUNCT
ajmsi-2312	231	14	cytogenetic	cytogenetic	ADJ
ajmsi-2312	231	15	and	and	CCONJ
ajmsi-2312	231	16	molecular	molecular	ADJ
ajmsi-2312	231	17	comparisons	comparison	NOUN
ajmsi-2312	231	18	.	.	PUNCT
ajmsi-2312	232	1	leukemia	leukemia	NOUN
ajmsi-2312	232	2	,	,	PUNCT
ajmsi-2312	232	3	28(7	28(7	NUM
ajmsi-2312	232	4	)	)	PUNCT
ajmsi-2312	232	5	,	,	PUNCT
ajmsi-2312	232	6	1472	1472	NUM
ajmsi-2312	232	7	-	-	SYM
ajmsi-2312	232	8	1477	1477	NUM
ajmsi-2312	232	9	.	.	PUNCT
ajmsi-2312	233	1	https://doi.org/10.1038/leu.2014.3	https://doi.org/10.1038/leu.2014.3	VERB
ajmsi-2312	233	2	tefferi	tefferi	ADJ
ajmsi-2312	233	3	,	,	PUNCT
ajmsi-2312	233	4	a.	a.	NOUN
ajmsi-2312	233	5	,	,	PUNCT
ajmsi-2312	233	6	&	&	CCONJ
ajmsi-2312	233	7	pardanani	pardanani	PROPN
ajmsi-2312	233	8	,	,	PUNCT
ajmsi-2312	233	9	a.	a.	NOUN
ajmsi-2312	233	10	(	(	PUNCT
ajmsi-2312	233	11	2019	2019	NUM
ajmsi-2312	233	12	)	)	PUNCT
ajmsi-2312	233	13	.	.	PUNCT
ajmsi-2312	234	1	essential	essential	ADJ
ajmsi-2312	234	2	thrombocythemia	thrombocythemia	NOUN
ajmsi-2312	234	3	.	.	PUNCT
ajmsi-2312	235	1	n	n	PROPN
ajmsi-2312	235	2	engl	engl	PROPN
ajmsi-2312	235	3	j	j	PROPN
ajmsi-2312	235	4	med	med	PROPN
ajmsi-2312	235	5	,	,	PUNCT
ajmsi-2312	235	6	381(22	381(22	NUM
ajmsi-2312	235	7	)	)	PUNCT
ajmsi-2312	235	8	,	,	PUNCT
ajmsi-2312	235	9	2135	2135	NUM
ajmsi-2312	235	10	-	-	SYM
ajmsi-2312	235	11	2144	2144	NUM
ajmsi-2312	235	12	.	.	PUNCT
ajmsi-2312	236	1	https://doi.org/10.1056/nejmcp1816082	https://doi.org/10.1056/nejmcp1816082	PROPN
ajmsi-2312	236	2	wang	wang	PROPN
ajmsi-2312	236	3	,	,	PUNCT
ajmsi-2312	236	4	w.	w.	PROPN
ajmsi-2312	236	5	c.	c.	PROPN
ajmsi-2312	236	6	,	,	PUNCT
ajmsi-2312	236	7	ware	ware	PROPN
ajmsi-2312	236	8	,	,	PUNCT
ajmsi-2312	236	9	r.	r.	PROPN
ajmsi-2312	236	10	e.	e.	PROPN
ajmsi-2312	236	11	,	,	PUNCT
ajmsi-2312	236	12	miller	miller	PROPN
ajmsi-2312	236	13	,	,	PUNCT
ajmsi-2312	236	14	s.	s.	PROPN
ajmsi-2312	236	15	t.	t.	PROPN
ajmsi-2312	236	16	,	,	PUNCT
ajmsi-2312	236	17	iyer	iyer	PROPN
ajmsi-2312	236	18	,	,	PUNCT
ajmsi-2312	236	19	r.	r.	PROPN
ajmsi-2312	236	20	v.	v.	PROPN
ajmsi-2312	236	21	,	,	PUNCT
ajmsi-2312	236	22	casella	casella	PROPN
ajmsi-2312	236	23	,	,	PUNCT
ajmsi-2312	236	24	j.	j.	PROPN
ajmsi-2312	236	25	f.	f.	PROPN
ajmsi-2312	236	26	,	,	PUNCT
ajmsi-2312	236	27	minniti	minniti	PROPN
ajmsi-2312	236	28	,	,	PUNCT
ajmsi-2312	236	29	c.	c.	PROPN
ajmsi-2312	236	30	p.	p.	PROPN
ajmsi-2312	236	31	,	,	PUNCT
ajmsi-2312	236	32	rana	rana	PROPN
ajmsi-2312	236	33	,	,	PUNCT
ajmsi-2312	236	34	s.	s.	PROPN
ajmsi-2312	236	35	,	,	PUNCT
ajmsi-2312	236	36	thornburg	thornburg	PROPN
ajmsi-2312	236	37	,	,	PUNCT
ajmsi-2312	236	38	c.	c.	PROPN
ajmsi-2312	236	39	d.	d.	PROPN
ajmsi-2312	236	40	,	,	PUNCT
ajmsi-2312	236	41	rogers	rogers	PROPN
ajmsi-2312	236	42	,	,	PUNCT
ajmsi-2312	236	43	z.	z.	PROPN
ajmsi-2312	236	44	r.	r.	PROPN
ajmsi-2312	236	45	,	,	PUNCT
ajmsi-2312	236	46	kalpatthi	kalpatthi	PROPN
ajmsi-2312	236	47	,	,	PUNCT
ajmsi-2312	236	48	r.	r.	PROPN
ajmsi-2312	236	49	v.	v.	PROPN
ajmsi-2312	236	50	,	,	PUNCT
ajmsi-2312	236	51	barredo	barredo	PROPN
ajmsi-2312	236	52	,	,	PUNCT
ajmsi-2312	236	53	j.	j.	PROPN
ajmsi-2312	236	54	c.	c.	PROPN
ajmsi-2312	236	55	,	,	PUNCT
ajmsi-2312	236	56	brown	brown	PROPN
ajmsi-2312	236	57	,	,	PUNCT
ajmsi-2312	236	58	r.	r.	PROPN
ajmsi-2312	236	59	c.	c.	PROPN
ajmsi-2312	236	60	,	,	PUNCT
ajmsi-2312	236	61	sarnaik	sarnaik	NOUN
ajmsi-2312	236	62	,	,	PUNCT
ajmsi-2312	236	63	s.	s.	PROPN
ajmsi-2312	236	64	a.	a.	PROPN
ajmsi-2312	236	65	,	,	PUNCT
ajmsi-2312	236	66	howard	howard	PROPN
ajmsi-2312	236	67	,	,	PUNCT
ajmsi-2312	236	68	t.	t.	PROPN
ajmsi-2312	236	69	h.	h.	PROPN
ajmsi-2312	236	70	,	,	PUNCT
ajmsi-2312	236	71	wynn	wynn	PROPN
ajmsi-2312	236	72	,	,	PUNCT
ajmsi-2312	236	73	l.	l.	PROPN
ajmsi-2312	236	74	w.	w.	PROPN
ajmsi-2312	236	75	,	,	PUNCT
ajmsi-2312	236	76	kutlar	kutlar	PROPN
ajmsi-2312	236	77	,	,	PUNCT
ajmsi-2312	236	78	a.	a.	PROPN
ajmsi-2312	236	79	,	,	PUNCT
ajmsi-2312	236	80	armstrong	armstrong	PROPN
ajmsi-2312	236	81	,	,	PUNCT
ajmsi-2312	236	82	f.	f.	PROPN
ajmsi-2312	236	83	d.	d.	PROPN
ajmsi-2312	236	84	,	,	PUNCT
ajmsi-2312	236	85	files	file	NOUN
ajmsi-2312	236	86	,	,	PUNCT
ajmsi-2312	236	87	b.	b.	PROPN
ajmsi-2312	236	88	a.	a.	PROPN
ajmsi-2312	236	89	,	,	PUNCT
ajmsi-2312	236	90	goldsmith	goldsmith	PROPN
ajmsi-2312	236	91	,	,	PUNCT
ajmsi-2312	236	92	j.	j.	PROPN
ajmsi-2312	236	93	c.	c.	PROPN
ajmsi-2312	236	94	,	,	PUNCT
ajmsi-2312	236	95	.	.	PUNCT
ajmsi-2312	236	96	.	.	PUNCT
ajmsi-2312	236	97	.	.	PUNCT
ajmsi-2312	237	1	thompson	thompson	PROPN
ajmsi-2312	237	2	,	,	PUNCT
ajmsi-2312	237	3	b.	b.	PROPN
ajmsi-2312	237	4	w.	w.	PROPN
ajmsi-2312	237	5	(	(	PUNCT
ajmsi-2312	237	6	2011	2011	NUM
ajmsi-2312	237	7	)	)	PUNCT
ajmsi-2312	237	8	.	.	PUNCT
ajmsi-2312	238	1	hydroxycarbamide	hydroxycarbamide	ADV
ajmsi-2312	238	2	in	in	ADP
ajmsi-2312	238	3	very	very	ADV
ajmsi-2312	238	4	young	young	ADJ
ajmsi-2312	238	5	children	child	NOUN
ajmsi-2312	238	6	with	with	ADP
ajmsi-2312	238	7	sickle	sickle	NOUN
ajmsi-2312	238	8	-	-	PUNCT
ajmsi-2312	238	9	cell	cell	NOUN
ajmsi-2312	238	10	anaemia	anaemia	NOUN
ajmsi-2312	238	11	:	:	PUNCT
ajmsi-2312	238	12	a	a	DET
ajmsi-2312	238	13	multicentre	multicentre	NOUN
ajmsi-2312	238	14	,	,	PUNCT
ajmsi-2312	238	15	randomised	randomise	VERB
ajmsi-2312	238	16	,	,	PUNCT
ajmsi-2312	238	17	controlled	control	VERB
ajmsi-2312	238	18	trial	trial	NOUN
ajmsi-2312	238	19	(	(	PUNCT
ajmsi-2312	238	20	baby	baby	NOUN
ajmsi-2312	238	21	hug	hug	NOUN
ajmsi-2312	238	22	)	)	PUNCT
ajmsi-2312	238	23	.	.	PUNCT
ajmsi-2312	239	1	lancet	lancet	PROPN
ajmsi-2312	239	2	,	,	PUNCT
ajmsi-2312	239	3	377(9778	377(9778	NUM
ajmsi-2312	239	4	)	)	PUNCT
ajmsi-2312	239	5	,	,	PUNCT
ajmsi-2312	239	6	1663	1663	NUM
ajmsi-2312	239	7	-	-	SYM
ajmsi-2312	239	8	1672	1672	NUM
ajmsi-2312	239	9	.	.	PUNCT
ajmsi-2312	240	1	https://doi.org/10.1016/	https://doi.org/10.1016/	PROPN
ajmsi-2312	240	2	s0140	s0140	PROPN
ajmsi-2312	240	3	-	-	PUNCT
ajmsi-2312	240	4	6736(11)60355	6736(11)60355	NUM
ajmsi-2312	240	5	-	-	PUNCT
ajmsi-2312	240	6	3	3	NUM
ajmsi-2312	240	7	wolanskyj	wolanskyj	ADV
ajmsi-2312	240	8	,	,	PUNCT
ajmsi-2312	240	9	a.	a.	NOUN
ajmsi-2312	240	10	p.	p.	PROPN
ajmsi-2312	240	11	,	,	PUNCT
ajmsi-2312	240	12	lasho	lasho	NOUN
ajmsi-2312	240	13	,	,	PUNCT
ajmsi-2312	240	14	t.	t.	PROPN
ajmsi-2312	240	15	l.	l.	PROPN
ajmsi-2312	240	16	,	,	PUNCT
ajmsi-2312	240	17	schwager	schwager	NOUN
ajmsi-2312	240	18	,	,	PUNCT
ajmsi-2312	240	19	s.	s.	PROPN
ajmsi-2312	240	20	m.	m.	PROPN
ajmsi-2312	240	21	,	,	PUNCT
ajmsi-2312	240	22	mcclure	mcclure	PROPN
ajmsi-2312	240	23	,	,	PUNCT
ajmsi-2312	240	24	r.	r.	PROPN
ajmsi-2312	240	25	f.	f.	PROPN
ajmsi-2312	240	26	,	,	PUNCT
ajmsi-2312	240	27	wadleigh	wadleigh	NOUN
ajmsi-2312	240	28	,	,	PUNCT
ajmsi-2312	240	29	m.	m.	NOUN
ajmsi-2312	240	30	,	,	PUNCT
ajmsi-2312	240	31	lee	lee	PROPN
ajmsi-2312	240	32	,	,	PUNCT
ajmsi-2312	240	33	s.	s.	PROPN
ajmsi-2312	240	34	j.	j.	PROPN
ajmsi-2312	240	35	,	,	PUNCT
ajmsi-2312	240	36	gilliland	gilliland	PROPN
ajmsi-2312	240	37	,	,	PUNCT
ajmsi-2312	240	38	d.	d.	PROPN
ajmsi-2312	240	39	g.	g.	PROPN
ajmsi-2312	240	40	,	,	PUNCT
ajmsi-2312	240	41	&	&	CCONJ
ajmsi-2312	240	42	tefferi	tefferi	ADJ
ajmsi-2312	240	43	,	,	PUNCT
ajmsi-2312	240	44	a.	a.	NOUN
ajmsi-2312	240	45	(	(	PUNCT
ajmsi-2312	240	46	2005	2005	NUM
ajmsi-2312	240	47	)	)	PUNCT
ajmsi-2312	240	48	.	.	PUNCT
ajmsi-2312	241	1	jak2	jak2	PROPN
ajmsi-2312	241	2	mutation	mutation	NOUN
ajmsi-2312	241	3	in	in	ADP
ajmsi-2312	241	4	essential	essential	ADJ
ajmsi-2312	241	5	thrombocythaemia	thrombocythaemia	NOUN
ajmsi-2312	241	6	:	:	PUNCT
ajmsi-2312	241	7	clinical	clinical	ADJ
ajmsi-2312	241	8	associations	association	NOUN
ajmsi-2312	241	9	and	and	CCONJ
ajmsi-2312	241	10	long	long	ADJ
ajmsi-2312	241	11	-	-	PUNCT
ajmsi-2312	241	12	term	term	NOUN
ajmsi-2312	241	13	prognostic	prognostic	ADJ
ajmsi-2312	241	14	relevance	relevance	NOUN
ajmsi-2312	241	15	.	.	PUNCT
ajmsi-2312	242	1	br	br	PROPN
ajmsi-2312	243	1	j	j	PROPN
ajmsi-2312	243	2	haematol	haematol	NOUN
ajmsi-2312	243	3	,	,	PUNCT
ajmsi-2312	243	4	131(2	131(2	NUM
ajmsi-2312	243	5	)	)	PUNCT
ajmsi-2312	243	6	,	,	PUNCT
ajmsi-2312	243	7	208	208	NUM
ajmsi-2312	243	8	-	-	SYM
ajmsi-2312	243	9	213	213	NUM
ajmsi-2312	243	10	.	.	PUNCT
ajmsi-2312	244	1	https://doi.org/10.1111/j.1365-2141.2005.05764.x	https://doi.org/10.1111/j.1365-2141.2005.05764.x	PROPN